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Abstract
Tissue engineering aims to replace diseased or damaged tissue, one approach for which is to
implant cells and a scaffold developed in vitro. One of the engineering challenges is the design
of the cell-material interface. Cells respond to a wide range of signals from their substrate,
which can be used to control cell behaviour and improve the properties of the implant. Of
particular interest to regenerative medicine is that substrate properties can influence stem cell
self-renewal and differentiation. This thesis aimed to first better understand how substrate
properties such as chemical composition and topography affect stem cell behaviour. For this,
two substrates were studied: one with micrometre scale topography, and one with varying
chemical composition and nanometre scale topography, for their effect on murine embryonic
stem cell (ESC) self-renewal and early differentiation. On micrometre scale topography, the
first example of central pit formation due to substrate cues was observed, and the substrates
mitigated endoderm specification. On nanometre scale topography, ESC early differentiation
markers were diminished, and both substrate topography and chemical composition affected
cell behaviour. Then attention was shifted to how biological cues from the substrate, such as
ligands specific to cell surface receptors, could guide stem cell chondrogenic differentiation.
In that study, the changing adhesion requirements of human mesenchymal stem cells were
studied in the form of integrin transcript expression and finally, the role of one specific in-
tegrin was shown to affect chondrogenic differentiation in vitro. This was the first complete
characterisation of integrin expression and the first demonstration of the role of integrin αvβ8
in chondrogenic differentiation. Overall, these results improve the understanding of how stem
cells respond to substrate cues, including some of the crucial cues they require in differentia-
tion, and could therefore be used to improve the design of tissue engineering scaffolds.
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Scope of the Thesis
Tissue engineering is a maturing field, which has begun to design scaffolds to specifically
incorporate cues known to guide cell behaviour. However, little is known about the effects
of many of these cues, particularly on stem cell differentiation. In the case of chondrogenic
differentiation, where peptide adhesion ligands are used to improve cell attachment and be-
haviour, little is known about the adhesion requirements of mesenchymal stem cells as they
become chondrocytes. This thesis is concerned with the cues stem cells receive and require
from their substrates and overall, it aims to inform the design of tissue engineered scaffolds.
In Chapter 1, the current state of the art in tissue engineering is introduced, opening with
commentary on its recent progress and on the evolution of scaffold design. As it becomes
apparent that understanding cell-substrate interactions is crucial to successful tissue engineer-
ing, both the extracellular matrix and cell-surface receptors are introduced, as background to
Chapters 4 and 5, where the role of integrins in chondrogenic differentiation is studied. Since
many tissue engineering approaches involve the use of embryonic or adult stem cells as a cell
source, these cell types are also introduced and relate to Chapters 2-5, where both embryonic
and mesenchymal stem cells are studied. Then two major classes of cell-substrate interac-
tions are reviewed: the cell response to artificial, or physical, substrate cues and to biological
substrate cues. The former refers to bulk substrate properties such as chemical composition,
mechanical properties, or topographical features, while the latter refers to soluble factors and
signalling from insoluble proteins and peptides. In light of the wide range of topics covered
in this thesis, much of the literature specific to each chapter is included at the start of the
respective chapter rather than in this more general introduction.
In Chapter 2, the effects of micrometre scale topography on murine embryonic stem cell
(ESC) differentiation and morphology were studied. A materials science approach was used
to fabricate substrates comprising closely-packed silica colloidal crystal microspheres. Stem
cells were grown without differentiation inhibitors and their morphology was examined with
scanning electron microscopy, light microscopy, and white light interferometry. Upon see-
ing morphological changes, quantitative PCR was used to probe genes central to stem cell
maintenance, semi-quantitative PCR was used to determine lineage commitment, and im-
munofluorescence examined a hypothesis about a developmental event. The findings in this
chapter relate to one of the major aims of tissue engineering reviewed in Chapter 1, which is
to mediate differentiation with substrate cues rather than soluble growth factors.
5
In Chapter 3, the effects of nanometre scale topography and bulk chemical composition on
murine embryonic stem differentiation were studied. This followed from Chapter 2, where
micrometre scale topography had a profound effect on stem cell morphology and differen-
tiation. Until this study, the effects of < 5 nm topography had not been seen, nor had a
system decoupling the effects of chemical composition and topography on embryonic stem
cells been used. Monolayer-protected metal nanoparticles were synthesised and characterised,
after which they were covalently assembled into a bulk substrate. Stem cell proliferation was
observed with BrdU uptake and the genes central to stem cell maintenance were measured by
quantitative PCR. Oct4 localisation was determined by immunofluorescence, and finally, lin-
eage commitment was assessed by semi-quantitative PCR. The results extended the size range
in which stem cells are known to respond to topographical cues, following from Chapter 2,
and also gave insight into how topography and chemical composition may work synergistically
to influence stem cell behaviour.
Chapter 4 was inspired by the latter part of Chapter 1, which introduces how biological cues
can guide cell behaviour for cartilage tissue engineering. The idea for the experiment came
from the observation that many groups aim to replicate normal developmental processes to
improve tissue formation for cartilage tissue engineering, yet there is a lack of knowledge of
the signals cells receive in chondrogenic differentiation. To answer this dearth of knowledge,
this study characterised the changing integrin expression of mesenchymal stem cells as they
underwent chondrogenic differentiation in three different models of in vitro chondrogenesis.
Quantitative PCR was used to probe expression of 14 integrin subunits and eight phenotype
markers. Their expression was followed over the time-course of differentiation, and the effects
of medium composition and chondrogenesis model were also studied. This work represents
the first comprehensive study of integrin expression in multiple chondrogenic differentiation
models. It achieved one of the major aims of the thesis, which was to inform the design of
tissue engineering scaffolds.
In Chapter 5, the role of one of the integrins found to be up-regulated in chondrogenesis
in Chapter 4 is further investigated. Integrin αvβ8 is known to be involved in the activation
of insoluble TGF-β, yet its role in chondrogenic differentiation or in mesenchymal stem cells
was previously unknown. Lentiviral shRNA was used to knockdown ITGB8 , and the effect
of the knockdown on phenotype markers related to chondrogenesis and on the other integrin
subunits was established with quantitative PCR.
Finally, Chapter 6 summarises the major findings of the thesis and goes on to discuss
future work. Additionally, it aims to provide a wider context for the research, establishing its
contribution to regenerative medicine and tissue engineering.
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1. INTRODUCTION
1.1 Tissue engineering
1.1.1 Commentary on an emerging field
Tissue engineering is an interdisciplinary field that aims to generate biological replacements for medical
conditions involving tissue loss or disease. Its definition has changed over time, but here, it will be
considered to refer to the use of a combination of cells and a scaffold to replace tissue or induce its
formation. The scope of the field reflects the vast clinical need, with recent efforts yielding therapies
directed towards virtually every tissue and organ in the body. The evolution of the paradigm of tissue
engineering will be highlighted in the next section, but it should suffice to say that it remains an emerging
field with great promise and ambitious goals, but daunting challenges to match.
The clinical need for tissue replacements is immense and on the rise with an increasingly older popula-
tion encountering the conditions that comprise the targets for tissue engineering, such as cardiovascular
disease, osteoarthritis, and diabetes. A parallel increase in the expectations for health and mobility in
the ageing population has, unfortunately, been met with rather meek clinical outcomes of the tissue
engineered products to date. However, recent years have shown incredible promise and many researchers
consider it a reasonable reality that physicians and surgeons will soon have access to tissue replacements
sent from a laboratory rather than the organ donor pool.
For many years, the gold standard for tissue replacement has been the autograft— the transplantation
of a tissue from one part of the patient’s body to another. Although this procedure has well-documented
problems with donor site morbidity, increased number of surgical procedures, and longer recovery periods,
it is a good option for some of the tissues found in relative excess, such as bone and skin. However, even
with these examples, it is easy to imagine scenarios where autografts are not an option. Other alternatives
such as allografts, which is the transplantation from another patient or cadaver, are commonly employed
in organ donation. And yet, the clinical need vastly outnumbers the availability of donor organs and
there remains a risk of rejection.
Tissue engineered tissue and organs could potentially be available in nearly unlimited supply and should
they incorporate the patient’s own cells, could mitigate the need for immunosuppressive therapy fol-
lowing surgery. The current paradigm involves some sort of supportive scaffold, cells with a desired
phenotype, and both soluble and insoluble cues. The scaffold should have specific structural, chemical,
mechanical, and biological functions to aid in tissue development. This comprises a major challenge of
tissue engineering— scientists are being asked to develop a single material to replicate millions of years
of evolution and the complex environment of development.
One can imagine the daunting nature of designing a scaffold to guide cells to become a functioning tissue.
It seems that just about every material property studied has an effect on cell behaviour and when also
considering soluble factors, the number of potential combinations to try is prohibitively large. Therefore,
there is an immense need for more systematic studies into how external cues can drive cell behaviour.
With more of this information, tissue engineers can begin to rationally design materials, and hopefully
patients can begin to experience more benefits from this line of research.
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1.1.2 Evolution of scaffold design
The three major components of a tissue engineered construct— cell type, biological factors, and scaffold
material have all been widely studied and reviewed.1 In the case of the cell type and biological factors,
it is mainly a scientific endeavour, requiring experiments to form an understanding of cell signalling and
developmental biology. For the scaffold design, however, it is more a matter of paradigm and philosophy
and this section aims to highlight the progression of paradigms that emerged from a better understanding
of cell-substrate and cell-extracellular matrix (ECM) interactions.
1.1.2.1 First and second generation
In the earliest attempts at tissue engineering, researchers used readily available materials that were either
serendipitously found to be suitable for biomedical applications or passed biocompatibility tests. This
was in the era before a basic understanding of the immune system existed and so there was a great deal
of trial and error but nonetheless, a selection of materials were found to be non-toxic and could be used
as implants. Examples from this era include vanadium steel and titanium for orthopaedic implants. The
key to these materials was not their activity in the body, but rather their inertness and the emphasis
was simply to replace a tissue with a material. This soon gave way to the notion that cells should be
incorporated in the material or it should at least actively promote desirable cell behaviour.
The second generation was represented by a paradigm shift from aiming for inertness to aiming for activity.
The notion of osteoinduction and osteoconduction in the field of bone and dental implants was a key
example of this thinking. Bioactive glasses and ceramics based on hydroxyapatite were routinely used to
promote implant fixation through osteoconduction.2 When they were included as implant coatings, bone
would integrate into the coating and improve their fixation. A second example of activity is in the form
of implant resorption, an example of which is the development of polymers that underwent controlled
degradation and had clinically relevant degradation times. Selecting the composition of the hydrolytically
degradable copolymer of polylactic and polyglycolic acid (poly(lactic-co-glycolic acid)) permitted tailoring
of the material strength and degradation rates.3 By the mid-1980s, resorbable sutures were routinely used,
and scientists had started considering how controlled degradation could improve drug delivery. In the
early 1990s, the first human to receive a tissue engineering implant was a patient with Poland syndrome,
a rare birth defect resulting in a deformed rib cage and absence of a sternum. A synthetic polyglycolic
acid scaffold seeded with autologous chondrocytes was incubated in a bioreactor and implanted in place
of the missing sternum.4
1.1.2.2 Third generation
The third generation of scaffold design was characterised by its aim of mimicking the properties and,
crucially, the role of the natural ECM. This was implemented by the incorporation of biological cues in
tissue engineering scaffolds. There was not an entirely linear progression to the third generation as some
groups had been incorporating collagen and glycosaminoglycans into sheets for skin tissue engineering as
early as the 1970s, but nonetheless, it was a major change in the way of thinking.
The era began with some early studies demonstrating improved cell behaviour due to the inclusion of
bioactive molecules such as growth factors into scaffolds. This was where the field began to take what was
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known from biology and attempt to exploit that information for regenerative medicine. In one elegant
early example of tissue engineering inspired by development, some of the signals known to promote an-
giogenesis were incorporated in the design of a porous poly(lactide-co-glycolide) (PLG) scaffold.5 VEGF
(vascular endothelial growth factor) and PDGF (platelet-derived growth factor) are temporally regulated
in angiogenesis. VEGF was encapsulated in polymer particles and was released at high concentrations
over the first week and lower concentrations thereafter, resulting in a dense vasculature of immature
vessels. Then PDGF release from PLG microspheres was sustained over a period of weeks and it sub-
sequently promoted mature vessel formation. An interesting outcome of the study was that release of
either growth factor alone, or of one after the other, resulted in inferior angiogenesis. And so began an
onslaught of scaffolds with designs based on endogenous cell function or on knowledge of development.
The discovery published in 1984 that RGD (arginine-glycine-aspartic acid), a tripeptide derived from
fibronectin, could support integrin-mediated cell attachment as well as full length fibronectin resulted
in an enormous effort to simplify the ECM down to its minimally active components.6 At the time of
publication, integrins had not been identified, but by the time the field of biomaterials became interested
in using peptides to control cell behaviour, integrins were highly studied and known to be involved in
diverse cell signalling roles. The theme in the era of third generation biomaterials was of simplicity. Two
growth factors controlling angiogenesis, three amino acids controlling cell adhesion, the incorporation of
a cell-cleavable sequence to promote migration,7 and the use of substrate stiffness to differentiate stem
cells,8 all demonstrated remarkable elegance and simplicity. While there were many successful advances,
some of which will be highlighted in the sections to follow, many designs were falling short on clinical
success. This paved the way to most recent paradigm shift in scaffold design: the incorporation of
complexity.
1.1.2.3 Fourth generation and the future
In order to generate heterogenous structures, such as organs, it became clear that more signals would have
to be incorporated in a more complex scaffold. One of the major innovations was the idea of a top-down
approach, resulting in a technique known as decellularisation of whole organs. This approach removes
all of the immunogenic cell material from an organ that is otherwise unsuitable for transplantation,
while maintaining the ECM structure and components, and then in a process called recellularisation, the
scaffold is seeded with patient-derived cells. Following a maturation step, often involving some type of
bioreactor, the organ is then ready for implantation.
There are a number of successful examples of decellularised organs for tissue engineering. The idea
itself dates back to the 1960s, when bone matrix was demineralised and decellularised and then the
remaining ECM components were found to induce bone formation in an ectopic location.9 The previously
unknown bone morphogenetic proteins (BMPs) were discovered in that experiment and bone formation
was attributed to their presence in the decellularised ECM. More recently, a rat heart was successfully
decellularised by perfusion of detergent and recellularised by perfusion of endothelial and cardiac cells.10
The ECM components and architecture were preserved and the recellularised construct was beating and
drug responsive after one week in culture. The vascular network never reached maturation but this study
was nonetheless an important step towards generating donor organs. A similar approach was used on rat
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liver.11 As with the heart, the perfusion protocol maintained the architecture of the vascular network,
enabling the decellularised construct to be connected to the host vasculature. By now, most organs have
undergone a similar treatment, including the lung,12 kidney,13 and many others. A landmark in tissue
engineering was achieved in 2009 when a patient was transplanted with a donor trachea that had been
decellularised and recellularised using the patient’s mesenchymal stem cells that had been differentiated in
a bioreactor.14 While the trachea is a relatively simple tissue, it nonetheless demonstrated the feasibility
of whole organ decellularisation.
Whole organ decellularisation is just one example of the increasing complexity in scaffold design. Re-
searchers are now coming to terms with developmental processes and are understanding that both tempo-
ral and spatial control is required for cell differentiation. Attempting to replicate development has led to
some of the most exciting advances in recent years. Yoshiki Sasai and his group were able to coax neural
stem cells derived from embryonic stem cells to form optic cups by carefully replicating some of the organ-
isation present in development.15 Furthermore, high-throughput screening techniques are being used to
generate vast amounts of information about cell-ECM interactions and the effects of small biomolecules.
Combining native ECM, developmental programmes, and specific cues will no doubt continue to improve
the outcomes of tissue engineering scaffolds.
1.2 The extracellular matrix
Cells in vivo are surrounded by a complex variety of proteins and proteoglycans called the extracellular
matrix (ECM). As described in the previous section, understanding and replicating the ECM is a decisive
parameter in tissue engineering. Whilst it was once considered merely a packing material for the cells,
the ECM is now unequivocally known to be important in virtually every aspect of cell behaviour. It is
crucial for the survival of adherent cells and for tissue development in embryogenesis, as emphasised by
the profound loss of function phenotypes of ECM components.16,17 The characteristics of the ECM are
what give tissues and organs distinct physical properties, such as strength and elasticity.18
There are hundreds of ECM proteins in vertebrates. They are large and complex, containing distinct
domains, and are highly evolutionarily conserved.19 ECM components can be divided into large families:
glycosaminoglycans (GAGs), proteoglycans, collagens, and non-collagenous glycoproteins. Together, they
give the ECM enormous complexity in both structure and function.
GAGs are linear, unbranched polysaccharides of a repeating disaccharide unit comprising a hexosamine
and a uronic acid. The individual members of this family are defined by their abundant side groups (car-
boxyl, hydroxyl, sulphate, etc.), which confer a net negative charge to the molecule, attracting sodium
ions and drawing water into the interstitial spaces between chains. In addition to the mechanical prop-
erties resulting from the swelling, GAGs can promote cell invasion and migration. All except hyaluronan
exist in sulphated forms and are covalently linked to core proteins to form large proteoglycans. Hyaluro-
nan is not exempt from assembly, however, and is known to interact with proteoglycan aggregates in the
formation of the pericellular matrix.
Collagens are the most abundant proteins in animals. There are 28 known types, all trimeric, and
comprising 49 distinct α chains. The three α chains in each type of collagen contain helical regions of
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peptides in the form Gly-X-Y, where X and Y can be any amino acid but are frequently proline and
hydroxyproline, respectively.20 On either side of the helical regions are the non-collagenous domains.
The collagen family can be broadly divided into fibrillar and non-fibrillar collagens but there are also
network-forming and transmembrane collagens, among others. Their most conserved role is in limiting
tissue distension, a property achieved by their tensile strength, but they also control cell adhesion, support
migration, and direct morphogenesis. Tissues usually have one dominant type of collagen (for example,
type II in hyaline articular cartilage) but there is often a mixture of more than one type.
The non-collagenous glycoproteins, include families of fibronectin, laminin, elastin, tenascin, and many
others. Fibronectin is the product of a single gene but alternative splicing results in at least 20 variations
in humans.21 It typically exists as a dimer, where each monomer consists of three subunits (I, II, and III)
known as fibronectin repeats. The protein is composed of 12 type I repeats, two type II repeats, and 15-17
type III repeats. There are two sources of fibronectin: the soluble form is synthesised by hepatocytes
and is found at high concentrations in plasma, and the insoluble form is synthesised by local cells for
their ECM. Like collagen, fibronectin has a structural role, but it is mainly known for its cell binding
properties. In addition to binding integrins (particularly through the well known RGD and PHSRN
sites), it binds heparin, collagen, and fibrin. Laminin is the first ECM protein detected in embryogenesis
and is later found as the major component of basement membranes and in the ECM.22–24 There are 16
known trimers in mouse and human, comprising α, β, and γ chains. They are very large (from ∼400–900
kDa), T-shaped proteins that can be cleaved by proteolytic enzymes into smaller fragments. Similar to
fibronectin, the major cell receptors are integrins but it also interacts with other glycoproteins. Elastin
fibres confer recoil to tissues that undergo stretching, such as skin and vascular tissue, and the tenascin
family is involved in embryogenesis and wound healing.25,26
The glycosaminoglycans, proteoglycans, collagens, and non-collagenous glycoproteins all play a role in
the structural integrity of the tissue and how it responds to physical forces. Mechanotransduction is
the ability of a cell to turn physical forces into biochemical cues. The way the cell responds to forces is
highly studied and well-reviewed.27–30 The ECM has an important role in mediating the physical forces
transmitted to a cell and the cell-ECM interactions are where the signalling initiates. Physical stresses
can cause conformational changes in proteins and the mechanical release of soluble molecules within the
ECM. Cells in vivo do not function independently, but are coordinated by their surrounding ECM to
form both cell-ECM and cell-cell contacts to act as a unit in response to force.31
The structural role of the ECM is clear, but its biological role in sequestering and releasing growth
factors is still being understood. It is capable of establishing gradients of growth factors, which can guide
developmental processes involving patterning. An example is the binding of growth factors to heparin
and heparan sulphate, found in many ECM proteoglycans. Release and activation of the growth factors
is by ECM or glycosaminoglycan degradation. Beyond acting as a growth factor reservoir, the ECM can
also coordinate the binding of growth factors and a coreceptor. Two well-studied examples of this are
the binding of FGF to FGFR (its receptor), which requires simultaneous binding to a heparan sulphate
chain and effectively generates a FGF-FGFR dimer on the cell surface, and the binding of TGF-β to its
ligands, which requires proteoglycans to coordinate the ligand presentation.32,33
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In terms of its role in tissue engineering, the ECM can provide inspiration for both the physical and the
biological properties of scaffolds and materials to control cell fate. The elasticity and compression moduli
can be measured and mimicked, as can the topographical features, such as alignment of collagen fibres
in the cornea or the nanometre scale proteins that decorate the villa and crypts of the small intestine.
Its biological properties can be mimicked by designing materials with the same ECM components, or
by using growth factor sequestering molecules, such as heparan sulphate and heparan sulphate-binding
peptides to mimic the native presentation of proteins.
1.2.1 Extracellular matrix receptors
The importance of the ECM is unquestionable and therefore cells need a reliable way to interact with its
physical and chemical properties. Cells can sense the ECM indirectly, but signalling is mainly through
ECM receptors. These can be divided into non-integrin receptors and integrins (the latter are more
thoroughly introduced in Chapter 4). In addition to these receptors, the cell surface contains a dizzying
array of lipids, proteins, and carbohydrates, all of which can act as ECM receptors.34 The membrane
proteins can account for over a third of the cell surface area. The glycocalyx, the polysaccharide layer
conjugated to many membrane lipids, coats the cell membrane and can extend over 200 nm in the case
of an endothelial cell. A schematic of the cell surface is shown in Figure 1.1.
1 µm
10 nm
Glycocalyx
Cell membrane
Figure 1.1: A representation of the cell surface. A 10 nm area of a red blood cell, showing lipids (pink),
membrane proteins (blue), and carbohydrates (orange). There can be more than 30,000 membrane
proteins per 1 µm2, through which most cell-ECM and cell-substrate interactions occur. Adapted from
Mager et al.34
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The non-integrin receptors are proteoglycans, CD36, and some laminin-binding proteins. The proteogly-
cans are the most studied, in particular CD44 and syndecan. CD44 is a glycoprotein on the cell surface
that binds type I and IV collagen and hyaluronan. Its receptor affinity is regulated through posttransla-
tional modifications, and can exist in a soluble form following enzymatic modification of the cell surface.35
In its role as a transmembrane molecule, it is important in cell-cell adhesion, cell-matrix adhesion, signal
transduction, pericellular matrix assembly, and hyaluronan metabolism. In mammals, the syndecans are
a family of four proteoglycans comprising a cytosolic domain, a hydrophobic transmembrane domain,
and an extracellular domain.36 Syndecans usually contain heparan sulphate chains and sometimes con-
tain chondroitin sulphate chains. All syndecans interact with actin and have an additional role in binding
matrix glycoproteins and collagens along with integrins. In some cases, syndecans and integrins bind the
same ECM protein, thereby triggering multiple signalling pathways.
One of the goals of tissue engineering is to target ECM receptors to activate specific signalling pathways
and obtain a desired cell response. Surfaces can be designed to contain the ligands for ECM receptors.
These ligands can either be the full length molecules covalently or otherwise attached to the substrate,
or derivations of the molecules (for example, peptides from ECM proteins) containing the cell binding
domains. The integrin ligands are introduced in Chapter 4, but substrates can also include molecules to
target immunoglobulins, lectins, and syndecans. Figure 1.2 demonstrates some of ligand-receptor pairs
for cell adhesion and signalling. In all cases, design factors such as orientation, spacing, and tether length
can affect binding. These interactions are reviewed by Juliano et al. in greater detail.37
Protein–peptide interactions Protein/peptide–carbohydrate interactions
Cyclic RGD peptide NCAM peptide Galactose Heparan-sulphate 
binding domains
Integrin Immunoglobulin Lectin Syndecan
Figure 1.2: A representation of the diversity of cell surface receptors available for binding to substrates.
Integrins and immunoglobulins are proteins that can bind peptides derived from ECM proteins (RGD:
the Arg-Gly-Asp tripeptide, NCAM: neural cell adhesion molecule). Lectins are proteins that bind
sugars, such as galactose. Syndecans can bind peptides via either their protein or carbohydrate domains.
Adapted from Mager et al.34
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1.3 Stem cells
Stem cells have two unique properties: they can self-renew for prolonged periods (or even indefinitely)
and they can give rise to adult cell types. In addition to their role in development, they are involved in
the repair of adult tissue, though the extent to which this happens is highly dependent on the tissue.
Typically, stem cells were classified as either embryonic or adult, but as of 2006, induced pluripotent
stem cells comprise a third classification. Despite these definitions and classifications, our understanding
of what comprises a stem cell and how they might be used in both basic research and clinical therapies
is constantly evolving.
Stem cells proliferate through symmetric division and self-renew or differentiate through asymmetric divi-
sion. These two processes are tightly regulated and are influenced by the stem cell niche and biomolecules.
In mammalian self-renewal, however, asymmetric division is not restricted to always producing one stem
cell and one committed daughter. Rather, asymmetric division occurs on a population-wide level and in
the case of a single stem cell, there is simply a probability of producing either stem or daughter cells.
Furthermore, there is continuum between stem cells and committed progenitors in some tissues.38
Tissue engineers are interested in stem cells for two major reasons. First, they can solve the problem of
cell availability. With the right cues, stem cells can be differentiated into any cell type, whereas in the
case of many organs or tissues, we lack a reservoir of extra adult cells. This may also overcome challenges
associated with immune recognition though some doubt has recently been cast on this notion. Secondly,
many scientists believe that giving cells the opportunity to mature in situ, or in their local environment,
produces a more stable phenotype, so would prefer to use stem cells and replicate developmental events
over starting with adult cells.
1.3.1 Embryonic stem cells
Embryonic stem cells (ESCs) are derived from the inner cell mass of the preimplantation blastocyst.39
In mice, the blastocyst stage is 3.5 days after fertilisation, while in humans it is 4-5 days. In normal
development, these cells would go on to generate the over 200 cell types found in an adult. However, upon
isolation, they can be cultured in vitro for prolonged periods and with the correct cues, can maintain
their developmental state of pluripotency.
The central network of stem cell self-renewal and pluripotency is governed by Oct4 (Pou5f1 ), Sox2,
and Nanog. Oct4 and Nanog are transiently expressed in ESCs in development, while Sox2 has other
roles, but these three transcription factors function together through the positive regulation of their own
promotors to form what is termed an interconnected autoregulatory feedback loop.40 They also activate
genes required for ESC maintenance and repress genes involved in differentiation. Without this level of
regulation, uncontrolled self-renewal could produce a tumour and spontaneous differentiation would cause
uncontrolled tissue formation in development. In the positive feedback loop corresponding to self-renewal,
ectopic Oct4, Sox2, and Nanog activates transcription of the corresponding genes (Pou5f1 or Oct3/4 ,
Sox2 , and Nanog). This feedback loop continues to sustain production of the transcription factors, even
in the absence of further input. However, as soon as one is no longer functionally available, the cell enters
a differentiation programme.
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Traditionally, mouse ESCs were maintained by coculture on a feeder layer of mitotically inactivated mouse
embryonic fibroblasts (MEFs), a source of leukaemia inhibitory factor (LIF), and in the presence of serum
or BMPs to activate differentiation inhibiting proteins. However, recent evidence promotes the notion that
self-renewal might, in fact, be the default state for stem cells and that by removing the differentiation
inducers (instead of providing differentiation inhibitors), the cells can be maintained in a pluripotent
state.41 In one study, differentiation was found to stimulate the mitogen-activated protein (MAP) kinase
(ERK1/2) pathway by fibroblast growth factor 4 (Fgf4). Blocking this pathway with small molecule
inhibitors enabled robust self-renewal, even without differentiation inhibitors. An overview of the LIF
pathway is shown in Figure 1.3, though the network regulating stem cell self-renewal and pluripotency is
far more involved than only LIF signalling. Whereas LIF signalling has been shown to be most important
in mouse ESCs, it is not implicated in the maintenance of human ESCs, where instead, Activin/Smad-2
and -3 signalling is involved.
LIF
Gp130 LIFR-β
JAK JAK
Stat-3
Stat-3P
Shp2
Shp2 P
PI(3)K
Akt
Klf4
Grb2
MAPK
Tbx3
Nanog
Pou5f1
Sox2
Membrane
Nucleus
Figure 1.3: In LIF-mediated self-renewal, LIF binds to Gp130 and the LIF receptor to activate three
pathways (Jak-Stat3, Grb2-MAPK, and Shp2-PI(3)K-Akt) to activate transcription factors (Klf4 and
Tbx3 ) and thereby the central network of stem cell transcription factors (Sox2 , Nanog , and Pou5f1 ).
Klf4 and Tbx3 mainly activate Sox2 and Nanog , respectively, which then activate Pou5f1 . MAPK
inhibits Tbx3 transcription. The dotted lines indicate a more moderate activation than the solid lines.
Adapted from Okita et al. and Niwa et al.42,43
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One of the many challenges of using ESCs for regenerative medicine is the presence of subpopulations.
This was once a problem thought to be unique to adult stem cell populations, but studies have recently
shown that ESC subpopulations also have highly distinct capacities for differentiation, both in vitro
and in vivo.44 Using a retroviral marking strategy and PCR to track individual cells, the authors found
nonfluctuating subpopulations of cells that contributed to lineage specification in embryoid bodies in vitro
but lacked clonogenic capacity (the ability to self-renew as single cells), even though they were capable
of self-renewal at a population level. A clonogenic population, however, readily formed teratomas but
did not differentiate well in embryoid bodies. This demonstrated population heterogeneity and ESCs
were further shown to give rise to distinct cell markers, gene expression, proliferation, and differentiation
potential.
Cell types differ from each other in terms of their gene expression, epigenetic modifications, and pheno-
type. However, in recent years, it has become clear that there is much more plasticity in cell types than
previously thought. Early somatic cell nuclear transfer had demonstrated that transferring the nucleus
of an adult somatic cell into an unfertilised oocyte, such as in the cloning of Dolly the sheep, could repro-
gramme cells to an early developmental state. Another method, involving the fusion of a somatic cell and
a stem cell, confirmed this reprogramming capability. However, it was the 2006 discovery by Takahashi
and Yamanaka and the many studies that followed that conclusively demonstrated the plasticity of cell
types.45
The exciting part of the experiments from Takahashi and Yamanaka was that expression of a minimal
set of transcription factors could confer ESC-like pluripotency on a terminally differentiated adult cell.
They used fibroblasts with a neomycin cassette under the Fbx15 promoter (only found in ESCs) to screen
a panel of 24 retroviruses containing cDNAs for genes known to be involved in stem cell maintenance.
None of the 24 genes alone were sufficient to induce antibiotic resistance, but all 24 together induced
expression of the embryonic cell promoter. They then proceeded to transduce their cells with 23 of the
24 genes to identify which cDNAs were responsible for forming the ESC-like colonies. After identifying
ten genes, they continued their iterative approach to finally identify four genes that, when co-transduced,
could reprogramme mouse fibroblasts into cells with ESC characteristics, termed induced pluripotent
stem cells (iPS cells): Oct3/4 , Sox2 , c-myc, and Klf4 . Nanog was notably lacking from this list, though
Klf4 is known to activate its transcription.
Following the identification of four transcription factors that together could reprogramme adult cells
into an embryonic state, it was necessary to thoroughly characterise the resulting cells to determine
how similar they really were. Early work showed they were self-renewing and capable of forming both
embryoid bodies and teratomas. They also underwent in vitro differentiation into a variety of cell types.
And finally, they were able to generate viable chimeric embryos (up to embryonic day 13.5) when injected
into mouse blastocysts. However, there were also some short-comings with these cells. There was clone-
to-clone variability that meant in some cases, the gene expression had substantial variations compared
to the controls. And, importantly, the iPS cells did not contribute to tissues postnatally.
Many papers have followed up on the first iPS discovery. The DNA methylation, gene expression,
and chromatin state were determined to be similar in iPS cells and ESCs when activation of Oct4
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and Nanog were used as selection rather than the Fbf15 promoter.46 Alternative combinations of the
transcription factors responsible for reprogramming have also been published. A small molecule blocking
TGF-β signalling eliminated the need for Sox2 by instead activating Nanog.47 Two groups discovered
that human cells could undergo similar reprogramming, with one using a lentiviral strategy.48,49 A rat-
mouse chimera demonstrated that rat iPS cells could rescue mouse organs, specifically, to generate a
mouse pancreas.50 While many questions remain, including the teratoma formation,51 and the extent of
pluripotency,52 there is great potential for the cells to be used in regenerative medicine strategies such
as disease modelling and tissue engineering.53
1.3.2 Adult stem cells
Adult stem cells are capable of prolonged self-renewal that can produce at least one type of decendent.
Usually, there is an intermediary cell type produced– a committed progenitor with limited proliferation
and restricted differentiation.
Hematopoietic stem cells (HSCs), the cell population responsible for generating all cell types in blood,
are by far the most studied stem cell type. However, the focus to begin with here is on mesenchymal stem
cells (MSCs) due to their relevance to musculoskeletal tissue engineering. MSCs are further introduced
in Chapter 4 in the context of chondrogenic differentiation.
1.3.2.1 Mesenchymal stem cells
The discovery of MSCs has been attributed to Friedenstein et al. in 1966.54 They found that cells
isolated from human bone marrow could go on to form bone when transplanted in mice. They noted
a high degree of heterogeneity in the cell population, and it was later shown that the same cells could
produce fat and cartilage, among other tissue types. This trilineage potential (bone, fat, and cartilage),
which was first used to describe bone marrow-derived MSCs, has also been found in cells derived from
many adult and embryonic tissues. Despite their long use in vitro, it remains controversial as to whether
their differentiation ability is the same in vivo.55 There are some strong arguments against the existence
of a true mesenchyme progenitor. For example, in embryogenesis, muscle and bone develop from different
subpopulations so it would be surprising if a single committed progenitor exists.
The in vitro differentiation of MSCs into tissues from the mesoderm lineage has repeatedly been demon-
strated. However, they have also been shown to differentiate into non-mesoderm tissues. They could be
induced to form epithelial cells by culture in low serum and vascular endothelial growth factor (VEGF),
and the resulting cells were capable of forming capillary-like structures.56 Some MSCs treated with 5-
azacytinide, a cytosine analogue known to influence differentiation, began spontaneous beating.57 These
cells formed myotube-like structures, and beat synchronistically after three weeks. They had morpho-
logical features, action potentials, and gene expression similar to cardiomyocytes. The differentiation of
MSCs into hepatocytes is a demonstration of how lineage borders (i.e. the restriction to the mesoderm
lineage) can be overcome with multistep differentiation protocols.58 The synergy of soluble factors such
as dexamethasone, ITS (insulin-transferrin-selenium), and nicotinamide affected hepatogenesis in serum-
free conditions. And as a final example, MSCs derived from dental pulp (and therefore originating from
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neural crest cells) could form neurons with markers, morphology, and function consistent with controls.59
These examples could go on, but the point is that the plasticity of MSCs is still expanding and being
understood.
In addition to being able to differentiate into many cell types in vitro, it appears that MSCs or similar
cells can be found in many cell types in vivo. There may not be any correlation between these finding, but
nonetheless, MSCs have been extensively studied in vivo. One of the first aims was to identify their niche,
leading to the discovery that they reside close to the blood vessels and may be considered pericytes.55
This is not to say that all pericytes are MSCs, as there are many other cell types in the same niche,
including HSCs and muscle stem cells. A better understanding of the role of MSCs in vivo will surely
improve their use in regenerative medicine.
While HSCs and MSCs are the most well-known adult stem cell types, virtually every adult tissue contains
a population of stem or, more accurately, progenitor cells. Satellite cells, found in muscle, and pancreatic
stem cells, are just two examples of the diversity of progenitor cells. These are the cells that can become
activated in the case of damage to the tissue and undergo terminal differentiation to repair the injury.
It is well known, however, that different tissues have different abilities to respond to damage, and this
is not always directly correlated with the presence or abundance of the resident stem cell population.
In the liver, for example, which has a high regenerative ability, it is the adult hepatocytes that reenter
the cell cycle and undergo mitosis. When hepatocyte proliferation is blocked, however, a progenitor cell
population is recruited and these cells differentiate into both hepatocytes and biliary cells.60
1.3.2.2 Reprogramming of adult stem cells
The discovery of iPS cells underlined the potential for plasticity in somatic cells. Indeed, if somatic cells
could return to their embryonic state, it should follow that they could then be differentiated into any
adult cell type desired. But then another series of discoveries found that adult cells could be directly
reprogrammed into other adult cells using a similar technique of gene expression. Incredibly, this was first
shown with the conversion of fibroblasts to muscle cells by MyoD induction in 1987,61 but was revived
as a research line after 2006.
Since then, many cells types have been generated by direct reprogramming. Fibroblasts are a popular
starting point due to their availability in a clinical setting. By adopting the iPS approach of expressing
multiple transcription factors, they have been reprogramming into diverse cells types including hepato-
cytes62 and neural stem cells, which could then become oligodendrocytes and neurons.63 This technology
is especially promising for regenerative medicine as patient-specific cells can be produced.
Reprogramming is not limited to in vitro experiments. Mouse pancreatic exocrine cells could be repro-
grammed to β-cells by retrovirus injection in the pancreas to induce transient expression of Ngn3 , Pdx1 ,
and Mafa. The resulting cells produced insulin and could ameliorate hyperglycaemia in diabetic mice.64
This experiment was of particular interest because it may have not worked in vitro, where β-cells are
notoriously difficult to culture. One group that had previously shown that cardiac fibroblasts could be
directly reprogrammed into cardiomyocytes in vitro by the expression of the transcription factors Gata4 ,
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Mef2c, and Tbf5 translated their experiments to living mice. Following myocardial infarction, the nor-
mal function of these fibroblasts, which arise from a different subpopulation than cardiomyocytes, is to
migrate to the injury site and proliferate. However, direct injection of a retrovirus in the hearts of mice
reprogrammed them to mature cardiomyocytes.65
1.3.3 Stem cells in the clinic
Hematopoietic stem cell transplantation, or a bone marrow transplant, is a common procedure that was
the first use of stem cells in medicine. However, since its conception in the mid-20th century, there have
been few similarly successful uses of stem cells in the clinic. Worryingly, there have been recent reports
of direct-to-consumer advertising for treatment of diverse diseases and conditions, many of which are
fraudulent and outright dangerous. Presently, the clinical translation of stem cell research is a mix of
highly promising and highly disappointing therapies.
The use of mesenchymal stem cells (MSCs) to treat connective tissue defects is an example of both
promise and disappointment. Initially, it was thought that the cells could undergo differentiation (either
in vitro or in vivo) to repair damaged tissue. Early studies involving both systemic and local injection
reported MSC homing and engraftment at the injury site. These results did not stand up to further in-
vestigation, but they did provide the foundation for a key paradigm shift, which was based on exploiting
the paracrine effects of the transplanted cells.66 MSCs appear to have a role in inhibiting inflammatory
responses, reducing apoptosis, preventing fibrosis, stimulating endogenous repair signalling, and promot-
ing vascularisation. These trophic, indirect effects have now been developed into a number of therapies,
especially for myocardial infarction.
One of the major discoveries relating to the therapeutic potential of MSCs was to do with their im-
munomodulatory effects. The cells themselves are immune privileged, so can be used allosterically.67 But
most importantly, they also have a strong systemic immunosuppresive effect. Graft-versus-host disease is
a major threat in bone marrow and organ transplantation. There was no treatment for the most severe
steroid-resistant form until MSC infusion was found to cure the disease.
As shown with MSCs, for stem cells to be therapeutically useful, they need to be non-immunogenic. It
was therefore highly worrying when researchers first found that human ESCs cultured in the presence
of animal products such as serum and feeder layers began expressing a non-human sugar on their cell
surface.68 The sugar, N-glycolylneuraminic acid (Neu5Gc), can be recognised by human antibodies and
would cause the cells to be destroyed in vitro. Fortunately, instead of halting ESC research, this discovery
encouraged innovation and the development of culture methods not requiring any animal products.
As of yet, the only instances of ESCs in the clinic have been following their terminal differentiation. The
first Phase I human ESC trial started in 2009. Researchers from Geron Corporation (California, USA)
and the University of California (Irvine) implanted human ESC-derived oligodendrocytes into the spinal
cords of patients with spinal cord injuries occurring no more than two weeks prior to implantation. The
trial was put on hold for nearly a year when microscopic cysts were discovered in some of the rats used
in the pilot experiments but was eventually resumed. In these rats, improved locomotion was attributed
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to the restoration of myelin sheaths, but to date, no results from the trial have been published. Geron
left the field of stem cell research in 2011, cutting the trial short. Two other trials based on the terminal
differentiation of ESCs are currently underway. Both aim to restore vision in patients with macular
dystrophy or degeneration by injecting their eyes with retinal epithelial cells derived from human ESCs.
Early reports underlined no negative effects and some promise for improved vision.69
With many tissue engineering strategies for promoting and controlling stem cell differentiation, there will
no doubt be more stem cell therapies available in the future. It does, however, appear that these therapies
will be based on the implantation of fully differentiated stem cells rather than stem or progenitor cells.
An example is the implantation of a decellularised extracellular matrix and chondrocytes derived from
MSCs to replace a damage trachea.14 For treatments like these to be successful, a better understanding
of how to differentiate stem cells using both physical and biological cues will have to be developed.
1.4 Cell response to physical substrate cues
One way to control stem cell differentiation, or other cell behaviour, is to use physical cues from their
substrate. During development in vivo, cells are known to respond to physical cues, such as migration and
alignment from topographical features and mechanotransduction from morphogenesis. Similar behaviour
can be replicated in vitro. Overall, using physical cues to guide cell behaviour is an attractive alternative
to biological cues. Signalling can be more localised, and may be more resistant to modification over time.
Physical cues can also be developed in the manufacturing process and eliminate the need for biomolecules
derived from humans or animals. However, despite an increasing understanding, we still lack the ability
to predict cell response to physical cues beyond the simplest examples of morphology. In order to use
physical cues to guide cell behaviour, a much more thorough understanding is required. Furthermore,
one of the interesting challenges of using physical cues to guide cell behaviour is designing a material to
withstand, or incorporate, the cell-mediated and environmental remodelling.
Many bulk and interfacial substrate properties have been shown to affect cell behaviour. Here, the effects
of chemical, physical, and topographical features are introduced, focussing on their effects on stem cell
behaviour wherever possible.
1.4.1 Chemical cues
Cells can respond to the chemical composition of their substrates. One common method of studying
the effects of various chemical groups is the fabrication of self-assembled monolayers (SAMs). Both the
chemical composition and the density can be controlled through relatively simple stoichiometry. In the
case of cell response to chemical groups, it is especially important to consider the effect of the groups
on protein adsorption as the intermediary.70 An example of this is the effect of adsorbed fibronectin
conformation on integrin binding and subsequent cell behaviour.71
As an example of chemical modifications for cell differentiation, one study used SAMs of aklanethiols with
four different end groups: CH3 (hydrophobic), COOH (negative charge), NH2 (positive charge), or OH
(neutral hydrophilic).72 These SAMs were formed on gold and incubated in human fibronectin, ranging
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from 0 to 20 µg/ml. Human mesenchymal stem cells (MSCs) were then seeded on the substrates and their
propensity to differentiate towards adipogenic, chondrogenic, and osteogenic lineages was assessed. The
amount (in ng/cm2) of fibronectin was kept constant, despite varying affinity to the SAMs, by controlling
the incubated concentration. Fibronectin was crucial for promoting cell attachment on the CH3 substrates
but not the others. There were some limitations to the study, especially in controlling the cell-cell
interactions, but nonetheless, substrate chemistry affected MSC differentiation. The NH2 substrates best
promoted osteogenesis and adipogenesis, while the OH substrates only promoted osteogenesis. None of
the substrates promoted chondrogenic differentiation, even in the presence of inductive biomolecules.
How these results relate to the fibronectin adsorption remains to be studied.
As an example of chemical modifications for cell propagation, a combinatorial approach to the investi-
gation of substrate chemistry demonstrated that polymers composed of hydrophobic acrylate monomers
could promote colony formation of human embryonic stem cells (ESCs).73 Owing to the problems as-
sociated with animal-derived factors in stem cell culture, the authors aimed to generate a completely
synthetic substrate that would eliminate the need for any soluble cues. As an additional challenge, the
substrate should support clonal growth of single cells, and not just survival of proliferating clones. To do
this, arrays were formed of polymers from 22 acrylate monomers with varying hydrophobicity and cross
linker density. Ultimately, 496 copolymers were deposited on a non-cell adhesive layer on a glass slide.
Cells were first sorted for Oct4 and were then seeded at a low density (2-10 cells on each spot) on the
polymer array. Since protein adsorption from serum also occurs rapidly in vivo, a series of serum proteins
(fibronectin, laminin, bovine serum albumin, and fetal bovine serum (FBS)) were separately absorbed.
Generally, FBS had a positive effect on stem cell proliferation, whereas fibronectin and laminin resulted
in a down-regulation of Oct4, indicative of differentiation. The FBS-coated copolymers were then as-
sessed for their ability to promote colony formation. After seven days, cells were probed for Oct4, and
another stem cell marker, SSEA-4. A positive correlation between moderate wettability and stem cell
maintenance was established, though many other factors were also identified. The authors performed one
final experiment to begin to explain the mechanism for this interaction, and found the involvement of
vitronectin-binding integrins.
1.4.2 Mechanical cues
During embryogenesis, cells are subjected to mechanical forces which have been shown to regulate many
physiological processes. It is not surprising then that upon mechanical stimulation, cellular receptors
convert these forces into biological signals through a mechanism known as mechanotransduction. These
signals are important in normal tissue development. Indeed, the knockout of myosins, a class of force
generating molecules, in embryogenesis prevents the earliest instances of cell differentiation.74 Many types
of physical stimulation have been shown to affect cell behaviour. Hydrostatic pressure, shear stress, and
cyclical forms of both have been repeatedly shown to affect differentiation and other cell behaviour.75
However, it is cell response to substrate stiffness that has garnered the most attention in stem cell research.
In 2006, Engler et al. published a paper that has since defined the field of mechanotransduction of stem
cells.8 They made polyacrylamide gels with varying stiffness controlled by varying the concentration
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of N,N′methylene-bis-acrylamide and acrylamide with a crosslinker and initiator. Sulfo-SANPAH was
covalently attached to the gel, resulting in a free ester, which could attach to the lysine in collagen,
making the gels cell adhesive. Mesenchymal stem cells (MSCs) were seeded on the gels and remarkably,
they were found to express markers in cells found in tissues with similar stiffnesses as the gels. The
MSCs started to show a neuronal phenotype when cultured on the softest gel with an elasticity similar
to brain tissue. On substrates with an elasticity similar to striated muscle, they expressed a myogenic
marker. Finally, on the stiffest substrates, with an elasticity similar to osteoid, the cells expressed an
osteogenic marker. All of these lineage commitments occurred in the absence of differentiation-inducing
biomolecules. In order to start to elucidate the signalling pathways involved in mechanotransduction,
the authors used blebbistatin to inhibit myosin II contractility, and found that the mechanosensing was
abolished. Interesting, blebbistatin treatment had no effect on the cell response to soluble cues.
Since 2006, there have been many follow up studies. Recently, there is growing evidence that the substrate
elasticity alone was not responsible for lineage commitment. Polydimethylsiloxane (PDMS) substrates
with similar tuneable mechanical properties as the polyacrylamide gels were also coated with sulfo-
SANPAH and collagen.76 Human epidermal stem cells adhered and underwent differentiation (marked
by involucrin expression) on all substrates, regardless of their stiffness. Then the same experiment was
repeated on polyacrylamide gels instead of PDMS and while cell shape was unaffected by varying stiffness
on PDMS substrates, it was highly affected by varying stiffness of polyacrylamide substrates. As expected,
cells were more spread on the stiffer gels in agreement with the previous experiments on polyacrylamide.
This effect was not due to the presence of collagen as the same observations were made when fibronectin
was covalently attached to the gels. Interestingly, in tests with MSCs, it appeared that the force they
could exert of fibronectin (with a FRET-reporter for stretching) was only influenced by bulk stiffness in
polyacrylamide gels and not PDMS.
Ultimately, following electron microscopy of the gels, it was determined that the differences in porosity
may explain these otherwise puzzling results. Instead of directly sensing substrate stiffness, the cells in
this experiment were responding to the ligand density. There are many questions remaining in the field
of mechanotransduction, but there is no doubt that it represents yet another sensitive way cells respond
to cues from their substrates.
1.4.3 Topographical cues
The extracellular matrix has distinct topographical features in different tissues, with features down to
the nanometre scale. Many in vitro experiments have demonstrated that cells can sense and respond to
these features. The early examples of cells responding to topography were of contact guidance, where the
cell aligns along a feature. This has been shown in many cells types on many different shapes. At the
lower end of the size regime, collagen fibrils from 20-200 nm in diameter can assemble to form micrometre
scale fibres and the basement membrane also has a texture in the nanometre range.77 The features on
the cell membrane that interact with the ECM are also on the order of nanometres, such as integrins
and cilia. With modern technology, complex topographies in both 2- and 3-dimensional substrates can
be fabricated. Cell response to micrometre and nanometre scale features are introduced in Chapters 2
and 3, respectively, so two other forms of cell response to topographical cues are introduced here.
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1.4.3.1 Ligand spacing
Integrins are the major class of cell surface proteins that form physical attachments with the surrounding
extracellular matrix. Because of their connection to the actin cytoskeleton, they are also important in
generating cellular forces. Furthermore, they activate a number of important signalling pathways, result-
ing in biochemical changes in the cell as a response to its environment. Many studies by the Spatz group
have demonstrated how fully differentiated cells can respond to integrin ligand spacing by alignment,
integrin activation, and morphological changes.78,79 In one recent study, Frith et al. demonstrated the ef-
fects of ligand spacing on mesenchymal stem cells.80 They made poly(styrene-block-ethylene oxide) block
copolymers that self-assembled into micro-phase separated vertically oriented cylinders of PEO chains
in a PS matrix. The PEO was further functionalised with the cell-adhesive RGD tripeptide and due to
the size of the domains, only one integrin could bind each RGD. Antibodies against integrin subunits
established that the cells were binding via integrins α5, αv, β1, β3, and β5. The average spacing of the
RGD domains was 34, 44, 50, or 62 nm. Cells on the 34- and 44-nm-spaced RGD peptides had well-
defined stress fibres compared to cells on the 50- or 62-nm-spaced domains, which also had decreased FAK
expression. The ligand spacing further affected cell differentiation, with enhanced osteogenesis measured
on the smaller domains and enhanced adipogenesis on the larger domains.
1.4.3.2 Cell shape
As with some of the other physical forces, cell shape is normally changing during embryogenesis and so
it is another factor that can influence cell behaviour.81 Micropatterned surfaces can be formed on PDMS
stamps and coated with an ECM protein such as fibronectin or collagen. Cell growth is then restricted
to the area with the protein and cell shape is therefore easily controlled.
McBeath et al. found that cell shape drives mesenchymal stem cells to either adipogenesis or osteogene-
sis.82 They generated micropatterns of fibronectin and blocked the surrounding regions with a nonadhesive
molecule. Two sizes of micropatterned shapes were made: 1024 or 10,000 µm2 and the cells spread to
the boundaries of their shapes. Equal parts of adipogenic and osteogenic medium were mixed and the
cell were cultured for one week. Upon staining for alkaline phosphatase (for osteogenesis) and lipids (for
adipogenesis), it was clear that the cell shape had an effect on differentiation. Cells on the small patterns
were undergoing adipogenesis and cells on the large patterns were undergoing osteogenesis. Impairing
myosin-generated cytoskeletal tension with a ROCK inhibitor did not affect the cell morphology but
resulted in increased lipid synthesis. Further controls indicated that shape sensing was ROCK-mediated
and that RhoA might transduce these signals.
Many other studies went on to demonstrate how cell size and shape can affect differentiation, but one
of the more interesting studies underlined the notion of cytoskeletal contractility. Kilian et al. used a
similar micropatterning protocol to produce shapes of octanedithiolate on gold-coated glass.83 Following
passivation of the uncoated regions of the slide, it was immersed in a solution of fibronectin, which
adsorbed to the hydrophobic thiol. Mesenchymal stem cells could attach and they spread to assume
the shape of the pattern. They were cultured in a mixture of adipogenic and osteogenic medium, again
with competing cues. Cells were cultured on squares and rectangles, where the patterns with a higher
32
1. INTRODUCTION
aspect ratio were found to be better promotors of osteogenesis. But the most interesting results were
on pentagonal shapes with varying degrees of curvature (almost round flower, pentagon, and a star with
convex curves). There was increasing cytoskeletal contractility in the star compared to the flower. The
percentage of cells undergoing osteogenesis seemed to follow with contractility. Cytoskeletal stress fibres
demarcated the corners of the shapes and these effects were all eliminated when cytoskeleton disrupting
or integrin blocking reagents were used.
Overall, the response of cells to physical cues speaks to the importance of understanding the stem cell
niche in order to control their behaviour. Whether engineering elasticity, topographical features, ligand
spacing, or cell shape and size, it is clear that cells have an inherent ability to convert these cues into
biochemical signals and that exploiting this will improve scaffolds for tissue engineering.
1.5 Cell response to biological substrate cues
Physical cues unquestionably influence cell behaviour but most of the signalling in embryogenesis and
adult tissue repair is by biomolecules. Cells are known to respond to a number of these, including growth
factors and small molecules. They can be exogenous (released from a scaffold or delivered in the culture
medium), autocrine (released by the cells), or paracrine (released from nearby cells). In tissue engineering,
biomolecules can be used to guide cell behaviour in both soluble (in the culture medium) or insoluble (in
the scaffold) forms.
1.5.1 Soluble biomolecules
Growth factors are signalling molecules that strongly influence processes from development to adult tissue
homeostasis. Some of their effects are strong enough to override other environmental signals, which
makes them attractive for stem cell differentiation in tissue engineering. Examples underlining their
diverse effects include bone morphogenetic proteins (BMPs), which are capable of inducing the formation
of bone and cartilage,84 platelet-derived growth factor (PDGF), which plays a significant role in blood
vessel formation,85 and nerve growth factor (NGF), which is crucial for the survival and maintenance of
neurons.86
Indeed, growth factors are commonly used to direct stem cells to either proliferate or differentiate. This
effect was demonstrated on human neural stem cells exposed to gradients of epidermal growth factor
(EGF), fibroblast growth factor 2 (FGF2), and platelet-derived growth factor (PDGF).87 A microfluidic
platform generated gradients of these factors that continuously flowed across the cells for seven days.
Their proliferation or differentiation into astrocytes was directly related to the concentration of growth
factors, with differentiation occurring in the regions of low concentration.
The incorporation of growth factors in a tissue engineering scaffold has been shown to improve the survival
and differentiation of implanted cells.88 A scaffold containing an RGD peptide was designed to provide
sustained delivery of hepatocyte growth factor (HGF) and FGF-2. The scaffold was implanted along with
myoblasts in a mouse muscle laceration model. The combination of a cell-adhesive scaffold and growth
factors improved myoblast survival and prevented terminal differentiation until the cells had migrated
and engrafted in the host tissue.
33
1. INTRODUCTION
In addition to growth factors, cells can be strongly influenced by the presence of small molecules. Stem cell
fate, for example, can be directed in vitro by the addition of small molecules such as β-mercaptoethanol,
dexamethasone, vitamin C, sodium pyruvate, and many others.89,90
Growth factor delivery is an interesting challenge in scaffold design. In particular, mimicking the natural
binding and release of growth factors is thought to be important since growth factor activity in vivo is
largely regulated by their binding to the ECM.91 This has been achieved with many strategies, one of
which is the use of a synthetic ECM incorporating heparan sulphate-binding peptides to bind growth
factors via a heparin bridge.92 When bone morphogenetic protein-2 (BMP2) was incorporated in a scaffold
without the heparin-binding peptides, it had a positive effect on bone healing. However, incorporating
it in its native conformation (i.e. bound to heparin), the effect was further improved. This could be
considered an example of a soluble growth factor assuming an insoluble position in the scaffold.
1.5.2 Insoluble biomolecules
The extracellular matrix and its role in signalling was discussed in Section 1.2. Here, some examples of how
mimicry of the biological components of the extracellular matrix can improve tissue engineering strategies
are given. Generally, tissue engineers have been successful in replicating the physical environment of
the ECM but the biological components have been more difficult to mimic. One strategy is the use
of decellularised ECM, but this section will briefly highlight some achievements in the use of peptides
derived from proteins and similar biomolecules. A well-known example of protein-derived peptides is in
cell adhesion. RGD, as an example, is found in many extracellular matrix proteins and binds integrins to
promote cell attachment and spreading. This, and other similar examples, are introduced in Chapter 4.
Protein activity can also be reproduced by a short sequence corresponding to its active region. Even
if the resulting peptide has reduced activity, the ease of manufacturing and the high concentration at
which they can be included in a scaffold can overcome this limitation. The activity of growth factors
can be mimicked by peptides derived from their sequences. Angiogenesis was achieved in mice with a
multi-domain synthetic peptide derived from FGF-2.93 In vitro, the peptide could stimulate ERK1/2
phosphorylation and other endpoints of FGF-2 signalling. A considerable advantage of using peptides
lies in their ability to be covalently bound to a substrate without affecting their activity (which can be
difficult with full length proteins) and their improved stability. In addition to the top-down approach
of reducing growth factors to their active peptides, a bottom-up approach of screening libraries of small
molecules or peptides can also lead to a desirable cell effect.
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1.6 Conclusion
In this Chapter, some of the key challenges and limitations of tissue engineering have been discussed.
The field of tissue engineering is evidently still emerging, especially in terms of the recent changes to the
design of scaffolds. Particularly, knowledge from development, more systematic studies on cell response,
an understanding of the pathways involved, and the incorporation of design complexity will be key for
future design decisions. The topics in this Chapter cover both the native and the engineered stem cell
niche. By starting with an introduction of the extracellular matrix and of the state of the art in stem
cell research, it should be clear that more studies on the recapitulation of these properties for tissue
engineering are required. Finally, examples of cell response to both physical and biological substrate cues
were given to demonstrate the responsiveness of cells to their environment and to motivate the work in
the next chapters.
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Chapter 2
Embryonic stem cell response to
micrometre scale topography
This work was in collaboration with Dr Lijun Ji, who conceived and synthesised the silica
colloidal crystal substrates. Significant portions of this chapter have been published in:
Ji L, LaPointe VL (* co-first), Evans ND, Stevens MM. Changes in embryonic stem cell
colony morphology and early differentiation markers driven by colloidal crystal
topographical cues. Eur Cells Mater 23, 135-146 (2012).
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2.1 Introduction
The use of materials properties to guide cell behaviour is an attractive option for regenerative medicine,
where controlling stem cell behaviour is important for the establishment of a functioning cell population.
In this chapter, the effects of nano- to micrometre scale topography on cell behaviour were studied. The
extracellular matrix and basement membrane are composed of a rich array of architectural features such
as aligned fibres, interconnected pores, and ridges that range from 10-300 nm in size, implicating the
size range in guiding cell behaviour.94 Silica colloidal crystal (SCC) microsphere substrates were used to
investigate the effects of topography on feeder-free embryonic stem cells (ESCs). The substrates were
conferred ordered hemispherical topography through the packing of microspheres of varying diameter and
were highly reproducible and simple to fabricate. By examining colony morphology, gene expression, and
protein expression, we herein test the hypothesis that these substrates can modulate ESC colony mor-
phology and behaviour and hence provide a means to investigate the fundamental effects of topography
on ESCs in vitro and to inform the rational design of biomaterials for regenerative medicine.
Synthesis of silica colloidal crystal microspheres
Substrate fabrication through self-assembly and sintering
Seeding of murine embryonic stem cells
Ambient temperature
3 hAmmonia
Ethanol
dH2O
pH 9.0
+ tetraethoxysilane Silica colloidal 
microspheres in 
solution
Dry solution
Self-assembly
800 ℃
3 h
Sintering
1 µm
SCC substrate
SCC substrate
~ 1.3 cm2
Type I collagen 
incubation
ESC seeding in 
growth medium
2.7 x 105 cells/cm2
Figure 2.1: Silica colloidal crystal microspheres were synthesised by the hydrolysis of tetraethoxysilane,
which resulted in monodisperse colloidal particles in solution. The solution was then allowed to dry and
ordered face-centred cubic packing resulted through self-assembly. Sintering was performed to increase
the mechanical competence of the substrates, which were then cut down to size. After an incubation in
type I collagen, murine embryonic stem cells were seeded on the substrates.
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2.1.1 Cell-substrate interactions
Cell-substrate interactions play an important role in regulating and determining cell fate both in vivo
and in vitro.95 The prospect of controlling cell behaviour using engineered substrates is particularly
attractive for both fundamental research and therapeutic applications. Engineered substrates may permit
the elucidation of various adhesion-dependent signalling pathways to further our understanding of the
influence of material properties on cell behaviour. This knowledge can be used to inform material design
decisions for therapeutic applications such as in regenerative medicine. For these reasons, in recent years
there has been considerable interest in tailoring substrate properties in order to generate a desired cell
response.
Several biological and physical substrate properties are known to affect cell behaviour in vitro. It has
been repeatedly demonstrated in both tissue engineering and developmental biology that many cell types
require specific protein constituents in their extracellular matrices (ECM). For example, pancreatic β-cells
encapsulated in hydrogels containing certain laminin-derived peptides demonstrated improved survival
and function compared to cells in hydrogels without targeted cell-matrix interactions.96 Similarly, the
self-renewal of murine embryonic stem cells (ESCs) has been shown to be regulated through integrin
signalling, again underlining the importance of cell-matrix interactions on cell behaviour.97,98 In addition
to these biological signals, many physical properties have been shown to affect cell behaviour. Substrate
chemistry affects protein adsorption to subsequently influence adhesion71 and differentiation.99–101 Sub-
strate stiffness, or matrix elasticity, is one of the most widely studied properties and can direct both
mature cells and stem cell lineage choice and differentiation,8,102–104 a phenomenon that has recently be
linked to the ability of the cells to form ECM tethers.76
Another highly studied property is the role of surface topography, which is of particular interest due to its
relevance to cell behaviour in vivo, where cells experience a variety of different topographies, such as the
architecture of the basement membrane and differing orientations of ECM proteins.105 Several methods,
such as deposition techniques, lithography, and rapid prototyping have been developed in the last decade
to create tailored substrates designed to probe the effects of topography on cells. Interestingly, different
cell types respond differently to these topographical influences, potentially due to their widely varying
extracellular environments in vivo.17
In elegant early work, micropatterned surfaces coated with ECM proteins were used to show that adhe-
sion site spacing could determine cell shape and whether individual cells grow or die.106 Further work
in the field established the relationship between cell shape and differentiation in mesenchymal stem
cells (MSCs). MSC differentiation is now known to be governable by cell shape independent of soluble
factors.82,83,107 Furthermore, topographical features on the nanometre scale have been shown to affect
osteogenic differentiation108 and self-renewal of MSCs.109 The combination of topographical features and
chemical motifs has also been shown to direct MSC differentiation.110
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2.1.2 Silica microspheres
Ever since a method for synthesising monodisperse silica particles was developed by Werner Sto¨ber et al.
in 1967, it has been relatively simple to create substrates with ordered hemispherical topography, known
as artificial opals.111 Their use in electronics was launched by the description of a theoretical photonic
band gap by Eli Yablonovitch112 and they have since been widely studied in the field of photonics. More
recently, the silica colloidal crystal (SCC) particles have been used in biomedical applications. SCCs
coated with collagen- and GFP-containing viruses were able to infect the cells they came in contact with,
demonstrating their use in drug delivery.113 Colloids can also be used as a template to make scaffolds
with controlled pore sizes and topography.114 Due to their porous structure, they can be combined with
molecules such as heparin for specific tissue engineering purposes, such as the formation of cartilage.115
The substrates are formed by self-assembly and offer significant advantages over lithographic techniques
in terms of conferring uniform topography over large areas. The building blocks are silica spheres, which
can be easily synthesised in a very narrow size distribution. The major limitation is the presence of
imperfections in the self-assembly, but these can be minimised through optimisation of conditions.116
a b
c d
Figure 2.2: Scanning electron microscopy of silica colloidal crystal films. Even over a wide range of
particle size (a: 480 nm, b: 635 nm, c: 850 nm, and d: 1000 nm), the substrates have a high degree of
long-range order. Scale: 5 µm. Adapted from Wong et al .116
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2.1.3 Cell response to microtopography
Topographical cues can influence cell behaviour independent of biochemistry. An overview of the field
is described in Section 1.4.3, so here, the focus is on micrometre scale features. Many studies of topo-
graphical effects on cell behaviour have revolved around microstructured surfaces due to the wide range
of fabrication techniques and the relative simplicity of surface characterisation. The most common tech-
nique is lithography, which can be used to create substrates with high intra- and inter-batch consistency
and fine control over the features. A wide range of topographical features have therefore been studied.
150x
a b
Figure 2.3: SEM micrographs of two tissues, demonstrating the types of architectural features found
in vivo. a) The corneal basement membrane has a complex architecture. Scale: 500 nm, adapted from
Flemming et al.117 b) Articular cartilage has a topography that varies throughout the depth of the tissue.
Adapted from Jeffery et al.118
When cells come in contact with a substrate, they probe their surroundings with filopodia. The resulting
feedback initiates a cascade of biochemical events that have been demonstrated to affect virtually all as-
pects of cell behaviour. Cell response to topography is reasonable, considering the structural organisation
present in extracellular matrix (Figure 2.3). The first observation of this response in vitro was in 1911,
when frog embryo cells were seen to align along spider web fibres.119 The term “contact guidance”, now
in wide use was first used by Paul Weiss in 1939 when he observed that neurite outgrowth followed the
topography of the underlying substrate.120 Since then, it has been repeatedly reported that microscale
topography can influence a wide range of cell responses, including cytoskeletal arrangement,121,122 os-
teoblast mineralisation,123 and stem cell differentiation. Mesenchymal stem cell differentiation into either
adipocytes or osteoblasts can be controlled by microscale topography, and was found to be activated by
the RhoA pathway.82 Similarly, differentiation into either chondrocytes or myoblasts was found to be me-
diated by Rac1 and N-cadherin.124 These differentiation studies were particularly interesting examples
of the use of topography as the features were designed to put the cell into a specific orientation, which
caused the observed effects. For a summary of many microstructured surfaces and the effects they had
on a wide variety of cells, see the reviews by Flemming et al.117 and Ross et al.125
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2.1.3.1 Embryonic stem cell response to topographical cues
Embryonic stem cells (ESCs) have the potential to be a potent cell source for regenerative medicine ther-
apies due to their ability to differentiate into all somatic cell types found in the adult organism, and their
sensitivity to small changes in culture conditions.39 In the presence of leukaemia inhibitory factor (LIF),
a differentiation-inhibiting cytokine, murine ESCs can be maintained in culture in an undifferentiated
state. Differentiation protocols in vitro typically involve the formation of embryoid bodies (EBs), which
are aggregates of cells derived from ESCs that represent the earliest stages of differentiation. ESCs can
also be differentiated on two-dimensional substrates in the presence of exogenous factors, such as soluble
growth factors or substrate-adsorbed ECM molecules.126 Compared to other adherent cell types, little is
known about the effects of substrate properties on ESC behaviour, perhaps because ESCs are typically
grown on a layer of feeder cells, which effectively obscures the substrate.
It follows that there is little known about the effects of topographical features on ESCs. Most of the
work on topography affecting stem cell differentiation has pertained to mesenchymal stem cells (MSCs).
However, one group recently used lithography to produce an array of microstructures, composed of square
or round pillars in different lateral combinations and different pillar heights, for a total of 504 different
topographies.127 They seeded two strains of ESCs and observed changes in morphology and phenotype.
Colony number was affected by both the vertical and lateral dimensions. It decreased as the vertical
height of the pillars was decreased and as pillar size increased. Colony spreading was associated with
diminished alkane phosphatase activity, a marker of stem cells, demonstrating an effect of topography on
ESC differentiation.
Before that, it had been shown that human ESCs participate in contact guidance in a similar manner
as other adherent cell types.128 PDMS (polydimethylsiloxane) substrates with line grating of 600 nm
ridges, with 600 nm spaces, and 600 nm height were coated with fibronectin to promote cell attachment.
The ESCs aligned and elongated with the ridges, which led to cytoskeletal organisation and reduced
proliferation. This effect was diminished when actin disrupting agents were used.
Topography has also been used to control the size of EBs. The protocol for differentiation of ESCs into all
three germ layers begins with forming cell aggregates. These aggregates typically take the form of EBs,
which are suspended, spherical cell aggregates. It is known that the size of the EBs affects the efficiency
of the subsequent differentiation and so one group used photolithography to make a substrate that could
control the size of ESC aggregates.129 Interestingly, their aggregates remained adhered to the substrate
instead of becoming free-floating. However, they observed enhanced cardiac differentiation when they
made aggregates 200 µm in diameter, an indication that topography can be used to control stem cell
differentiation through the EB intermediary.
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2.2 Materials & Methods
2.2.1 Substrate fabrication
Monodisperse silica microspheres (SCCs) with diameters of 120, 400, and 600 nm were synthesised through
alkaline hydrolysis of tetraethoxysilane (Sigma-Aldrich, UK; 99%) according to Sto¨bers method.130
Briefly, aqueous ammonia was added to a mixture of ethanol and deionised water in a round bottom
flask to obtain a pH of 9.0. The basic solution was stirred rigorously at ambient temperature, and
tetraethoxysilane was added for hydrolysis. Silica microspheres formed in the solution in 3 h. SCC
substrates were then fabricated by drying the silica microsphere suspension, causing it to self-assemble
into a closely packed substrate. In order to increase the mechanical competence of the substrates, the
SCCs were sintered at 800◦C for 3 h to promote partial coalescence between the silica microspheres. The
substrates composed of approximately 120, 400, and 600 nm SCCs are referred to as SCC120, SCC400,
and SCC600, respectively. SCC substrates and glass cover slips (used as a reference material for topog-
raphy; Agar Scientific, UK) with an area of approximately 1.3 cm2 were coated with collagen to permit
cell adhesion. Rat tail collagen (type 1; First Link Ltd, UK) was purchased as a sterile solution and was
diluted in HEPES buffer to a concentration of 125 µg/ml. Substrates were incubated overnight, washed
in PBS, and dried at ambient temperature before cell seeding.
2.2.2 Collagen quantification
In order to confirm equal collagen adsorption on both the SCC substrates and the glass cover slips,
adsorption was quantified using a previously reported method based on the binding of biotinylated fi-
bronectin to type I collagen.131 Substrates were weighed and incubated for 30 min in a blocking buffer
of 2% (w/v) bovine serum albumin and 0.05% (v/v) Tween-20 in PBS. They were then incubated for
1 h at 37◦C in a 0.2 µg/ml solution of fibronectin (Sigma-Aldrich, UK) biotinylated with an EZ-Link
Sulfo-NHS-Biotinylation Kit (Pierce Biotechnology, UK) according to the manufacturer’s instructions.
Substrates were rinsed three times in 0.1% (v/v) Tween-20 in PBS and incubated in 50 ng/ml horseradish
peroxidase-streptavidin in blocking buffer for 30 min at 37◦C. Substrates were rinsed three times and
incubated in 3, 3′, 5, 5′-tetramethylbenzidine (TMB) for 10 min at room temperature. The reaction was
stopped with an equal volume of 2M H2SO4. After 30 min, 200 µl of the mixture was transferred to a
96-well plate and absorbance values were measured on a colorimetric plate reader at 450 nm (SpectraMax
M5, Molecular Devices, USA).
2.2.3 Cell culture
Cell culture reagents were from Invitrogen (UK) unless specified otherwise. Murine embryonic stem
cells (ESCs; ATCC CRL-1821 (TG2α/E14) obtained from LGC Standards, UK) were subcultured in
growth medium (DMEM supplemented with 10% (v/v) fetal bovine serum, 2 mM l-glutamine, 50 U/ml
penicillin, 50 mg/ml streptomycin, 100 µM β-mercaptoethanol (Sigma-Aldrich, UK), and 1 µl/ml condi-
tioned medium from LIF-producing Cos-7 cells (homemade by Dr Nick Evans, plasmid kindly provided
by Professor Vasso Episkopou, Imperial College London, UK) at 37◦C and 5% CO2. Cells were seeded on
SCC substrates and cover slips at a density of approximately 2.7 x 105 cells/cm2 and cultured in growth
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medium for five days with daily medium changes, after which the cells were cultured in differentiation
medium (growth medium without supplemented LIF or β-mercaptoethanol).
Embryoid bodies (EBs) were formed by dispersing ESCs into aggregates of approximately 10-30 cells by
incubation with 0.05% (w/v) trypsin-EDTA for 1 min. Cell aggregates were pelleted by centrifugation
at 50 x g for 2 min, and the aggregates were transferred to microbiological-grade Petri dishes (Bibby
Sterilin, UK) and fed daily with the same medium as cells on the SCC substrates and glass cover slips.
2.2.4 Quantitative PCR
At the indicated time points, RNA was isolated using an RNeasy mini kit (Qiagen, Germany) according
to the manufacturer’s instructions. Sensimix OneStep kit (Quantace, UK) was used to perform both
reverse transcription and qPCR. Thermocycling and SYBR Green detection were performed on a Corbett
Rotorgene 6000 (Qiagen, Germany) with 40 cycles consisting of annealing at 57◦C, extension at 72◦C, and
denaturing at 95◦C. Primers were selected from Primer Bank (Harvard University, USA; http://pga.
mgh.harvard.edu/primerbank/) and are listed in Appendix A. Transcript expression was calculated
using the ∆∆Ct method relative to ESCs prior to seeding, with Gapdh as the internal control. Data
are presented as 2−∆∆Ct - 1 for positive values (such that the control sample is set to zero) and as the
negative inverse for negative values (such that down-regulation is presented on a negative scale).
2.2.5 Semi-quantitative PCR
Semi-quantitative PCR was performed to assess mRNA expression for a panel of stem cell and differen-
tiation markers (Mouse/Rat Pluripotent Stem Cell Assessment Primer Pair Panel; R&D Systems, UK).
First strand cDNA synthesis was performed using Superscript III Platinum (Invitrogen, UK) from 100
ng RNA in a 20 µl reaction and was followed by RNase treatment. cDNA was diluted in water, and
semi-quantitative PCR was performed using Phusion High Fidelity DNA Polymerase (New England Bio-
Labs, USA) according to the manufacturer’s instructions, with 35 cycles consisting of annealing at 57◦C,
extension at 72◦C, and denaturing at 95◦C. Loading buffer was added to each reaction and 5 µl were run
on a 1.5% (w/v in 1X TAE) agarose gel, stained with SYBR Safe (Invitrogen, UK) and visualised with
a BioSpectrum 500 (UVP, UK).
2.2.6 Light interferometry
ESC colony morphology was examined using white light interferometry. Cells were fixed in 2.5% (v/v)
gluteraldehyde in sodium cacodylate buffer (SCB) for 2 h, washed in SCB and dehydrated in a graded
series of ethanol (50, 50, 75, 80, 90, and 100%; 5 min each) followed by hexamethyldisilazane for 30
min. Specimens were then sputter-coated with gold in preparation for microscope-based white light
interferometry (NewView 200, Zygo Corporation, Germany).
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2.2.7 Scanning electron microscopy and particle measurement
In order to observe substrate and cell morphology, scanning electron microscopy (SEM) was performed.
Cells were washed with sodium cacodylate buffer (SCB) and fixed in 2.5% (v/v) gluteraldehyde in SCB
buffer for 2 h. After fixation, cells were washed in SCB and dehydrated in a graded series of ethanol
(50, 50, 75, 80, 90, and 100%; 5 min each) followed by hexamethyldisilazane for 30 min. Samples were
air-dried and sputter-coated with chromium oxide in preparation for SEM (Leo 1525, Carl Zeiss, UK).
SEM was performed at 10 kV accelerating voltage. At least 200 particles were measured using Photoshop
software (Adobe, UK).
2.2.8 Immunofluorescence
Immunofluorescence was used to detect proteins of interest in fixed samples. Cells were fixed for 10 min
in 4% (w/v) paraformaldehyde, washed in PBS, permeabilised in 0.25% (v/v) Triton X-100, washed,
and blocked in 5% (v/v) goat serum in PBS-T (0.1% (v/v) Tween-20 in PBS). Cells were incubated in
primary antibody diluted in PBS-T overnight at 4◦C (mouse anti-E-cadherin (Abcam ab76055, 1/250)
and rabbit anti-ZO-1 (Abcam ab59720, 1/50)). Specimens were then washed, incubated in species-specific
AlexaFluor-conjugated secondary antibodies (1/2000 from Invitrogen, UK) diluted in PBS-T for 1 h at
room temperature in the dark, washed, incubated in 300 nM 4,6-diamidino-2-phenylindole (DAPI), and
stored in PBS until confocal microscopy on the same day. Imaging was performed on an inverted confocal
microscope (SP5 MP/FLIM, Leica, Germany; UV, Argon (488 nm) and HeNe (568 nm) lasers) under
standardised gain and offset. Line averages were used. For z-stacks, each stack was 0.84 µm thick.
2.2.9 Statistical analysis
Unless specified otherwise, all data are presented as mean ± standard deviation. Relative mRNA expres-
sion was determined using the ∆∆Ct method with ESCs at day 0 as the reference sample and Gapdh
as the house-keeping gene. Statistical analyses were performed using Students t-test, with p < 0.05
considered significant, and p < 0.01 considered highly significant.
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2.3 Results
In order to study how the nano- to micrometre scale dimensions of the substrate affect stem cell behaviour,
silica colloidal crystal (SCC) substrates were synthesised, characterised by electron microscopy, and coated
with collagen to permit cell adhesion. Murine embryonic stem cells (ESCs) were cultured on four types
of surfaces with varying topography: collagen-coated glass cover slips (as a reference material), 120 nm
diameter SCC substrates, 400 nm SCC substrates, and 600 nm SCC substrates. ESCs were seeded and fed
daily with growth medium supplemented with leukaemia inhibitory factor (LIF) and β-mercaptoethanol
for five days, at which point the supplements were removed and cells were fed daily in differentiation
medium for up to another ten days. The effect of topography on the expression of stem cell and early
differentiation genes was investigated using polymerase chain reaction, and stem cell colony features
were probed using white light interferometry and scanning electron microscopy (SEM). Finally, protein
expression related to epithelialisation was examined using immunofluorescence.
2.3.1 Substrate fabrication and collagen adsorption
The size of the particles and the substrate topography were evaluated using scanning electron microscopy.
The SCC substrates were composed of monodisperse (polydispersity index (PDI) = 1.00, referring to the
ratio of the mass-average diameter to the number-average diameter) microspheres with ordered face-
centred cubic packing up to an area of 1 cm2 (Figure 2.4) The mean sizes and standard deviations of the
particles were 124 ± 4 nm, 430 ± 4 nm, and 602 ± 12 nm for SCC120, SCC400, and SCC600, respectively.
The specific surface areas of SCC120, SCC400, and SCC600 were 68.1, 38.7, and 26.2 m2/g, as measured
by nitrogen absorption (performed by Dr Lijun Ji). A collagen quantification assay confirmed that type
I collagen had adsorbed to the SCC substrates and glass cover slips in approximately equal amounts
(maximum two-fold deviation between samples; N = 6).
a b c
Figure 2.4: SEM micrographs of SCC substrates a) SCC120, b) SCC400, and c) SCC600 composed of
particles of 124 ± 4 nm, 430 ± 4 nm, and 602 ± 12 nm diameter, respectively, showing their ordered
face-centred cubic packing (scale: 400 nm). Courtesy of Dr Lijun Ji.
2.3.2 Gene expression
2.3.2.1 Quantitative polymerase chain reaction (qPCR)
The gene expression of selected stem cell and early differentiation markers was determined using qPCR
(Figure 2.5). There were significant changes in gene expression in cells grown on the SCC substrates
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compared to glass cover slips. The transcript levels of ESCs at day 0 prior to seeding onto the exper-
imental substrates were set to zero, and all data are shown relative to that value with Gapdh as an
internal reference transcript. Any negative values (corresponding to down-regulation) are displayed as
the negative inverse. Nanog, a transcription factor involved in the self-renewal of undifferentiated ESCs,
was significantly down-regulated on all substrates after eleven days in culture (six days following the
removal of LIF and β-mercaptoethanol from the culture medium) (Figure 2.5a). The mRNA levels in
cells seeded on the three SCC substrates (SCC120, SCC400, and SCC600) were less down-regulated than
on glass and in embryoid bodies. By day 15, the levels of Nanog mRNA remained significantly down-
regulated in cells on all substrates but had returned to levels closer to the day 0 levels. Fgf5 , which is
expressed in the primitive ectoderm but not in undifferentiated ESCs, is a marker of early differentiation.
Its expression increased with culture time and was significantly greater in cells within EBs and on the
glass substrates than in cells cultured on SCCs (Figure 2.5b). Foxa2 , a mesendodermal marker expressed
during gastrulation followed a similar pattern of expression to Fgf5 . It was up-regulated in cells on the
SCC substrates but to a much lesser extent than cells on the glass cover slips (Figure 2.5c). Together,
these data suggested that cells on the SCC substrates were promoting an undifferentiated phenotype more
than glass cover slips, which led us to further investigate lineage specification and colony morphology to
better understand how topography may be influencing stem cell behaviour.
a b c
Nanog
Fgf5 Foxa2
Figure 2.5: Quantitative PCR showing the relative gene expression of ESCs grown on SCC substrates
compared with ESCs grown on glass cover slips: a) Nanog, a stem cell marker was less down-regulated on
the SCC substrates than on glass cover slips; b) Fgf5 , a marker of early differentiation, and c) Foxa2 , a
marker of endoderm specification were less up-regulated on the SCC substrates than on glass cover slips.
White bars: day 5, grey: day 11, black: day 15. N = 3 independent experiments.
2.3.2.2 Semi-quantitative polymerase chain reaction (PCR)
With the quantitative PCR demonstrating significant changes to some stemness and early differentiation
markers, a panel of primers was used to take a closer look at the fate of the differentiating cells. Figure
2.6 shows the amplicons for an array of genes, including Gapdh (a housekeeping gene), Dppa5a, Nanog,
Pou5f1 , and Sox2 (ESC markers), Sox2 , Nestin, Otx2 , and Trp63 (ectoderm), Afp, Gata4 , Pdx1 , Sox17 ,
and Foxa2 (endoderm), T (mesoderm), and Stella (germ cells). ESCs at day 0 (the first column) had a
high expression of all stem cell markers, which was maintained in EBs and ESCs cultured on both glass
cover slips and SCC400 substrates after 11 days in culture. Only Sox2 expression was diminished on the
SCC400 substrates, though its expression is also indicative of ectoderm specification. Most interestingly,
the expression of the endoderm markers Afp, Gata4 , Sox17 , and Foxa2 all increased in EBs and ESCs
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on glass, but were found only at low levels in ESCs on the SCC400, suggesting these topographies are
particularly active in repressing endoderm specification.
Figure 2.6: Semi-quantitative PCR of stem cell and differentiation markers in day 0 ESCs, and day 11
EBs, ESCs on glass slides, and ESCs on SCC400 substrates. Transcript levels of the stem cells markers
Dppa5a, Nanog, and Pou5f1 were preserved in all samples. The stem cell and ectoderm marker, Sox2 ,
was down-regulated on the SCC400 substrate. Endoderm markers Afp, Gata4 , Sox17 , and Foxa2 , were
all closer to undifferentiated ESC levels in cells cultured on the SCC400 substrates than in cells in EBs
or on glass cover slips.
2.3.3 Colony morphology
2.3.3.1 Scanning electron microscopy
While an adsorbed layer of type I collagen was required for cells to attach to the SCC substrates but not
to the glass cover slips, both types of substrates were coated with collagen prior to cell seeding. With
this collagen pre-incubation, ESCs initially attached on all substrates and proliferated to form colonies.
Under phase contrast microscopy, only cells on the SCC120 and SCC400 surfaces were visible, as SCC600
did not transmit light. Therefore, white light interferometry and scanning electron microscopy were
used to closely examine colony morphology. Cells on the SCC120, SCC400, and SCC600 substrates five
days after seeding formed spherical colonies with similar morphology on all substrates (Figure 2.7) and
exhibited similar central pit formation at a later time point (discussed in Ji et al.,132 but mostly omitted
from this Chapter). Since all SCC-seeded cells also exhibited similar levels of gene expression (Figure
2.5), all future studies were performed only on the SCC400 substrate compared to the glass cover slips.
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a b c
Figure 2.7: SEM micrographs of ESC colonies five days after seeding on a) SCC120, b) SCC400, and
c) SCC600 showed similar colony morphology, so experiments were continued with only the SCC400
substrate. Scale: 100 µm.
2.3.3.2 White light interferometry
To further characterise the effects of topography on stem cell colony morphology, white light interfer-
ometry was performed and colony height was found to vary between the SCC substrates and the glass
cover slips (Figure 2.8a; images courtesy of Dr Lijun Ji). One day after seeding, the colonies had a mean
height of 8.4 ± 1.4 µm on the SCC400 substrates, and 16.9 ± 2.1 µm on glass cover slips. While this
difference was statistically significant (p < 0.05), it only represented a height difference of one or two
cells. On both substrates, the colony height on day one was representative of approximately 2-3 cells,
given an estimated post-fixation cell diameter of 5-10 µm, as measured from SEM micrographs.
After five days in culture, there was a statistically significant (p < 0.001) difference between the height
of colonies on the SCC400 substrates and the glass cover slips, representing a height difference of many
cells. The colony height on the SCC substrates had increased to 69.9 ± 16.9 µm, while it had decreased
on the glass cover slips to 14.6 ± 1.1 µm. These data suggest that cell spreading was reduced by the
structure of the SCC surface, which subsequently led us to investigate stress fibre morphology.
2.3.3.3 Phalloidin histochemistry
The distribution of phalloidin staining further demonstrated the strikingly different colony morphology
on SCC substrates compared to the glass cover slips. Phalloidin stains the actin filaments and is therefore
useful for visualising cell morphology. Five days after seeding, the colonies on SCC substrates retained
their spherical morphology, resembling undifferentiated ESCs (Figure 2.8b). The colonies were composed
of many round cells with diffuse cytoskeletons and an absence of stress fibres. In stark contrast, the cells
grown on glass cover slips had spread and were in a monolayer with highly established and elongated
stress fibres (Figure 2.8c).
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b
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p < 0.05
p < 0.001
Figure 2.8: a) White light interferometry was used to measure the colony heights on day 1 and day
5 after cell seeding. By day 5, the colonies on SCC400 were composed of multiple layers of cells, but
on glass cover slips, the cells were growing in a monolayer (N = 25, p < 0.05 considered statistically
significant). Cytoskeleton staining in an ESC colony on b) SCC400 demonstrated strikingly different
cytoskeletal morphology compared to on c) a glass cover slip, which exhibited highly elongated stress
fibres (red: phalloidin, blue: DAPI). Scale: 20 µm.
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2.3.4 Central pit formation
In addition to the differences seen in cell spreading and colony height, SEM micrographs and white light
interferometry of ESC colonies growing on SCC substrates revealed another interesting phenomenon not
observed by phase contrast microscopy. Approximately five days after seeding, ESC colonies on the SCC
substrates began to develop increasingly large cavities located in the centre of the colonies, which we have
termed central pits. These pits increased in size and prevalence up to fifteen days after seeding, when
virtually all colonies contained a large pit. Central pits were never observed on glass cover slips.
The evidence for this phenomenon, including SEM micrographs and LIVE/DEAD staining was published
in Ji et al.132 Figure 2.9a depicts a schematic of different ESC colony morphology observed on glass cover
slips and the SCC substrates. In Figure 2.9b, white light interferometry shows a representative image of a
colony that has developed a central pit after fifteen days in culture. ESC colonies on the SCC substrates
with central pits were typically 100 - 300 µm in diameter, with a minimum height of approximately 80
µm. Figure 2.9b shows a typical central pit with a depth of 33 µm, which is equivalent to the diameter
of 3-7 single ESCs.
Figure 2.9: ESCs grown on the SCC substrates develop central pits. a) A schematic demonstrating the
different colony shape on the glass cover slips and the SCC substrates, where on the latter, the cells
formed a central pit. b) White light interferometry showed a representative colony at day 15 on the
SCC400 substrate. Scale: 50 µm, z-axis in micrometres.
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2.3.5 Immunofluorescence
Upon observing the formation of central pits, immunofluorescence was used to examine whether the
cells around the upper layers of the colonies were epithelial cells. This hypothesis was based on the
examination of scanning electron micrographs of colonies with central pits where the cells around the
pit had organised, epithelial-like morphology.132 E-cadherin is found in cell-to-cell junctions of epithelial
tissues, where its presence increases the strength of cellular adhesions within a tissue. The distribution of
epithelial cells was revealed via immunofluorescence staining of E-cadherin and ZO-1, a protein associated
with intercellular tight junctions. Figure 2.10 shows the strongest expression for both E-cadherin and
ZO-1 was at the periphery of the colony base on the SCC400 substrate. From the base to the top of
the colony, E-cadherin and ZO-1 expression decreased gradually but the strongest expression in every
cross-section remained at the periphery (Figure 2.10b-e), suggesting that cells in the outside layer of the
colony are expressing epithelial markers. DAPI staining of cell nuclei showed the area at the base of the
colony was much smaller than that of other layers, confirming that the colonies were not spreading on
the SCC400 substrates to the same extent as they did on glass cover slips.
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DAPI E-Cadherin ZO-1 Merge
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c
d
e
Figure 2.10: Immunofluorescence demonstrating a central pit. The colony in contact with a) the SCC400
substrate has a small area which increases b) 15 µm, c) 30 µm, and d) 35 µm from the substrate. DAPI
staining indicates a lack of nuclei in the centre of the colony. E-cadherin staining is strongest at the
bottom of the colony (a) and becomes more diffuse towards the middle and top (b, c, d). ZO-1 staining
is strongest at the bottom of the colony (a) and the periphery (b, c, e). A merge of all z-stacks (0.84 µm
each) is shown in e). Scale: 50 µm.
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2.4 Discussion
In this study, silica colloidal crystal (SCC) microspheres were synthesised with diameters of approximately
120, 400, and 600 nm and substrates were fabricated from them with topographical features of the same
sizes. The total amount of pre-adsorbed collagen was similar on each substrate and the cells therefore had
a similar quantity of collagen available for binding. In order to determine how the substrates influence
murine embryonic stem cell behaviour, gene expression, colony morphology, and protein expression were
examined on the SCC substrates and on glass cover slips.
It was first observed that cells cultured on SCC substrates maintain gene expression more similar to ESCs
than cells on glass cover slips or in embryoid bodies. Nanog was down-regulated, and Fgf5 and Foxa2
up-regulated, to a lesser extent in cells on SCCs than either on glass cover slips or in EBs, indicating that
population-wide differentiation was less pronounced in SCC substrate specimens. Looking at markers
for specification into ectoderm, endoderm, or mesoderm, it was found that the SCC400 topography
appeared to specifically inhibit the endoderm differentiation which occurred in EBs and in ESCs cultured
on glass cover slips after eleven days in culture. The substrate effects on these differentiation markers
may have been through a number of mechanisms. Firstly, SCC substrates were observed to inhibit ESC
colony spreading. Since cell spreading, stimulated by ECM components promotes ESC differentiation by
the activation of integrin signalling pathways97 and conversely, the reduction of cell-substrate contacts
promotes self-renewal,133 we suggest that culture on the SCC substrates, which inhibit spreading, in turn
repress the effectors of integrin signalling, and therefore limits differentiation. A thorough review of the
effects of feature spacing on integrin adhesion by Biggs et al. also suggests that features in the size range
we studied may disrupt integrin binding, which is consistent with the diminished colony spreading we
observed.134 Andersson et al. found that human bladder cells on hemispherical structures appeared less
spread than those on flat samples with a corresponding decrease in cytokine production.135 Additionally,
the increased paracrine growth-factor signalling between ESCs in more three-dimensional, tightly packed
colonies on the SCC substrates may also stimulate self-renewal. Dani et al. showed that even in the
absence of LIF, paracrine factors in ESC colonies can stimulate self-renewal.136 Of course, this is also
true in EBs, but since EBs are in the region of 300 -1000 µm in thickness (compared to approximately 80
µm for colonies on the SCC substrates), other factors such as increased cell migration, nutrient depletion,
and distance-dependent paracrine signalling antagonistic to self-renewal may obscure this effect.
The most differential feature noted was the reproducible formation of a central pit in the centre of ESC
colonies cultured on SCC substrates. This characteristic was observed by both scanning electron mi-
croscopy and white light interferometry and is shown in Ji et al.132 A similar phenomenon in vitro has been
observed by Behr et al., when rhesus monkey ESCs were cultured on mouse embryonic fibroblast (MEF)
feeder layers.137 Immunofluorescence indicated their cells were undergoing an epithelial-mesenchymal
transition and the central pit formation was attributed to the presence of the feeder layer. In this study,
it was shown that central pit formation was induced by the SCC substrates. It was initially considered
that pit formation may have been the result of cell death at the centre of the colonies cultured on SCC
substrates. However, no cell death in the pit location was observed.132 Without any evidence supporting
cell death as a cause for central pit formation, it was instead suggested that the lack of spreading and
subsequently enhanced cell-cell contacts in the spherical colonies promoted the central pit formation.
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Cells in the top layer of the colony around the central pit were columnar in shape and radially arranged.
Epithelial markers E-cadherin and ZO-1 were expressed more strongly around the edge of the colony
than in the centre. Columnar cells showing epithelial-like characteristics were also observed by Ullmann
et al. in the top layer of human embryonic stem cell colonies when the epithelial-mesenchymal transition
(EMT) process was taking place, although no central pit morphology was reported.138 Here, it is possible
that a process similar to EMT is taking place around the central pit, where cells lose expression of
epithelial markers and begin to assume a mesenchymal, migratory phenotype. Immunofluorescence for
both epithelial and mesenchymal markers at various time points would have to be performed on these
substrates to assess whether an EMT is occurring.
Modern technologies have made it possible to fabricate diverse, complex, and reproducible topographies
across large surface areas. In combination with other substrate cues known to affect cell behaviour,
topographical features could potentially guide stem cell differentiation strongly enough to create the
homogenous cell population needed in regenerative medicine applications. Future work on the effects of
these substrates on ESC self-renewal would complement the morphology observations in this study and
reconcile the apparent decrease in differentiation markers with the appearance of a morphological feature
reminiscent of an early differentiation event.
54
2. STEM CELL RESPONSE TO MICROMETRE SCALE TOPOGRAPHY
2.5 Conclusion
In conclusion, substrates of well-defined and highly reproducible nano- to micrometre topography were
fabricated and their effects on ESCs were studied. It was found that substrate topography can influence
both the shape and fate of differentiating colonies of ESCs. Specifically, cells grown on the substrates
with topography retained a spherical colony morphology and eventually developed a central pit. In this
work, the profound effects substrate topography can have on ESCs was shown. This system provides
a possible method of visualising and characterising cell arrangements in early mammalian development
and for better understanding the effects of topography on embryonic stem cells.
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Chapter 3
Embryonic stem cell response to
nanoscale chemistry and topography
Significant portions of this chapter have been submitted for publication in:
LaPointe V, Fernandes A, Bell N, Stellacci F, Stevens MM. Nanoscale topography and
chemistry affect embryonic stem cell self-renewal and early differentiation.
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3.1 Introduction
Adherent cells respond to a wide range of substrate cues, including chemistry, topography, hydrophobicity,
and surface energy. The cell-substrate interface is therefore an important design parameter in regenerative
medicine. In this chapter, the effects of nanometre scale topography and chemistry on cell behaviour were
studied. Thin films composed of 4.5 nm gold nanoparticles coated with a mixture of two alkanethiols were
fabricated, conferring hemispherical topography and specific chemistry to bulk substrates. The behaviour
of murine embryonic stem cells (ESCs) on the thin films was compared to their behaviour on self-assembled
monolayers of the same alkanethiols on vapour-deposited gold, which lacked the topographical features.
Cells were cultured both with and without differentiation inhibitors. Immunofluorescence for Oct4 and
qPCR for Fgf5 , Foxa2 , Nanog, Pou5f1 , and Sox2 were performed. We herein test the hypothesis that
nanoscale topography and chemistry can influence ESC differentiation.
HO
SH
6-mercapto-1-hexanol (MH)
HS CH3
1-octanethiol (OT)
Alkanethiols used in both substrates
Gold-coated glass preparation
Glass slide Vapour deposition
Self-assembled monolayer of MH and OT
Domains of > 5 nm
“Flat SAMs”
Nanoparticle synthesis
Stucky method
Dried 
particles
Methanolic 
solution
Thin film of nanoparticles
AFM
Particle diameter ~ 4.5 nm
“Nanoparticle Thin Films”
Figure 3.1: Two immiscible alkanethiols (6-mercapto-1-hexanol (MH) and 1-octanethiol (OT)) were
used in the fabrication of self-assembled monolayers (“Flat SAMs”) and thin films composed of gold
nanoparticles with an alkanethiolate shell (“Nanoparticle Thin Films”). Flat SAMs were self-assembled
on a vapour-deposited gold-coated glass slide and formed alkanethiolate domains of > 5 nm. Nanoparticle
Thin Films were composed of gold nanoparticles synthesised by a modified Stucky method, dried, and
solubilised in methanol. The 4.5 nm nanoparticles were covalently attached to a silanised glass slide
by a layer-by-layer technique with alternating incubations of a dithiol crosslinker and the nanoparticle
solution. The atomic force microscopy (AFM) image demonstrates the substrate after the thin film was
built up (scale: 500 nm, courtesy of Dr Jeff Kuna). The two types of substrates had different topography
(domains of either > 5 nm or ∼ 4.5 nm for the Flat SAMs and Nanoparticle Thin Films, respectively)
and tailorable chemistry, governed by the stoichiometric ratios of MH and OT used in the synthesis.
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3.1.1 Gold nanoparticles
For many centuries, the optical properties of gold nanoparticles (AuNPs) have been used by artists to
produce vibrant pigments and dyes. More recently, the same properties have led to the use of AuNPs
in a wide range of technological applications, from medicine to electronics. This chapter focuses on the
coating of gold nanoparticles with self-assembled monolayers.
Schiffrin first showed that Faraday’s two-phase colloid synthesis could be combined with phase transfer
and alkanethiol/gold chemistry to synthesise small gold nanoparticles (≤ 5 nm) coated with an alkanethi-
olate monolayer.139,140 A major advantage of the alkanethiolate-coated nanoparticles is that they can be
isolated from and redissolved repeatedly in organic solvents without experiencing irreversible aggregation
or decomposition. This varies from nanoparticles synthesised by other routes.140 Futhermore, monodis-
perse particles are straightforward to synthesise and their stability in air makes them relatively easy to
handle.141
Self-assembled monolayer formation of thiolated molecules on gold nanoparticles involves initial physisorp-
tion of the molecules on gold followed by chemisorption through the sulphur-heads over a few minutes and
then the slow formation of ordered domains over a few hours or up to days.142–145 Once chemisorbed by
losing the mercaptan hydrogen, ligands can diffuse on the nanoparticle to more energetically favourable
conformations.146 The ligand shell confers a number of properties to the nanoparticle such as stability
against aggregation,147 solubility,148 biological sensing,149 and assembly properties.150,151
Following synthesis, gold nanoparticles are easily immobilised on surfaces through thiol-gold chemistry.
For instance, a glass surface can be coated with a silane containing a thiol group, to which the nanopar-
ticles can attach. When poludisperse gold nanoparticles pack on a surface, they form hexagonal domains
with the larger nanoparticles in the centre, surrounded radially by progressively smaller particles. These
configurations will be repeated throughout the surface and are thought to be optimal in minimising the
van der Waals forces. Similar packing was observed even with highly polydisperse particles.152
3.1.2 Monolayer-protected metal nanoparticles (MPMNs)
Monolayer-protected metal nanoparticles (MPMNs) are composed of a noble metal core surrounded by a
3D self-assembled monolayer (SAM) of organic ligands bound through a thiol-gold bond.150 They have
recently been exploited for many uses in physics,153 chemistry,154 material science,155 biology,149 and
medicine.156 They are relatively simple to synthesise and exhibit useful optical and electronic properties
derived from their size and shape.
3.1.2.1 Formation of phase-separated domains
SAMs composed of a mixture of ligands have long been known to phase-separate as can be observed by
scanning tunnelling microscopy (STM), but the phases do not exhibit any order.157,158 In 2004, Jackson
et al. first presented monolayer-protected metal nanoparticles with ordered phase-separated domains in
their ligand shell.159 They found that when a SAM of two alkanethiol ligands with varying tail groups
is formed around a gold nanoparticle, the ligands separate into stripes, or ripples, with domains as
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small as < 1 nm. This separation was first confirmed by STM and later by Fourier transform infrared
spectroscopy.160
The ripple formation has been modelled using atomistic and mesoscale simulations.161 It was shown that
for equimolar mixtures of ligands, ripples form due to a balance between enthalpic losses and entropic
gains due to mismatched alkane chain length or headgroup bulkiness. Bulk phase separation, as is
typically observed when two immiscible ligands are chemisorbed, is driven by free energy minimisation
(enthalpic losses). Ripple formation is driven by the increase in inferfaces (configurational entropic gain)
when long or bulky ligands are surrounded by short or less bulky ones. With sufficient entropic gain
to overcome the energetic penalty of forming extra interfaces, ripples will form instead of bulk phase
separation.
For a mixture of immiscible ligands with unequal length or bulkiness, simulations predicted bulk phase
separation would occur regardless of the radius of curvature of the surface. By either introducing a
sufficient difference of length or bulkiness, ripples will form on a surface with sufficient curvature. And
with a sufficient length difference, ordered phase-separated domains will form on a flat surface. This again
demonstrated the role of conformational entropy where increasing length differences acts to stabilise the
ripples. For extremely high degrees of curvature (very small gold core), bulk phase separation was
observed, and Janus particles were formed. Since the spheres are relatively small compared to the ligand
length, the chains already have sufficient conformational entropy and the gain in entropy by creating
interfaces is not so significant.
The presence of the ripples results in the formation of polar groups. Molecules in SAMs on flat surfaces
align to form a 2D crystal in which every molecule has the same tilt angle and direction relative to
the surface in order to maximise the van der Waals interactions with its neighbour ligands.162 However,
on a topographical sphere, such as a gold nanoparticle, a 2D crystal cannot exist without the presence
of two point defects.163 This is known as the Hairy Ball Theorem, which states that it is impossible
to align hairs on a sphere without generating two singularities. In the case of rippled MPMNs, the
ordered domains result in two profoundly demarcated polar singularities.150 Ligands at the poles are
not stabilised by the interactions with their neighbours and therefore act as highly reactive defects,
susceptible to place-exchange reactions. DeVries et al. utilised these unstable singularities to form chains
of nanoparticles in a demonstration of directional assembly.150 They performed a place-exchange reaction
in a two-phase reaction with the particles in the organic phase and the linker (1,6-diaminohexane) in the
water phase. Imaging with transmission electron microscopy (TEM) showed chains of pole-functionalised
rippled MPMNs. Carney et al. followed up on this work by showing that only MPMNs within a certain
size range can form chains, suggesting that ripples only form within that same size range.164
3.1.2.2 Unique properties of MPMNs
The formation of phase-separated domains, or ripples, is an interesting phenomenon in itself but it also
lends a number of unique properties that have been attributed to the ripples. For example, the solubility
and interfacial energy are not correlated to hydrophobicity. Subsequently, these properties also affect cell
behaviour, such as cellular uptake.
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Solubility : The solubility of MPMNs in ethanol does not monotonically increase with the concentration of
hydrophilic ligand as could be expected.159 When ordered phase-separated domains (ripples) are present,
the longer of the two ligands determines solubility.165 When unordered phase-separated domains are
present (no ripples), the concentration of hydrophilic ligands determines solubility. Interestingly, this
showed that solubility depends on domain morphology and not just on the chemical composition of the
ligand shell.
Interfacial energy : According to continuum thermodynamics, increasing hydrophobicity of a SAM leads
to increasing water contact angle and interfacial energy is linked to the work of adhesion. When a surface
is composed of multiple components, the overall interfacial energy is a weighted average of the interfacial
energies of the individual components. Interesting, this model falls apart for thin films of the rippled
nanoparticles.166 In these films, increasing hydrophobicity results in a non-linear relationship with water
contact angle.
Cellular uptake: The particles can be taken up by cells and end up in the cytosol. By design, many
biomolecules can fuse to and pass through the cell membrane without disruption. Cationic nano-objects
such as quantum dots can also pass through the cell membrane but in doing so, they induce transient
poration which is associated with cytotoxicity.167 Most nanoparticles become trapped in endosomes and
do not reach the cytosol.168 Verma et al. demonstrated that ∼6 nm rippled MPMNs were able to
enter the cytosol.169 These results were not seen in similar particles without rippled domains, which
suggested that the structural organisation of surface chemistry on the nanoparticle played a key role in
regulating cell membrane penetration. When fluorescently-tagged MPMNs were incubated with dendritic
cells, the MPMNs without ripples showed punctuate fluorescence which is typical of particles trapped in
vesicular structures such as endosomes. The rippled particles, however, showed strong fluorescence in the
cytosol. A follow-up study further demonstrated the role of the rippled nanoparticle domains in their
internalisation.170
Protein adsorption: Preliminary studies of protein interactions with rippled MPMNs suggested that
the particles appeared to avoid non-specific protein adsorption. This is possibly a consequence of the
subnanometre ordering of hydrophobic and hydrophilic regions on the ligand shell. The characteristic
size of a protein globule is more than an order of magnitude larger than the domain spacing on these
nanoparticles. When a protein approaches the surface it will experience a series of attractive and repulsive
forces due to the particle’s domains. Therefore, the net attraction of a protein to the particle is almost
zero and adsorption is not thermodynamically favourable. Jackson et al. used three model proteins:
1) cytochrome C, a medium-sized protein which binds to unordered MPMNs, 2) lysozyme, a small,
positively charged, rigid protein known to remain folded when adsorbed to hydrophilic monolayers, and
3) fibrinogen, a large protein known to unfold on hydrophilic monolayers. Using scanning tunnelling
microscopy (STM), atomic force microscopy (AFM), and Fourier transform infrared spectroscopy (FTIR)
they found that all proteins adsorbed well on monolayers of varying composition but did not adsorb on
rippled nanoparticles.159
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3.1.3 Cell response to nanotopography
Materials with nanometre scale features aimed at guiding cell behaviour are of particular interest because
of the many biological processes and interactions that occur at that scale. For example, collagen in the
extracellular matrix (ECM) supports cells and contains nanoscaled banding.77
In vitro, cells are known to respond to topographical cues independent of biochemistry, resulting in diverse
cell behaviour.95 An early study demonstrated that endothelial cells can be switched from growth to apop-
tosis simply by using micropatterned substrates containing progressively sparser protein islands to restrict
cell extension.106 Many other processes known to be affected by surface topography are key in cell survival
and phenotype, even as the topographical features approach the nanometre scale. Nanometre-scale spac-
ing between ligands affected hematopoietic stem cell adhesion, an effect attributed to integrin-mediated
signalling.171 Both endothelial cells and fibroblasts were found to align according to 13 nm islands created
by polymer demixing techniques.172,173 A technique called Dip Pen Nanolithography produced nanoscale
patterns of chemical modifications that initiated mesenchymal stem cell (MSC) differentiation.110 A va-
riety of nanoscale structures formed by electron beam microscopy and hot embossing showed that MSCs
can be exquisitely sensitive not only to the size and shape of substrate patterns but also to their arrange-
ment.108 Cells cultured on substrates with a symmetrical arrangement of nanotopographical features had
diminished adhesion and osteogenesis, whereas cells cultured on disordered nanotopographical features
expressed a higher degree of osteogenic markers. A follow-up using the same lithographical techniques
demonstrated that MSC multipotency was indeed preserved on the symmetrical nanotopography.109
Recently, tools have been developed that will allow for the mechanisms of the cell response to be studied.
One recent study used a combinatorial approach, previously reserved for chemistries, to present many
different topographical cues to MSCs and found effects on proliferation and osteogenic differentiation.107
These effects have been attributed to a number of signalling pathways, many of which involve integrin
clustering as the effectors and future work will no doubt aim to elucidate these pathways.78,174
3.1.3.1 Embryonic stem cell response to nanotopography
Despite the large body of work forming in the field, there remains little known about topographical
effects in the < 10 nm region175 and specifically about ESC response.94 This is probably due to both
the difficulty in producing such small features and in working with ESCs, which are typically grown on
a feeder layer. In terms of the fabrication technique, electron beam lithography may be the tool of best
quality for creating defined nanoscale features, but its resolution for arrays of patterns is only as low as
approximately 10 nm and even this can require special techniques to overcome the high intermolecular
forces that prevent the exposed resist molecules from dissolving in developer solution.176
There have, however, been a few recent studies on the effects of nanoscale topography on ESCs. Mouse
ESCs in contact with electrospun fibrous scaffolds differentiated into neural lineages and had enhanced
neurite outgrowth,177 while cells cultured on polydimethylsiloxane (PDMS) substrates with nanoscale
topography maintained self-renewal.178 Human ESCs seeded on nanoscale grooved substrates underwent
neuronal differentiation even in the absence of differentiation-inducing agents.179 Similarly, human ESCs
on glass substrates with nanoscale roughness underwent spontaneous differentiation.180
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3.2 Materials & Methods
3.2.1 Nanoparticle synthesis
Monolayer-protected metal nanoparticles (MPMNs) were synthesised using a previously published mod-
ified Stucky method.166,181 All reagents were purchased and used as received from Sigma-Aldrich (UK).
Approximately 1 mM chloro(tripheno-phosphine)gold(I) (AuPPh3Cl; 99%) was dissolved in 80 ml dichloro-
methane (DCM) heated to 55◦C in a water bath. After 10 min, a total of 1 mM alkanethiols (6-
mercapto-1-hexanol (“MH”, HS(CH2)6OH; 97%) and 1-octanethiol (“OT”, SH(CH2)7CH3; 98%)) were
added according to Table 3.2 and stirred for 10 min after which 10 mM borane tert-butylamine complex
((CH3)3CNH2·BH3; 97%) was added and the flask was tightly capped and stirred for 1 h at 55◦C. After
cooling to room temperature, 80 ml diethyl ether (Et2O) was added and the particles were precipitated
overnight at room temperature. The supernatant was removed and the particles were collected, washed
in Et2O, dissolved in a small volume of ethanol, reprecipitated in Et2O, and washed again. The particles
were dried in air and transferred to a glass vial for storage.
Table 3.1: Generalised MPMN synthesis
5:1 MH:OT 2:1 MH:OT 1:1 MH:OT 1:2 MH:OT 1:5 MH:OT
AuPPh3Cl 1 eq 1 eq 1 eq 1 eq 1 eq
(CH3)3CNH2BH3 10 eq 10 eq 10 eq 10 eq 10 eq
HS(CH2)6OH 5/6 eq 2/3 eq 1/2 eq 1/3 eq 1/6 eq
SH(CH2)7CH3 1/6 eq 1/3 eq 1/2 eq 2/3 eq 5/6 eq
Table 3.2: Typical MPMN synthesis in 80 ml solvent
5:1 MH:OT 2:1 MH:OT 1:1 MH:OT 1:2 MH:OT 1:5 MH:OT
AuPPh3Cl 496 mg 496 mg 496 mg 496 mg 496 mg
(CH3)3CNH2BH3 870 mg 870 mg 870 mg 870 mg 870 mg
HS(CH2)6OH 227 µl 181 µl 136 µl 91 µl 45 µl
SH(CH2)7CH3 58 µl 116 µl 174 µl 231 µl 290 µl
3.2.2 Nanoparticle thin film substrate fabrication
Glass chamber slides (Nunc, Germany) were oxygen plasma treated under 0.2 mbar pressure and 50 W
for 1 min (Plasma Prep 5, GaLa Instrumente, Germany). They were then vapour-silanised in a light
vacuum desiccator with a dish of 3-mercaptopropyl(trimethoxysilane) (HS(CH2)3Si(OCH3)3; > 97%)
(Sigma-Aldrich, Dorset, UK) for 2 h. The glass slides were washed profusely with ethanol, dried, and
incubated in a 0.25 mg/ml methanolic solution of MPMNs overnight at ambient temperature. Slides
were washed profusely in ethanol, dried, and incubated for 1 h in 5 mM ethanolic 1,9-nonanedithiol
(95%; Sigma-Aldrich). This alternate incubation of MPMNs followed by dithiol was repeated to obtain
seven layers of particles.
3.2.3 Self-assembled monolayers on Au-coated glass
Self-assembled monolayers (SAMs) of the same alkanethiols used in MPMN synthesis were prepared on
gold substrates prepared by electron beam physical vapour deposition (EB-PVD; performed by Miss Nia
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Bell) in an Auto 306 Coating Unit (Edwards, UK). Cleaned microscope slides were ozone plasma treated
before being placed in the evaporator where they were coated with a 5 nm layer of chromium followed
by an 80 nm layer of gold. A copper mask was used to limit the areas of the metal evaporated to 1
cm2. The substrates were transferred directly from the evaporator into 10 µM ethanolic solutions of
mixed alkanethiols in the same ratios as in the nanoparticle synthesis and incubated for 1 week. They
were rinsed profusely in ethanol and stored in air until use. Gold substrates without any self-assembled
monolayers were used as a reference material.
3.2.4 Transmission electron microscopy
Characterisation of particle size distribution was performed with transmission electron microscopy (TEM).
5 µl of 0.125 mg/ml ethanolic nanoparticle solution was pipetted on a 300 mesh carbon-coated copper
TEM grid (Agar Scientific, UK), wicked away, and allowed to dry in air for at least 30 min. Microscopy
was performed with the assistance of Miss Ana Tiago Fernandes and Miss Nia Bell on a JEOL 200CX
(Japan) at an accelerating voltage of 200 kV and 60,000-80,000 x magnification. A minimum of 400
particles were measured from micrographs of the same resolution using ImageJ software (available at
http://rsbweb.nih.gov/ij) and the size distribution was plotted as percent composition vs. diameter.
Polydispersity index (PDI) was calculated as Mw/Mn, where Mw is the weight average diameter and Mn
is the number average diameter.
3.2.5 Cell culture
TG2α/E14 (ATCC CRL-1821 from LGC Standards, UK) were subcultured on 0.1% (w/v) gelatin (Sigma-
Aldrich, UK) coated polystyrene dishes (Nunc, Germany) in ESC medium (DMEM with 10% FBS, 2 mM
l-glutamine, 100 µM non-essential amino acids (all from Invitrogen, UK), 100 µM β-mercaptoethanol
(Sigma-Aldrich) and 1000 U/ml LIF (Leukaemia inhibitory factor; Chemicon ESGRO, Millipore, UK).
On day 0, cells were seeded at 7,500 cells/cm2 in ESC medium supplemented with LIF. Starting on day
1, samples were fed daily either with or without supplemented LIF until collected for analysis.
3.2.6 Immunofluorescence
All reagents were purchased from Sigma-Aldrich (Dorset, UK) unless specified otherwise. BrdU (5-
bromo-2’-deoxyuridine, >99%) was added to medium to a final concentration of 10 µM 4 h before the
timepoint. Cells were fixed in fresh 3.7% (w/v) paraformaldehyde for 15 min then washed once in PBS.
Samples that had been incubated in BrdU were denatured in 2M HCl for 20 min then neutralised in 0.1M
sodium borate buffer (sodium tetraborate decahydrate, pH 8.5). All samples were washed twice in PBS,
permeabilised for 10 min in 0.25% (v/v) Triton X-100 in PBS, washed three times in PBS, and blocked
in 5% (v/v) goat serum in PBS-T for 20 min. Samples were incubated in rabbit anti-Oct4 (ab19857,
Abcam, UK, 1/1000) and WGA Alexa633 (Wheat Germ Agglutinin, Invitrogen, UK, 1/1000) or rabbit
anti-Annexin V (ab14196, Abcam, 1/1000), and mouse anti-BrdU (ab8152, Abcam, 1/1000) in 2.5%
(v/v) goat serum in PBS-T for 2 h at ambient temperature in the dark. They were washed three times
in PBS-T and incubated in Alexa Fluor-conjugated goat anti-mouse IgG or goat anti-rabbit IgG 1/2000
(Molecular Probes, Invitrogen) in 2.5% (v/v) goat serum in PBS-T for 1 h at ambient temperature in
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the dark then washed three more times in PBS-T. To counterstain the nuclei, samples were incubated for
1 min in 300 nM DAPI (4’,6-diamidino-2-phenylindole dilactate, Invitrogen) and washed once in PBS.
They were coverslipped using ProLong antifade gold reagent (Invitrogen), left to dry for 24 h at ambient
temperature in the dark and stored at 4◦C prior to visualisation.
3.2.7 RNA extraction
Cells were lysed in 100 µl Buffer RLT (Qiagen, Germany) with 1% (v/v) β-mercaptoethanol and stored
at -20◦C for up to two weeks. An additional 250 µl of the supplemented buffer was added and lysates
were thawed on ice. Lysates were homogenized using a QiaShredder column and RNA was extracted
using the RNeasy kit (Qiagen) according to the manufacturer’s instructions. RNA quantity and quality
was assessed on a NanoDrop 1000 (Thermo Scientific, USA).
3.2.8 cDNA synthesis and quantitative PCR
100 ng RNA was reverse transcribed using SuperScript III VILO (Invitrogen) in a 20 µl reaction according
to the manufacturer’s instructions. Real-time PCR was performed on a Rotorgene 6000 (Corbett, Qiagen)
with primers for Fgf5 , Foxa2 , Nanog, Pou5f1 , and Sox2 with Gapdh (Quantitect, Qiagen) as an internal
control using EXPRESS GreenER (Invitrogen) according to manufacturer’s instructions. Thermocyling
was performed as follows: 2 min at 50◦C, 10 min at 95◦C, then 40 cycles of 15 s at 95◦C and 60 s at
62◦C then a melt curve from 60-95◦C to ensure a single amplicon. Transcript expression was calculated
using the ∆∆Ct method relative to ESCs prior to the experiment, with Gapdh as the internal control.
Data are presented as 2−∆∆Ct - 1 for positive values (such that the control sample is set to zero) and as
the negative inverse for negative values (such that down-regulation is presented on a negative scale).
3.2.9 Confocal microscopy
Imaging was performed on an inverted confocal microscope (SP5 MP/FLIM, Leica, Germany) with a
63X oil objective under standardised gain and offset. Line averages were used. For z-stacks, each stack
was 0.84 µm thick.
3.2.10 Statistical analysis
Statistical analysis between samples was performed using Student’s t-test and between groups was per-
formed using ANOVA, with p < 0.05 considered significant.
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3.3 Results
One of the major aims of tissue engineering is to design materials that can control cell behaviour and
ultimately drive the cells to create a therapeutically relevant tissue. While there are many studies
demonstrating the potential for using substrate cues to generate this control, there remains a dearth
of information on the effects of nanometre scale cues and, in particular, their effect on embryonic stem
cells (ESCs). Furthermore, it is difficult to isolate the effects of only chemistry or topography when
many systems employed have these variables changing concurrently. In this study, materials science and
biology were combined to fabricate two classes of materials that allowed us to study the effects of nanoscale
chemistry and topography on murine ESCs. We synthesised gold nanoparticles with stoichiometrically
defined shell chemistry to create covalently bound, closely packed nanoparticle films (“Nanoparticle Thin
Films”) of defined topography and tailorable chemistry. We were able to isolate the effect of nanoscale
topography alone by fabricating self-assembled monolayers on vapour-deposited gold (“Flat SAMs”)
composed of the same nominal alkanethiol composition as in the Nanoparticle Thin Films, thereby holding
bulk chemistry constant. Similarly, we could study the effects of nanoscale chemistry alone by preparing
both the Nanoparticle Thin Films and the Flat SAMs with varying ratios of hydrophobic and hydrophilic
ligands, while holding substrate topography constant.
3.3.1 Nanoparticle synthesis
A minimum of three batches of each type of MPMNs (5:1, 2:1, 1:1, 1:2, and 1:5 MH:OT) were synthesised.
Schematics of the ligand SAMs are depicted in Figure 3.2. Based on the results of the UV-visible spectrum
and TEM analysis of the size distribution, one batch of each type was used to make the thin films used
in this experiment. The reaction yields for these batches are presented in Table 3.3. The reaction yield is
defined as the weight of particles divided by the starting amount of gold salt so by definition, two equally
efficient reactions of different types of particles will have a different reaction yield, but nonetheless, a
yield of approximately 30% was typical for this synthesis.
a) 5:1 b) 2:1 c) 1:1 d) 1:2 e) 1:5
Figure 3.2: Schematics depicting the arrangement of ligands in the self-assembled monolayer shell of gold
monolayer-protected nanoparticles. The ratio refers to the molar ratio of the alkanethiolate self-assembled
monolayer composed of 6-mercapto-1-hexanol (MH, red) and 1-octanethiol (OT, yellow) surrounding the
gold nanoparticle. In certain molar ratios, the phase separation becomes ordered and ripples form (b-d).
65
3. STEM CELL RESPONSE TO NANOSCALE CHEMISTRY AND TOPOGRAPHY
Table 3.3: Percentage yield of MPMN synthesis
Yield (mg) Yield (%)
5:1 MH:OT 226.6 mg 45.7
2:1 MH:OT 153.5 mg 30.9
1:1 MH:OT 159.1 mg 32.1
1:2 MH:OT 166.9 mg 33.6
1:5 MH:OT 97.3 mg 19.6
3.3.2 UV-visible spectroscopy and TEM of nanoparticle solutions
UV-visible spectroscopy and TEM was performed on MPMN solutions (i.e.- prior to substrate fabri-
cation) to assess the synthesis and size distribution of the particles (Figure 3.4. The plasmon peak of
approximately 500 nm is characteristic of gold nanoparticles this size. There were no statistically sig-
nificant differences in particle size for the batches used in the subsequent cell studies (p > 0.05). Table
3.4 summarises the surface plasmon peak wavelength, the average particle Feret’s diameter,182 and the
polydispersity index of the batch. Table 3.5 summarises the mean size and polydispersity index (PDI) of
the synthesised particles.
a b c
d e
Figure 3.3: Transmission electron microscopy was used to determine the size and size distribution of
the nanoparticles of five chemical compositions: a) 5:1 MH:OT, b) 2:1 MH:OT, c) 1:1 MH:OT, d)
1:2 MH:OT, and e) 1:5 MH:OT, where the ratio refers to the molar ratio of the alkanethiolate self-
assembled monolayer composed of 6-mercapto-1-hexanol (MH) and 1-octanethiol (OT) surrounding the
gold nanoparticle. Scale: 10 nm.
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Figure 3.4: UV-visible spectroscopy and transmission electron microscopy of nanoparticle solutions were
used to assess the nanoparticle synthesis. The ratio refers to the molar ratio of the alkanethiolate self-
assembled monolayer comprised of 6-mercapto-1-hexanol (MH) and 1-octanethiol (OT) surrounding the
gold nanoparticle. Absorbance in the UV-visible spectrum was taken of all batches, which show a plasmon
peak around 500-510 nm, characteristic of nanoparticles this size. Transmission electron microscopy was
used to measure particle size and a frequency distribution was plotted to demonstrate polydispersity.
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Table 3.4: Plasmon peak, average particle size, and polydispersity index of synthesised MPMNs
Plasmon Peak Average Particle PDI
(nm) Diameter (nm)
5:1 MH:OT 504 4.11 ± 0.69 1.02
2:1 MH:OT 509 4.40 ± 0.74 1.03
1:1 MH:OT 502 5.20 ± 0.93 1.02
1:2 MH:OT 504 4.29 ± 0.70 1.02
1:5 MH:OT 500 4.69 ± 0.86 1.03
5:1 2:1 1:1 1:2 1:5
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Figure 3.5: Box and whisker plot of nanoparticle size indicates similar size and polydispersity of the
nanoparticles (p > 0.05). The horizon line inside the box indicates the median, the dark circle indicates
the mean, the box spans the 25th-75th percentile, and the whiskers span the 5th-95th percentile. The
ratio refers to the molar ratio of 6-mercapto-1-hexanol (MH) and 1-octanethiol (OT) in the self-assembled
monolayers.
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3.3.3 BrdU uptake
Bromodeoxyuridine (BrdU) is a synthetic analogue of thymidine and its incorporation during the S
phase of mitosis, which can later be detected by an antibody, is an indicator of proliferation. We initially
considered that varying the bulk chemistry of Nanoparticle Thin Films may cause ESCs to proliferate
differently. However, both in the presence (Figure 3.6) and absence (Figure 3.7) of LIF, no differences
were observed in BrdU uptake after two days in culture.
a) Gelatin b) 5:1 MH:OT c) 2:1 MH:OT
d) 1:1 MH:OT e) 1:2 MH:OT f) 1:5 MH:OT
DAPI BrdU
Figure 3.6: Immunofluorescence demonstrates BrdU uptake by ESCs, an indicator of proliferation, on
Nanoparticle Thin Films after two days in culture in the presence of LIF. The ratio refers to the molar
ratio of 6-mercapto-1-hexanol (MH) and 1-octanethiol (OT) in the self-assembled monolayers. Similar
proliferation was observed on the substrates of varying chemistry. Scale: 20 µm.
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c) 2:1 MH:OT
d) 1:1 MH:OT
BrdU
f) 1:5 MH:OT
DAPI
b) 5:1 MH:OTa) Gelatin
e) 1:2 MH:OT
Figure 3.7: Immunofluorescence demonstrates BrdU uptake by ESCs, an indicator of proliferation, on
Nanoparticle Thin Films after two days in culture in the absence of LIF. The ratio refers to the molar
ratio of 6-mercapto-1-hexanol (MH) and 1-octanethiol (OT) in the self-assembled monolayers. Similar
proliferation was observed on the substrates of varying chemistry. Scale: 20 µm.
3.3.4 Quantitative PCR of stem cell markers
In order to evaluate how nanoscale chemistry and topography affect the genes crucial in stem cell main-
tenance, quantitative polymerase chain reaction (qPCR) was used to probe for mRNA levels of Pou5f1
(Oct4), Nanog, and Sox2 , markers of ESC pluripotency and self-renewal (Figure 3.8). Cells were seeded
on gelatin- and gold-coated glass as reference substrates, Nanoparticle Thin Films of varying chemistry,
and self-assembled monolayers (Flat SAMs) of the same nominal bulk chemical compositions as the
Nanoparticle Thin Films. Six days after seeding and having been cultured in the absence of LIF, a
differentiation inhibiting cytokine, cells on all substrates had diminished expression of Pou5f1 , Nanog,
and Sox2 compared to cells cultured in the presence of LIF. Not surprisingly, in the absence of LIF,
the highest expression of these genes, which are crucial to stem cell maintenance, was observed in cells
cultured on gelatin-coated glass, a standard substrate used for ESC expansion in vitro (Figure 3.8). For
all three stem cell markers, nanostructure had a statistically significant effect on transcript expression (p
< 0.05, comparing the group of Flat SAMs to Nanoparticle Thin Films). The trend was typically that
expression on the Nanoparticle Thin Films was higher than that on the Flat SAMs with the same nominal
bulk chemistry. For Pou5f1 and Sox2 , expression was unaffected by changing the substrate chemistry.
For Nanog, there were some differences that could be attributed to chemistry and the interactive p-value
was < 0.05, implying some combined effects of substrate chemistry and nanotopography.
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Figure 3.8: Quantitative PCR was used to determine the relative transcript levels of a) Pou5f1 (Oct4),
b) Nanog, and c) Sox2 six days after seeding ESCs, cultured without LIF supplementation. The cells
were grown on either self-assembled monolayers on gold substrates (“Flat SAMs”, grey bars) including
gelatin-coated glass (“Gel.”) and bare gold (“Au”) as reference materials, or thin films of densely packed
monolayer-protected gold nanoparticles (“Nanoparticle Thin Films”, black bars). The ratios refer to
the molar ratio of 6-mercapto-1-hexanol (MH) and 1-octanethiol (OT) comprising the self-assembled
monolayers. For Pou5f1 , expression was down-regulated in all samples relative to day 0 (p < 0.05)
though to a greater degree in the Flat SAMs than on the Nanoparticle Thin Films. The nanostructure of
the surface affected transcript expression (p < 0.05) but the chemical composition of the surface was less
important. For Nanog, both the nanostructure and chemistry of the surface played a role in transcript
expression (interactive p < 0.05). For Sox2 , the substrate nanostructure was also found to affect transcript
expression (p < 0.05). Bars represent mean ± standard deviation, relative to Gapdh as an internal control
and day 0 cells cultured on gelatin-coated glass as the baseline of 0. Statistically significant (p < 0.05)
differences (N =3 independent experiments, performed in technical triplicates) between Flat SAMs and
Nanoparticle Thin Films of the same nominal chemistries are denoted with an asterisk (*).
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3.3.5 Immunofluorescence of Oct4
To better understand how the changes in Pou5f1 gene expression affected Oct4 protein localisation,
immunofluorescence was performed with an antibody against Oct4 and cells were further stained with
wheat germ agglutinin (WGA), a lectin which labels the cell membrane to help visualise the cells, and
DAPI to stain the nuclei. There were few differences noted in colony shape or size, or Oct4 staining
across the Nanoparticle Thin Films or Flat SAMs of varying chemistry, providing more evidence that
the substrate chemistries in this study did not play a significant role in affecting Oct4. However, we
observed a marked difference in the Oct4 expression when comparing Nanoparticle Thin Films to Flat
SAMs of the same nominal bulk chemistry. Figure 3.9 shows a representative comparison between 1:1
MH:OT Nanoparticle Thin Films and 1:1 MH:OT Flat SAMs. After six days in culture either with or
without LIF supplementation, Oct4 staining was only present diffuse in the cytoplasm in cells cultured
on Nanoparticle Thin Films (Figure 3.9b and e). In contrast, the protein was located in the nucleus
in cells cultured on the Flat SAMs (Figure 3.9c and f), more similar to cells cultured on gelatin-coated
glass (Figure 3.9a and d). This follows the qPCR result demonstrating a role for nanoscale topography
in influencing Pou5f1 expression.
a) Gelatin-coated glass
b) Nanoparticle Thin Films
c) Flat SAMs
DAPI WGA Oct4 Merge
d) Gelatin-coated glass
MergeDAPI WGA Oct4
e) Nanoparticle Thin Films
f) Flat SAMs
Figure 3.9: Immunofluorescence demonstrates different localisation of Oct4, a protein crucial for stem cell
identity in cells on Nanoparticle Thin Films. The cells were cultured on either self-assembled monolayers
on gold substrates (“Flat SAMs”, including gelatin-coated glass and bare gold as reference materials),
or thin films of densely packed monolayer-protected gold nanoparticles (“Nanoparticle Thin Films”).
Both substrates were coated with a series of 6-mercapto-1-hexanol (MH) and 1-octanethiol (OT) self-
assembled monolayers. Immunofluorescence shows the nucleus (DAPI, blue), membrane (WGA (wheat
germ agglutinin), red) and Oct4 (green) expression in ESCs seeded on gelatin, 1:1 MH:OT Nanoparticle
Thin Films (representative of all nanoparticle samples) and 1:1 MH:OT Flat SAMs (representative of all
SAM samples) either with LIF (a-c) or without LIF (d-f). The ratio refers to the molar ratio of MH:OT
in the self-assembled monolayers. In both cases, the nuclear and membrane staining appears similar.
Oct4, however, is located differently in cells on the nanoparticle substrates (b, e) where it is expressed in
the cytoplasm rather than the nucleus. Scale: 20 µm.
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3.3.6 Quantitative PCR of early differentiation markers
Following our finding that Pou5f1 and Sox2 expression were affected by nanoscale topography and Nanog
was affected by both nanoscale topography and chemistry, two markers of early differentiation events were
examined with qPCR to further investigate the role of these substrate properties on ESC differentiation.
Foxa2 , a marker of early endoderm commitment, was highly affected after six days in culture without
LIF (Figure 3.10a). It was up-regulated on all Nanoparticle Thin Films and down-regulated on all Flat
SAMs. Interestingly, there were differences noted between the Nanoparticle Thin Films and the Flat
SAMs of the same nominal bulk chemistry (p < 0.05) but there were also differences noted between the
surfaces of similar topography but varying chemistry (p < 0.05), suggesting both nanoscale topography
and chemistry play a role in endoderm specification.
Fgf5 , a marker of differentiation into primitive ectoderm, which then contributes to all germ layers, is
a useful indicator of early differentiation events. Fgf5 was highly up-regulated on all substrates after
six days when LIF was removed from the culture medium (Figure 3.10b). To obtain some information
about the temporal pattern of Fgf5 expression, qPCR was performed at day 4, two days earlier. A nearly
identical trend for both time points was observed (Figure 3.11) but at the earlier time point, a lower
degree of up-regulation was measured. This suggests the cells are losing their stem cell phenotype and as
time progresses, more are differentiating. Fgf5 was significantly higher on all Nanoparticle Thin Films
compared to a Flat SAM of the same bulk chemistry (p < 0.05). However, chemistry alone cannot explain
the significant differences between the Nanoparticle Thin Films as Fgf5 expression does not correspond
to the changes in bulk hydrophobicity as the nanoparticle chemistry changes from 5:1 to 1:5 MH:OT.
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Figure 3.10: Quantitative PCR was used to determine the relative transcript levels of a) Foxa2 (endo-
derm specification) and b) Fgf5 (primitive ectoderm, early differentiation) six days after seeding ESCs
cultured without LIF supplementation. The cells were grown on either self-assembled monolayers on gold
substrates (“Flat SAMs”, grey bars, including gelatin-coated glass (“Gel.”) and bare gold (“Au”) as
reference materials), or thin films of densely packed monolayer-protected gold nanoparticles (“Nanopar-
ticle Thin Films”, black bars). The ratios refer to the molar ratio of 6-mercapto-1-hexanol (MH) and
1-octanethiol (OT) comprising the self-assembled monolayers. For both genes, the nanotopography of
the substrate was important (p < 0.05 for the differences between grey and black bars) but there was also
an important influence of the substrate chemical composition (p < 0.05 for the differences amongst grey,
and amongst black bars). Bars represent mean ± standard deviation (N =3 independent experiments,
performed in technical triplicates), relative to Gapdh as an internal control and day 0 cells cultured on
gelatin-coated glass as the baseline of 0. Statistically significant (p < 0.05) differences between Flat
SAMs and Nanoparticle Thin Films of the same nominal chemistries are denoted with an asterisk (*).
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Figure 3.11: Following Figure 3.10b, quantitative PCR was used to determine Fgf5 expression at an earlier
timepoint, four days after seeding. The ratios refer to the molar ratio of 6-mercapto-1-hexanol (MH) and
1-octanethiol (OT) comprising the self-assembled monolayers in the Nanoparticle Thin Films. A similar
trend was observed, albeit at lower levels at the earlier timepoint, showing the progressive increase of
Fgf5 expression in ESCs on Nanoparticle Thin Films. Bars represent mean ± standard deviation (N =3
independent experiments, performed in technical triplicates), relative to Gapdh as an internal control and
day 0 cells cultured on gelatin-coated glass as the baseline of 0.
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3.3.7 Semi-quantitative PCR of lineage markers
Semi-quantitative PCR was performed for genes relevant in lineage commitment to ectoderm, endoderm,
and mesoderm (Figure 3.12) after six days in the absence of LIF. Not surprisingly, ESCs cultured on
gelatin had begun differentiation at this late timepoint and were expressing Nestin and Otx2 , two markers
of ectoderm commitment. Cells cultured on both 1:1 MH:OT Nanoparticle Thin Films and Flat SAMs
had similar expression of these two genes. There was no expression detected for Trp63 , a third marker
of ectoderm or for Afp, Gata4 , Pdx1 , Sox17 (all markers of endoderm), T (mesoderm), or Stella (germ
cells).
Gapdh
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Figure 3.12: Semi-quantitative PCR was used to determine the presence of lineage commitment markers
in ESCs cultured without LIF supplementation. The cells were grown on either thin films of densely
packed monolayer-protected gold nanoparticles (“Nanoparticle Thin Films”), self-assembled monolayers
on gold substrates (“Flat SAMs”), or gelatin-coated glass as a reference material. Cells on all substrates
expressed Nestin and Otx2 , two markers of ectoderm specification six days after seeding but did not
express any of the endoderm or mesoderm markers studied (N =2 independent experiments).
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3.4 Discussion
In order to form domains of varying hydrophobicity on vapour-deposited gold, the substrates were incu-
bated for one week in ethanolic alkanethiol (6-mercapto-1-hexanol (MH) and 1-octanethiol (OT)) solutions
of 5:1, 2:1, 1:1, 1:2, and 1:5 molar ratios. To create the same nominal bulk chemistry with topograph-
ical features of approximately 4.5 nm, monodisperse nanoparticles were synthesised with self-assembled
monolayer coatings in the same molar ratios of MH and OT and a layer-by-layer assembly technique was
used to build up thin films of closely-packed particles.
Ethanolic solution of the nanoparticles had a plasmon peak of 500-510 nm, and statistically similar particle
size and distribution. Nanoparticle Thin Films were formed through a layer-by-layer technique, which we
have previously reported to create substrates with complete coverage, no pin-hole defects, and statistically
similar roughness.166 We were able to stoichiometrically control the chemical composition of the SAM in
the nanoparticle shell and thereby control the bulk chemistry of the substrate. A considerable advantage
of using SAMs on both gold nanoparticles and flat gold is that they do not reorganise or denature and
their chemistry can be easily tailored.162
Cellular uptake of nanoparticles is affected by particle size, shape, surface charge, ligand arrangement,
and the presence of certain membrane-penetrating or fusogenic motifs183 but in this study, particles
were covalently bound to the substrate and cells were seeded on top of the thin films. Previous work in
our group (unpublished- PhD Thesis of Dr Steve Mwenifumbo) demonstrated similar Nanoparticle Thin
Films could support human microvascular endothelial cells. We first tested whether the Nanoparticle
Thin Films would support ESC growth and proliferation and found similar BrdU uptake in cells on thin
films of varying nominal bulk chemistry regardless of whether LIF was supplemented in the medium.
ESCs are, in fact, characterised by their short G1 phase and high percentage of cells in S phase and so
the positive staining for BrdU was indicative of our stem cell population.184 Recently, however, there has
been evidence that ESCs with a prolonged G1 phase can still retain their pluripotency.185
Quantitative PCR showed that Pou5f1 , Nanog, and Sox2 were affected by the substrate nanoscale to-
pography. These genes are central to stem cell pluripotency and self-renewal, and form the central
stem cell transcriptional network. Nanog is a homeoprotein central to ESC self-renewal. Its knockdown
causes ESCs to lose pluripotency and to differentiate towards extraembryonic endoderm. Conversely, its
presence is sufficient to maintain self-renewal, independent of the LIF pathway.186 Pou5f1 is exclusively
expressed in ESCs, preimplantation embryos, epiblast, and germ cells, but its presence alone cannot
replace endogenous LIF signalling. Interestingly, both its up-regulation and down-regulation can cause
differentiation.187 Sox2 has also been shown to be essential for pluripotency.188 These transcription fac-
tors are also highly cooperative, and Pou5f1 and Sox2 have been shown to regulate Nanog .189 Sox2 is
known to cooperate with Pou5f1 .190 There is also complex self-regulation of these genes.191
There are some early reports of ESCs responding to topographical cues. When human ESCs were cul-
tured on a 3D sponge-like scaffold of poly(lactic-co-glycolic-acid)/poly(l-lactic-acid), the structure was
found to support attachment, proliferation, and differentiation.192 Addition of growth factors directed the
cells to form primitive 3D tissue structures, including capillary networks of vessel-like structures. In vivo
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implantation showed that the cells remained viable for at least two weeks. Three-dimensional poly(l-
lactic-acid) nanofibres also supported human ESC osteogenesis and tissue formation.193 A polyamide
mesh with nanofibrillar organisation intended to mimic the ECM architecture was successful in maintain-
ing proliferation and self-renewal of murine ESCs compared to cells cultured of tissue culture plastic in
the presence of LIF.194 This effect was attributed to the activation of Rac, the phosphoinositide 3-kinase
(PI3K) pathway, and an up-regulation of Nanog. In Chapter 2, it was found that substrates with 400 nm
topographical features mitigate endoderm specification.132 However, there is growing evidence that the
size of the features affects integrin clustering, which might explain how substrates with 4.5 nm features
resulted in an up-regulation of Foxa2 , a key endoderm marker.174
This study also demonstrated that Nanog expression was affected by substrate chemistry. Hydrophobicity
has previously been reported to improve ESC differentiation.174 However, in that study, cells went through
an embryoid body (EB) intermediary and hydrophobicity was employed to limit the EB size. A number
of studies have suggested that substrate properties such as elasticity act by affecting morphology, which
subsequently directs differentiation133,82 but in our study, the ESCs were typically spherical and did not
exhibit morphology changes related to either chemistry or topography.
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3.5 Conclusion
A better understanding of how stem cells response to substrate cues is crucial for their use in regenerative
medicine and is also an interesting scientific question. This study demonstrates for the first time that
ESCs are able to sense topographical features provided by gold nanoparticles 4.5 nm in diameter. In
terms of differentiation markers, they were also responsive to substrate chemistry in non-linear manner,
suggesting a possible synergistic role of these substrate cues for driving cell behaviour.
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Integrin expression of mesenchymal
stem cells in chondrogenic
differentiation
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integrin β8 in chondrogenic differentiation of mesenchymal stem cells.
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4.1 Introduction
There is a great need for tissue engineering of cartilage due to its low inherent ability to repair following
injury or disease. Strategies primarily involve the differentiation of mesenchymal stem cells (MSCs) into
chondrocytes on, or inside a scaffold. Short peptides derived from extracellular matrix (ECM) components
are often incorporated in the scaffold to promote MSC attachment or differentiation into chondrocytes
via cell-ECM interactions, yet it is unknown which cues the cells require. In particular, it is unknown how
the cell-ECM interactions of self-renewing MSCs differ from MSCs undergoing chondrogenic differentia-
tion and from mature chondrocytes. Given the importance of these interactions in every aspect of cell
behaviour, qPCR was used to study the temporal changes of integrin expression in chondrogenic differ-
entiation. Integrins are a major class of membrane-spanning receptors and are involved in virtually every
important cell process. Chondrogenic differentiation experiments were performed in three commonly used
in vitro chondrogenesis models: pellet culture, micromass culture, and a type II collagen hydrogel. Cells
were cultured in either growth or chondrogenic medium. In addition to the integrin subunits, a number
of phenotype markers relevant to chondrogenesis and chondrocytes were quantified.
Pellet Culture Micromass Col2 Hydrogel
Mesenchymal stem cells
Multiple patients
PromoCell, UK
> 95% positive:
CD44 (hyaluronan receptor), CD105 (endoglin)
> 95% negative:
CD31 (endothelial), CD45 (hematopoietic)
250,000 cells
Centrifuge to 
form a cell pellet
Culture in Falcon 
tube
250,000 cells
Low-adhesion 
round-bottom 
96-well plate
“Mesenchyme 
condensation”
g
250,000 cells
Cell culture
96-well plate
Bovine type II 
collagen
Growth medium Chondrogenic medium
Analysis
Phenotype to compare methods Integrin expression
Histology
qPCR of ECM protein and transcription factors
Day 0, 2, 4, 7, 14, 21
α and β subunits
Figure 4.1: In order to study the changing expression of integrins during chondrogenic differentiation,
human mesenchymal stem cells were cultured in three different chondrogenesis models: pellet culture,
micromass, and type II collagen hydrogels under two different conditions: growth medium and chondro-
genic medium. Analysis included histology and qPCR for phenotype markers, and qPCR for integrin
subunits over a time-course of 21 days.
81
4. INTEGRIN EXPRESSION OF STEM CELLS IN CHONDROGENESIS
4.1.1 Articular cartilage and chondrocytes
Hyaline articular cartilage has a glass-like appearance and is found covering the ends of articular bones,
where it acts as a lubricant, permitting the bones to move against each other. As a tissue, cartilage is
defined by its extracellular matrix (ECM) and its resulting mechanical properties. It is a metabolically
active, nonvascular connective tissue, and is capable of responding to the mechanical forces encountered
during normal load-bearing activity. Cartilage has three macroscopic zones: superficial, middle, and deep
zones (from the synovial fluid interface to bone interface). The zones are characterised by their differing
chondrocyte morphology and ECM components.
Cartilage ECM is in contact with the synovial fluid of the joint and is the defining feature of the tissue.
However, a great deal of the composition of cartilage is water (70-80% by weight in adults) and it can
therefore be considered a hydrogel.195 The dry weight is mainly collagens (50-70%) and proteoglycans
(15-30%), the specific ratios depending on the location within the tissue. Generally, collagen content is
highest in the superficial zone, and proteoglycan content is highest in the middle zone. Type II collagen
makes up the majority of the ECM but other types of collagen can also be found. Types V, VI, IX, and XI
are all thought to have important roles in the tissue structure, one of which is to provide support for the
type II collagen structures. Types IV and VI are found in the pericellular matrix, where they influence
the mechanics of the chondron and likely mediate cell-ECM interactions.196,197 Type X collagen, found
in the deep zone, forms the interface between calcified cartilage and bone.
In addition to the collagen content of the hyaline cartilage ECM, the proteoglycans also have a role in
the tissue structure. While collagen forms an organised structure, the proteoglycans also form a mesh
within that structure. Aggrecan is the most abundant proteoglycan and is characterised by its hyaluronan
core and glycosaminoglycan (GAG) side chains. Many aggrecan molecules bind to hyaluronan chains to
form large proteoglycan aggregates. The aggregates have a negative charge, which causes the matrix to
take on fluid and swell to an equilibrium point balanced by the elasticity of the collagen matrix.198 This
osmotic balance is critical to cartilage function and so the loss of proteoglycans is an indicator of disease.
While collagens and proteoglycans make up the vast majority of the tissue dry weight and are largely
responsible for its properties, there are a number of other proteins present in cartilage ECM.
In addition to the balance of osmotic pressure, there is well regulated balance in the turnover of the
ECM, with most of the turnover occurring in the regions directly next to the chondrocytes and very little
in the more distal regions. It also appears that the different components turnover at a different rate.
Collagen turnover is very slow (on the order of a human life span), whereas aggrecan has a half-life of 3.5
years.199,200 The remodelling is largely through matrix metalloproteases (MMPs), which are discussed
more thoroughly in Chapter 5.
Chondrocytes are the only cell type found within hyaline cartilage. When they are isolated from the differ-
ent cartilage zones, some varying characteristics such as morphology,201,202 proteoglycan metabolism,203
and matrix composition204 have been observed in vitro. The normal morphology of a chondrocyte is
round, except at tissue boundaries, where they are often flattened. From electron microscopy, it is known
that the cells have intracellular features typical of a metabolically active cell, including glycogen deposits,
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and ordered rough endoplasmic reticulum.205 They also tend to contain a primary cilium, which has been
implicated in mechanotransduction.206
Since cartilage is an avascular tissue, chondrocytes rely on diffusion, which can occur passively but is
aided by the mechanical compression during joint movement. The cell metabolism has developed to
operate under low oxygen tension, ranging from 10% in the superficial zone, down to < 1% in the deep
zone. Chondrocytes typically have few mitochondria, relying instead on glycolysis for energy. It would
be remiss, however, to consider them metabolically inactive.
4.1.2 Chondrogenesis
Chondrogenesis serves both to create mature cartilage and to form a template for bone growth (endo-
chondral ossification). Articular cartilage development is a highly conserved process that occurs mainly
during embryogenesis. It can, however, also occur in adults in instances such as fracture healing, during
which many of the developmental events are repeated.
The entire vertebral musculoskeletal system arises from two populations of mesoderm: the somites and
the lateral plate, both emerging from the posterior region of the primitive streak.207 Somites, located on
either side of the neural tube and notochord, are the origin of the post cranial axial skeleton (rib cage,
sternum, vertebral column, etc.), and many connective tissues and muscles. Somites are segmented and
it is the cells in the medial segment (the sclerotome) that ultimately become chondrocytes. The lateral
plate mesoderm, consisting of two mesenchymal sheets that lie lateral and ventral to the somites, along
with cells from the lateral edges of the somites, is the source of the limb bud which ultimately forms the
appendicular skeleton (upper and lower limbs). The Hox family of genes are largely responsible for the
coordination of the axial and appendicular skeletons.
Chondrocyte commitment : Generally, cartilage development involves three major phases: mesenchyme
condensation, proliferation, and chondrocyte differentiation. Chondrogenesis can be said to begin between
the first two phases, or when the mesenchyme cells begin to express the extracellular matrix components
that cause them to condense into nodules. Chondrogenesis can lead to all three types of cartilage: hyaline,
fibrous, and elastic. Many molecules are involved in chondrogenesis, and are thoroughly reviewed by
Mahmoudifar et al.208 Briefly, in the earliest stages of development, Wnt, Activin/Nodal, and BMP
signalling are all involved in primitive streak formation, and the cells express Mixl1 209 (mesendoderm),
T 210 (early mesoderm), Gsc 211 (mesendoderm), and Foxa2 212 (definitive endoderm). BMP-2 and BMP-
4 are crucial in early commitment to mesoderm, and the maturation of the mesoderm is controlled by
the down-regulation of T and up-regulation of Flk1 , PDGFRA, and PDGFRB. Much of the organisation
is known to be controlled by the Hox genes, which are themselves regulated by BMPs and Shh. This
complex signalling results in the formation of the limb bud, the result of proliferation of cells in both the
somites and the lateral plate mesoderm.
Mesenchymal cell migration into the limb field and subsequent condensation is controlled by TGF-β-
mediated regulation of fibronectin, which regulates NCAM and N-cadherin. Sox9 is the primary deter-
minant of these phases.213 This condensation is the first definitive commitment of mesenchymal limb
83
4. INTEGRIN EXPRESSION OF STEM CELLS IN CHONDROGENESIS
bud cells to chondrocytes and the cells can be considered chondroprogenitors at this stage. Chondropro-
genitors express type IIA (immature) collagen in an ECM rich in hyaluronan, which is depleted as the
cells aggregate. Following condensation, rapid ECM synthesis begins, coinciding with proliferation at
the margin of the condensate. The cells begin to secrete type IIB (mature) collagen and synthesise an
aggrecan-rich ECM. Integrin-mediated signalling and the interaction of DDR2 with collagen are both
critical at this stage.214 Proliferation on the outside of the condensate is inhibited by Noggin binding to
BMP. Differentiation into chondrocytes is then mediated by more Hox genes and by Scleraxis and Pax1 ,
two transcription factors that activate cartilage-specific genes.215 Mature articular chondrocytes can be
characterised by their ECM production, notably the presence of type II collagen. The high-mobility-
group domain transcription factors SOX9 , SOX5 , and SOX6 are all involved in phenotype maintenance
and ECM synthesis.216 Whether chondrocytes go on to become cartilage or whether they proceed to
endochondral ossification depends on both their origin and their location. The signalling events that
determine this specification remain unknown.
Endochondral ossification: In describing chondrogenesis, it is crucial to discuss endochondal ossification,
the process in development that coordinates cartilage production and bone growth. After cartilage tissue
forms from aggregated mesenchymal stem cells, it acts as a guide for bone growth. Scleraxis, in fact,
remains active until bone growth. In the formation of long bones, the mesenchyme cells that differen-
tiated into chondrocytes soon develop a hypertrophic core, secreting a different matrix characterised by
fibronectin, different types of collagen, and a lower level of protease inhibitor. These hypertropic chon-
drocytes permit blood vessel invasion, which carries in the bone cells that ultimately replace the dying
chondrocytes. This continues until bone forms and only the ends of the original condensate still contain
cartilage. There is a gradient present between the bone and the cartilage, known as the growth plate.
Here, the chondrocytes proliferate in the region furthest from the bone and are hypertrophic in the region
closest. It is in this hypertrophic region that more osteoblasts can invade and cause the bone to grow.
Endochondral ossification is therefore linked to the hypertrophy of chondrocytes.
4.1.3 Chondrogenic differentiation in vitro
One of the key challenges in cartilage tissue engineering is to obtain a large number of chondrocytes
for implantation. The isolation of mature chondrocytes from humans or animal sources is one method
to do this and research has largely focussed on promoting proliferation, maintaining their chondrocyte
phenotype, and preventing dedifferentiation. Primary cultures can be obtained from rabbit, cow, rodent,
human, and other mammals.217 Cell lines from chondrosarcomas and immortalised chondrocytes are also
available, though they both present the usual problems of non-primary cells, such as being unable to
replicate normal physiological processes or having different epigenetic signatures.218 Culturing chondro-
cytes in 3D matrices of materials such as alginate, agarose, hyaluronic acid, or collagen has shown to
mitigate their dedifferentiation but also tends to slow their proliferation and affects their viability.219–222
Specialised medium formulations containing ITS (insulin, transferrin, and selenous acid), l-ascorbic acid,
dexamethasone, proline, and TGF-β3 (or other members of the TGF-β superfamily) can improve chon-
drocyte maintenance.
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A second method of obtaining chondrocytes is through stem cell differentiation. Embryonic stem cells
(ESCs) have been differentiated towards chondrocytes by supplementing the medium with promesoderm
or prochondrogenic growth factors such as retinoic acid, TGF-β3,223 and BMP-2 and -4,224 or combi-
nations of the TGF-β and BMP families.225 Additionally, a number of coculture techniques have been
successful, such as coculture with articular chondrocytes226 or with limb bud progenitor cells.227 One
recent protocol exploited knowledge of development to induce ESC differentiation through intermediate
differentiation stages, including primitive-streak mesoderm and mesoderm intermediates in feeder-free
and serum-free conditions.228 Depending on the cell line, they were able to obtain up to 97% of cells
expressing SOX9 . A similar approach has been used with induced pluripotent stem cells, which created
a population of stem cells with chondrogenic and osteogenic potential.229
Chondrocytes can also be obtained from mesenchymal stem cells, which themselves are defined by their
ability to differentiate into osteoblasts, adipocytes, chondrocytes, and more recently, cells from other
connective tissues in vitro.230,231 Early studies also demonstrated their ability to form bone and cartilage
when implanted in vivo and follow-up studies have shown they can contribute to bone formation in
diseased animals.232,233 However, there remains a significant controversy over the extent to which MSCs
are multipotent and how they may contribute to repair or regeneration. This may be explained by
the heterogeneity inherent in a cell population defined largely by its colony-forming ability and derived
from a diverse range of fetal and adult tissues.55 Most likely, despite having some similar properties in
terms of multipotency, the MSCs vary depending on their origin and isolation method. As with ESCs,
MSC chondrogenic differentiation is improved by coculture with articular chondrocytes.234,235 Mechanical
stimulation has also be shown to be an effective inducer of chondrogenic differentiation236 and is thought
to replicate normal joint loading. Even with these options, many protocols for chondrogenic differentiation
still aim to mimic developmental processes such as mesenchyme condensation by culturing MSCs in closely
packed pellets in the presence of growth factors such as TGFs, FGFs, and BMPs.237,238
4.1.4 Osteoarthritis
The major disease associated with chondrocytes is arthritis, or which there are two types: rheumatoid
arthritis, and osteoarthritis (OA). Both are characterised by the progressive degeneration of the cartilage
matrix. There are a number of other chondrocyte pathologies, but osteoarthritis is, by far, the most
prevalent. It is clinically divided into two types: primary (no known cause) and secondary (identifiable
cause), which can often be considered to correspond to a disease of ageing or of traumatic injury, re-
spectively. In addition to changes to the articular cartilage, other components of the joint are affected.
The peri-articular bone, synovial joint lining, and surrounding supportive tissue can all undergo changes
related to the disease.
Over half of the population over 65 develops the focal lesions of articular cartilage that define OA,
making it a disease of the increasingly ageing population. Its diagnosis is radiological, with joint pain
as the primary symptom. Additional symptoms include inflammation, stiffness, and impaired mobility.
Ageing cartilage develops OA when chondrocyte differentiation is affected or the ECM is degraded.
There is, however, some evidence for a genetic involvement, especially in earlier onset OA. Injuries, such
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as meniscal tears, can also start the cascade of events that leads to matrix degradation. In response to
a trauma, chondrocytes express inflammatory mediators and matrix-degrading proteases.239 The disease
progression is related to the ECM degradation, which takes place after a series of signalling events. The
main effectors are matrix metalloproteinases (MMPs), ADAM-TS4 (a disintegrin), or ADAM-TS5 (a
metalloproteinase), which cleave collagen and proteoglycan motifs and begin the degradation.
Even in normal ageing, regardless of whether OA develops, there are changes in the cartilage.240 Aggrecan,
the major proteoglycan of hyaline cartilage, becomes disregulated in both its assembly and its structure.
It normally assembles in large complexes with link protein and hyaluronan but in ageing cartilage, the
matrix becomes less ordered, potentially due to a decrease in link protein synthesis.241 The relatively slow
turnover of type II collagen and aggrecan leads to their non-enzymatic post-translational modification
by reducing sugars, resulting in accumulated advanced glycation end products (AGEs) via a Maillard
reaction.242 AGEs reduce the mechanical properties of cartilage and disregulate tissue turnover but are
not necessarily indicative of OA. Ageing chondrocytes also have a lower anabolic metabolism and a
subsequent lower ability to repair the ECM.243
Chondrocytes play a major role in the changes to the ECM. In response to trauma, they both promote
matrix degradation and inhibit the processes related to repair. In early stages of OA, chondrocytes
increase their synthetic activity to replace the matrix but do so with collagen not normally found in
articular cartilage, such as type X collagen. Interestingly, an up-regulation of genes related to chon-
drogenesis has been observed, suggesting at least parts of a developmental programme are occurring.244
However, the attempts at repair are unsuccessful and the early increase in ECM synthesis is followed by
a transient proliferative response, and increased synthesis of catabolic cytokines and matrix-degrading
enzymes.245 The morphological changes, such as proteoglycan loss and type II collagen cleavage begin
in the superficial zone, where the tissue meets the synovial fluid. This leads to unbalanced hydrostatic
forces and an increase in fluid retention and loss of mechanical properties. Most well-known is the role of
the MMPs secreted from chondrocytes, which are found in the regions of cartilage degradation and in the
synovial fluid.246,247 It seems the cells have an adaptive response to MMP secretion, as TIMP-1 (tissue
inhibitor of metalloproteinases 1) is also found and correlates with MMP levels. However, despite this
protective mechanism, the matrix continues to degrade.248 As OA progresses, chondrocytes continue to
produce type X collagen (indicative of hypertrophic cartilage), type III collagen (not normally expressed
in cartilage), and type VI collagen.245 A number of cytokines and inflammatory factors further contribute
to the severity of the disease.
4.1.5 Cartilage tissue engineering
Articular cartilage has a low capacity for self-repair following traumatic injury or degeneration from
osteoarthritis, a disease associated with the increasingly ageing population. The extent of endogenous
repair is related to the size of the defect and is limited by the avascular nature of cartilage and the
low mitotic activity of chondrocytes, the only cell type found in the tissue. For many patients, surgical
solutions can reduce pain and swelling and improve joint motility but the resulting tissue typically resem-
bles fibrocartilage, which is mechanically inferior and less durable than articular cartilage, and tends to
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be accompanied by an immune response.249 There is therefore an unquestionable need for regenerative
medicine approaches to cartilage repair.
A wide range of tissue engineering strategies have been employed but the paradigm for most involves the
combination of cells, a scaffold, and soluble or insoluble cues, many iterations of which have been stud-
ied.208 For the cell source, some success has been achieved using chondrocytes,250 bone marrow-derived
mesenchymal stem cells,251,252 adipose-derived stem cells,253 embryonic stem cells,254 and combinations
thereof.234 The use of adult stem cells is inspired by their availability (especially compared to autologous
chondrocytes) and their ability to be expanded in vitro. As with the cell source, the scaffold design has
been a widely studied variable. Over recent years, there have been a number of successful engineering
approaches, mimicking many of the native properties of cartilage, in the hope that the cell phenotype
will respond accordingly. For example, the spatially varying mechanical properties of cartilage were mim-
icked using polymers and hydrogels,255 the nano- to micrometre topography was mimicked with polymer
fibres,256–258 and the extracellular matrix (ECM) components of cartilage were preserved through a decel-
lularisation technique.259,260 Unfortunately, embryogenesis remains the only reliable means of generating
native cartilage, and the best option available to surgeons is a selection of polymer fleeces, sponges, and
fibrous materials seeded with the patients own stem cells for implantation into the defect site.
The disparity between the promise of tissue engineering and its actual success in replicating chondrogen-
esis can be explained by many factors. For example, despite many available differentiation protocols, the
establishment of phenotypic chondrocytes, capable of producing a cartilage-like ECM, remains a chal-
lenge.228 Indeed, chondrocytes have a tendency to dedifferentiate towards a fibroblastic phenotype in
vitro, a phenomenon that has been linked to cell-matrix interactions that become disregulated over time.
The importance of the ECM as a survival factor has long been known and has also been demonstrated
in the case of chondrocytes.261,262 Even on surgical implants, providing the correct matrix cues affects
chondrocyte phenotype.263 However, it has been repeatedly shown that while removing chondrocytes
from their native ECM leads to dedifferentiation, providing tissue-specific ECM alone is not enough to
maintain the phenotype.264 This may be because the interaction of cells with their ECM is more than
for physical attachment, and rather, it importantly provides a source of sequestered growth factors and
signalling initiators, all of which are tightly spatially and temporally regulated.265
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4.1.6 Integrins
Cells interact with the ECM and other cells with a number of diverse yet specific receptors in their
plasma membrane. There are proteoglycans such as syndecan, glycoproteins such as CD44, cadherins,
and integrins, which will be introduced here.
Integrins are the major class of cell surface ECM receptors, though other proteins and proteoglycans
can facilitate these interactions.266,267 Integrins are transmembrane molecules that transmit bidirectional
signals across the plasma membrane. They regulate many important physiological functions by interacting
with ECM molecules or counter-receptors on other cells. They are heterodimeric (one α and one β
subunit) transmembrane glycoproteins, consisting of a large globular extracellular domain (up to 1104 or
778 residues for α and β subunits, respectively), and a smaller cytoplasmic domain, which interacts with
many cytoskeletal proteins and initiates signalling cascades.268 The globular “head” extends 170 A˚ from
the membrane. To date, 24 different αβ pairings have been discovered in mammals, resulting from 18
α- and 8 β-subunits (Figure 4.2). There is more homology found in the α subunits, where nine contain
the same ∼ 200 amino acids known as the I (for “inserted”) domain, related to the von Willebrand
Factor (vWF). Individual subunits find their binding partners in the endoplasmic reticulum and form
heterodimers there so the monomers never reach the cell surface.
Integrins are evolutionarily old proteins, present in all multicellular animals. The α and β subunits
evolved separately but likely underwent concomitant changes to permit heterodimerisation. Generally,
the subunits arose from homologous sequences that preexisted their function in mammals. The α subunits
can be grouped according to their evolution from similar proteins in Drosophila.271 α3, α6, and α7 are
related to the PS1 protein in Drosophila and heterodimerise with β1 or β4 to bind laminin. αIIb, αv,
α5, and α8 are related to the PS2 protein in Drosophila and have evolved to recognise RGD, a short
motif found in many ECM proteins. α4 and α9 can be considered as their own group and are unrelated
to the PS3 protein in Drosophila, which is only present in insects. The final group is of those containing
the αI domain. It is unlikely that any additional integrin subunits will be discovered in vertebrates, now
that whole genome sequencing has been completed in so many organisms. However, there may be more
heterodimerisations discovered and certainly new interactions with ECM or cell-surface proteins.
Integrins can exist in three conformational states, corresponding to their level of activation: “inactive”,
“primed”, or “active”. A fourth state could be said to exist when the ligand is bound. Precisely how
these states correspond to physical shape changes remains highly debated. The most accepted theory
to date is called the “switchblade” model, where the three conformational states correspond to integrins
that are bent, extended, and extended with an open headpiece.272,273 However, it does appear that not
all integrins obey this model and there is evidence that some ligand binding takes place not by extension
but by a Mn2+-induced shift of the metal coordination site.268 Since integrin signalling is known to
be bidirectional, it follows that conformational changes can also be induced in either an inside-out or
outside-in manner.274 Activation from the inside is initiated by the separation of the cytoplasmic α and
β subunits, which causes the headpiece (the ligand-binding region) to unbend and enter a primed state.
Outside-in activation occurs upon ligand binding, which stabilises the integrin and also separates the
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Figure 4.2: 24 unique αβ integrin subunit pairings can be found in vertebrates. Here, they are divided into
four groups: collagen binding (containing the I-domain), leukocyte-specific (related to the PS3 protein
in Drosophila), RGD binding (related to the PS2 protein), and laminin binding (related to the PS1
protein). Integrins can bind many more ECM and cell-surface molecules, as listed in Table 4.1. Adapted
from Barczyk et al.269
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Table 4.1: Integrins and their ligands
Integrin Ligands
α1β1 Collagen, laminin
α2β1 Collagen, laminin, thrombospondin, E-cadherin, tenascin
α3β1 Laminin, thrombospondin
α4β1 Fibronectin, thrombospondin, osteopontin, mADCAM-1, VCAM-1, ADAM
family, ICAM-4
α4β7 Fibronectin, osteopontin, mADCAM-1, VCAM-1
α5β1 Fibronectin, osteopontin, ADAM family, COMP, fibrillin, CD171, throm-
bospondin
α6β1 Laminin, ADAM family, CCN1, thrombospondin
α6β4 Laminin
α7β1 Laminin
α8β1 Fibronectin, osteopontin, vitronectin, tenascin, LAP TGF-β nephronectin
α9β1 Osteopontin, VCAM-1, tenascin, ADAM family, VEGF-C, VEGF-D
α10β1 Collagen, laminin
α11β1 Collagen
αvβ1 Fibronectin, osteopontin, LAP TGF-β, CD171
αvβ3 Fibronectin, thrombospondin, osteopontin, BSP, MFG-E8, Del-1, vitronectin,
vWF, tenascin, PECAM-1, LAP TGF-β, fibrillin, fibrinogen, ADAM family,
COMP, CCN1, CCN2, ICAM-4, MMP-2, CD171
αvβ5 Osteopontin, BSP, MFG-E8, Del-1, vitronectin, LAP TGF-β
αvβ6 Fibronectin, osteopontin, LAP TGF-β, ADAM family
αvβ8 LAP TGF-β
αIIbβ3 Fibronectin, thrombospondin, vitronectin, vWF, fibrinogen, CCN2, Cyr61,
ICAM-4, CD171
αDβ2 VCAM-1, ICAM, CCN1, fibrinogen, plasminogen, vitronectin
αEβ7 E-cadherin
αLβ2 ICAM-1, ESM-1, ICAM-4
αMβ2 ICAM-1, fibrinogen, Factor X, iC3b, ICAM-4, heparin, negative charges in
denatured proteins
αXβ2 ICAM, fibrinogen, iC3b, collagen, ICAM-4, heparin, negative charges in dena-
tured proteins
Adapted from Humphries et al.270
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cytoplasmic subunits. There are many factors that induce conformational changes or ligand binding,
including divalent cations and mechanical forces.
Integrins play an important role in virtually every aspect of embryogenesis and tissue maintenance. Here
are a few examples of their diverse roles in cells from different tissues:
Chondrogenesis: Cell-ECM interactions mediated by integrins are important in chondrocytes and chon-
drogenesis, and can be blocked by antibodies against integrin subunits.275,276 For example, blocking
integrin β1 severely interferes with chondrocyte adhesion to fibronectin, type II collagen, and type IV
collagen, and inhibits chondrogenesis.275,277 Integrins are also important in pericellular matrix develop-
ment and in dedifferentiation, the latter of which can be mitigated by inhibiting the αv or α5 integrin
subunits.278–280
Differentiation: Oligodendrocyte differentiation presents an interesting case of two integrins with diver-
gent roles, depending on the extracellular matrix constituents.281 In the first instance, cells bind PDGFαR
and vitronectin via the vitronectin-binding integrin αvβ3 to promote proliferation. Next, upon contact
with laminin-211, PDGFαR works with laminin-binding integrin α6β1 to promote cell survival. Here, cell
behaviour is influenced by a protein from the EGF family called neuregulin, which transmits proliferation
signals to precursor cells but differentiation signals to cells in contact with laminin-211.282
ECM components can maintain stem cell self-renewal through integrin binding in epidermal stem cells,283
neural stem cells,284 and hematopoietic stem cells.285 In murine embryonic stem cells, however, Hayashi
et al. found that ECM-integrin interaction negatively affected self-renewal. In particular, cells cultured
on fibronectin or laminin underwent differentiation, which could be reversed by blocking integrin β1-
mediated interactions with a blocking antibody. Conversely, forced up-regulation of α1 and α2 subunits,
subunits normally not found in ESCs cultured on collagen, a protein that normally promotes self-renewal,
results in an increase in differentiation markers.97
As a final example, epidermal stem cells have high levels of integrin β1, which can actually be used as
a marker of stemness in this population. As the cells differentiate, they progressively lose expression of
this integrin and after terminal differentiation they lack it completely.283
Apoptosis: Integrins are essential for cell survival. The death of a cell following disruption of its ECM
contacts was first described by Meredith et al., which they termed “anoikis”.261 This integrin-mediated
apoptosis is particularly interesting in the case where a cell is removed from the ECM in which it would
normally reside and placed in a foreign environment. Some cells are highly adaptive to these changes,
but mammary epithelial cells, as an example, undergo anoikis when they are cultured on type I collagen
(stromal ECM) instead of laminin (basement membrane).286 Interestingly, physical attachment to a
matrix was not sufficient for survival, and the cells seem to specifically require basement membrane.
Blocking β1 integrin doubled the rate of apoptosis, further implicating integrin signalling in cell survival.
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4.2 Materials & Methods
4.2.1 Cell culture
Human bone marrow-derived mesenchymal stem cells (hMSCs) were purchased from PromoCell (UK)
(CD44/CD105 > 95% positive, CD31/CD45 > 95% negative). Cells were maintained in growth medium
(Mesenchymal Stem Cell Growth Medium; PromoCell, UK) at 37◦C and 5% CO2. Prior to differentiation
experiments, cells were expanded to Passage 4 and lightly trypsinised using the DetachKit (PromoCell,
UK) according to the manufacturer’s instructions.
4.2.2 Chondrogenic differentiation
Pellet culture: 250,000 hMSCs were suspended in 500 µl of either growth or chondrogenic medium
(Mesenchymal Stem Cell Chondrogenic Medium; PromoCell, UK) and centrifuged at 450 x g for 10 min
in a 15 ml polypropylene conical tube. Cells were maintained at 37◦C and 5% CO2 in the conical tubes
with loosened caps for gas exchange. Medium was changed every 2-3 days.
Micromass: 250,000 hMSCs were suspended in 200 µl of growth medium in a 96-well round bottom
suspension culture plate (Nunc, UK). After 48 h, spheroids began to form spontaneously and cells were
fed with either growth or chondrogenic medium. Medium was changed every 2-3 days.
Type II collagen hydrogels: Bovine articular cartilage-derived type II collagen (obtained as protein
dissolved in acid, BD Biosciences, UK) was diluted on ice to a final concentration of 1.5 mg/ml in either
growth or chondrogenic medium and 2.5% (v/v) HEPES Buffer. The solution was neutralised (pH 7.4)
with NaOH and 250,000 hMSCs were seeded in a 200 µl total volume in a 96-well plate. The hydrogels
were incubated for 4-5 h at 37◦C and 5% CO2 and then an additional 125 µl of medium was added to
each well. Medium was changed every 2-3 days.
4.2.3 Histology
In order to evaluate cell morphology and the establishment of an extracellular matrix rich in sulphated
glycosaminoglycans (sGAGs) and collagen, histological staining was performed. After 21 days in culture,
the samples were washed in PBS, fixed in 3.7% (w/v) paraformaldehyde, washed thoroughly, and stored
at 4◦C in PBS until embedding. Parafin embedded samples were sectioned to 10 µm thickness, dewaxed,
and stained with hematoxylin/eosin, Alcian blue, and picrosirius red according to standard methods.
4.2.4 RNA extraction and cDNA synthesis
Cells were washed in PBS and 350 µl RLT supplemented with 1% (v/v) β-mercaptoethanol was added.
The samples was vigorously lysed with pipetting and vortexing and stored at -20◦C prior to RNA ex-
traction using an RNeasy mini kit (Qiagen, UK) according to the manufacturer’s instructions. RNA
quality and quantity were assessed on a NanoDrop 2000c. First-strand cDNA synthesis was performed
using Superscript III First-Strand Synthesis kit from Invitrogen (UK) according to the manufacturer’s
instructions. 100 ng total RNA was reverse-transcribed in a 20 µl reaction volume followed by an RNase
H treatment. cDNA was diluted 1:100 in dH2O prior to qPCR.
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4.2.5 Quantitative PCR
Quantification of mRNA transcripts occurred after 1, 2, 4, 7, 14, and 21 days. A day 0 sample, consisting
of hMSCs prior to trypsinisation was used to normalise integrin subunit expression. Quantitative PCR
was performed in a 10 µl volume on a Rotorgene 6000 (Qiagen, UK) using a Platinum SYBR Green
Supermix-UDG kit (Invitrogen, UK) according to the manufacturer’s instructions. Primer sequences to
the phenotype markers and integrin subunits were obtained from PrimerBank (Harvard University, USA;
http://pga.mgh.harvard.edu/primerbank/; listed in Appendix A) with the exception of primers to
ACAN, COL6A1 , ITGA4 and ITGA6 , which were purchased from Qiagen (Quantitect). Thermocycling
was as follows: 95◦C for 2 min, 40 cycles of 95◦C for 15 s and 62◦C for 30 s, and a high resolution melt
curve from 70-95◦C. For the Quantitect primers, the annealing temperature was 63◦C instead of 62◦C.
All primers were validated with a standard curve to ensure an efficiency of 0.9-1.0 and amplicons were
run on an agarose gel to ensure a single product of the correct size. GAPDH was used as a house-keeping
gene (p > 0.7 over the time-course, no significant differences in GAPDH detected by Western blotting).
Data for the integrin subunits were plotted as 2−∆∆Ct (i.e.- relative to GAPDH and to hMSCs prior to
trypsinisation), except when this value was negative, where they were plotted as -1/2−∆∆Ct. Data for
the phenotype markers were plotted as 2−∆Ct (i.e.- relative to GAPDH ) because the genes were typically
not detected in hMSCs.
4.2.6 Statistical analysis
Student’s t-test and ANOVA were used to determine statistical significance (p < 0.05). Quantitative PCR
data are from three independent experiments performed in technical triplicates. Relative expression was
calculated using the ∆∆Ct method, but down-regulation is presented as the negative inverse.
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4.3 Results
Before establishing the changing integrin expression during chondrogenesis, we sought an appropriate in
vitro model that resulted in a high expression of chondrogenic markers and the establishment of a hyaline
cartilage-like extracellular matrix. Quantitative PCR was used to characterise three different chondro-
genesis models (pellet culture, micromass culture, and a type II collagen hydrogel) for the expression
of phenotype markers related to chondrogenesis and cartilage, and histology was also used to detect an
ECM rich in collagen and sulphated glycosaminoglycans.
4.3.1 Histology
Histology was first performed to visualise the establishment of a hyaline cartilage-like ECM after 21
days in culture (Figure 4.3). Three different chondrogenesis models were used (pellet culture, micromass
culture, or a type II collagen hydrogel) and cells were cultured in either growth or chondrogenic medium.
Haematoxylin and eosin (H&E) stains the nuclei blue and the cell membrane orange and demonstrated
the gross morphology and arrangement of the cells. Picrosirius red (SR) stains collagen. In the pellet
culture, there was clearly more collagen when cells were cultured in chondrogenic medium. Cells in
the micromass had no apparent difference, and staining in the type II collagen hydrogels was due to
the scaffold background. Alcian blue (AB) stains sulphated glycosaminoglycans (sGAGs). It was also
strongest in the pellet culture in chondrogenic medium. Both cells in the micromass and the type II
collagen hydrogel also had enhanced sGAG production when cultured in chondrogenic medium.
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Figure 4.3: Histology was used to demonstrate the establishment of the extracellular matrix in hMSCs af-
ter 21 days of culture in three different chondrogenesis models (pellet culture, micromass culture, or a type
II collagen hydrogel) in either growth or chondrogenic medium. Haematoxylin and eosin (H&E) stains
the nuclei blue and the cell membrane orange. Picrosirius red (SR) stains collagen. Alcian blue (AB)
stains sulphated glycosaminoglycans (sGAGs). In all three culture systems, the addition of chondrogenic
medium improved both collagen and sGAG accumulation. hMSCs undergoing chondrogenic differenti-
ation in a pellet culture consistently had the most cartilage-like histology. Images are representative of
N =3 independent experiments with multiple sections from each. Scale: 200 µm.
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4.3.2 Phenotype markers
Figure 4.4 shows the temporal change of expression of two types of collagen mRNA relevant to articular
cartilage in hMSCs cultured in either growth or chondrogenic medium in the three different chondroge-
nesis models. Only hMSCs cultured in chondrogenic medium expressed COL2A1 (Figure 4.4a-c). Cells
cultured in a micromass had delayed expression of this key marker of articular hyaline cartilage ECM,
but a similar level of the transcript was achieved in all models after 21 days. COL6A1 , the defining
component of the pericellular matrix, was relatively unchanged in hMSCs in a pellet culture or a type II
collagen hydrogel (Figure 4.4d-f). However, in the micromass, it was down-regulated to non-detectable
levels after seven days.
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Figure 4.4: Quantitative PCR established mRNA expression in hMSCs cultured in three different chon-
drogenesis models (pellet culture, micromass culture, or a type II collagen hydrogel) in either growth
(black squares) or chondrogenic (red circles) medium over a time-course of 21 days. A high expression
of COL2A1 and COL6A1 are indicative of hMSCs assuming a chondrocyte phenotype and establish-
ing a hyaline cartilage-like matrix. In all three culture systems, there was a significant up-regulation of
COL2A1 in chondrogenic medium, with a similar level observed after 21 days. For COL6A1 , the cells in
the pellet culture and collagen II hydrogel had similar temporal expression, but for hMSCs in a micro-
mass, transcription dropped to undetectable levels after 7 days. Each point indicates mean expression
relative to GAPDH of N =3 independent experiments, and error bars represent the range of values. N.D.:
not detected. Statistical significance is in Appendix B, Figures S4-S5.
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COL1A1 and COL10A1 are both markers of chondrogenesis, but are more prevalent in fibrocartilage
rather than articular cartilage. For COL1A1 , there were no significant differences between the chondroge-
nesis models, but as to be expected, chondrogenic medium resulted in an up-regulation over time (Figure
4.5a-c). COL10A1 was highly up-regulated over time and to a higher degree in cells in chondrogenic
medium (Figure 4.5d-f). For both COL1A1 and COL10A1 , the chondrogenesis model had no apparent
effect on mRNA expression.
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Figure 4.5: Quantitative PCR established mRNA expression in hMSCs cultured in three different chon-
drogenesis models (pellet culture, micromass culture, or a type II collagen hydrogel) in either growth
(black squares) or chondrogenic (red circles) medium over a time-course of 21 days. A high expression
of COL1A1 and COL10A1 are indicative of hMSCs undergoing chondrogenesis but assuming a less hya-
line cartilage-like ECM. For both COL1A1 and COL10A1 , there were no significant differences when
comparing culture systems. Furthermore, culturing in chondrogenic medium resulted in a modest up-
regulation of both genes. Each point indicates mean expression relative to GAPDH of N =3 independent
experiments, and error bars represent the range of values. N.D.: not detected. Statistical significance is
in Appendix B, Figures S4-S5.
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Figure 4.6 demonstrates the temporal changes of mRNA expression of two important phenotype markers
for articular cartilage in hMSCs cultured in either growth or chondrogenic medium in the three different
chondrogenesis models. For ACAN, there were no significant differences between the chondrogenesis mod-
els, except a slight delay of transcript expression in the micromass, and only cells cultured in chondrogenic
medium expressed ACAN at detectable levels (Figure 4.6a-c). HSPG2 , the gene encoding perlecan, a
component of the pericellular matrix, was unaffected by the chondrogenesis system, but was expressed
at higher levels in cells cultured in chondrogenic medium (Figure 4.6d-f).
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Figure 4.6: Quantitative PCR established mRNA expression in hMSCs cultured in three different chon-
drogenesis models (pellet culture, micromass culture, or a type II collagen hydrogel) in either growth
(black squares) or chondrogenic (red circles) medium over a time-course of 21 days. A high expression
of ACAN (encoding aggrecan) and HSPG2 (encoding perlecan) are indicative of a hyaline cartilage-like
ECM. Both ACAN and HSPG2 were influenced by culturing hMSCs in chondrogenic medium. There
were no significant differences between the three chondrogenesis models. Each point indicates mean ex-
pression relative to GAPDH of N =3 independent experiments, and error bars represent the range of
values. N.D.: not detected. Statistical significance is in Appendix B, Figures S4-S5.
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Figure 4.7 demonstrates the temporal changes of mRNA expression of two important transcription factors
for lineage commitment of hMSCs in cells cultured in either growth or chondrogenic medium in the three
different chondrogenesis models. RUNX2 , a transcription factor central in osteogenesis, but with an
additional role in chondrogenesis, was highly up-regulated over time in the pellet culture and micromass
but was undetectable in the type II collagen hydrogels (Figure 4.7a-c). SOX9 , a transcription factor
central but not exclusive to chondrogenesis, was unaffected by either the chondrogenesis model or the
medium formulation over time (Figure 4.7d-f).
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Figure 4.7: Quantitative PCR established mRNA expression in hMSCs cultured in three different chon-
drogenesis models (pellet culture, micromass culture, or a type II collagen hydrogel) in either growth
(black squares) or chondrogenic (red circles) medium over a time-course of 21 days. RUNX2 and SOX9
are two transcription factors involved in osteoblast and chondrocyte differentiation, respectively. RUNX2
was significantly affected by both the chondrogenesis conditions and the medium formulation. SOX9 was
unaffected by either condition. Each point indicates mean expression relative to GAPDH of N =3 in-
dependent experiments, and error bars represent the range of values. N.D.: not detected. Statistical
significance is in Appendix B, Figures S4-S5.
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4.3.3 Endpoints
In order to determine the differences between integrin subunits expressed in hMSCs and chondrocytes,
RNA was isolated from hMSCs in standard culture conditions (48 h after seeding) and from chondrocytes
in a cartilage pellet (PromoCell, UK). Figure 4.8 shows the relative expression of ten α subunits and seven
β subunits. ITGA2 , ITGA3 , ITGA4 , ITGA6 , ITGA7 , ITGA10 , ITGB3 , and ITGB5 mRNA levels
were higher in hMSCs than in chondrocytes. ITGA1 , ITGB2 , and ITGB8 mRNA levels were higher
in chondrocytes than in hMSCs. Expression of ITGA5 , ITGA11 , ITGAV and ITGB1 were unchanged
between the two cell types. ITGB6 and ITGB7 were not detected in either hMSCs or chondrocytes.
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Figure 4.8: Quantitative PCR established mRNA expression of integrin subunits in hMSCs cultured on
tissue culture plastic in growth medium (black squares) and chondrocytes isolated from human tissue
(red circles). Each point indicates mean expression relative to GAPDH of N =2 experiments performed
in technical triplicate.
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4.3.4 Integrin expression
To better understand how the expression of integrin subunits changes during chondrogenic differentiation
of hMSCs, a time-course of transcript levels over 21 days was established with qPCR. Figure 4.9 shows
the expression of 14 integrin subunits relative to GAPDH as an internal control and to day 0 hMSCs
(prior to trypsinisation).
Effect of medium: In general, cells in growth medium (Figure 4.9a-c) had higher integrin expression than
in chondrogenic medium (Figure 4.9d-f). The medium composition had a significant effect (p < 0.05) on
all subunits measured except for ITGA6 , ITGA7 , and ITGA11 in the pellet culture, ITGA4 , ITGA6 ,
ITGA7 , ITGA10 , and ITGB1 in the micromass culture, and ITGA7 and ITGB1 in the type II collagen
hydrogel.
Effect of chondrogenesis model : Generally, integrin expression was well-conserved across the three chon-
drogenesis models with only four notable exceptions. Figures 4.10-4.16 show the details of mRNA ex-
pression for each of the integrin subunits. For cells cultured in growth medium, only ITGA7 (Figure
4.13) was different during the time-course across the different chondrogenesis models. For cells cultured
in chondrogenic medium, only ITGA5 , ITGA6 (Figure 4.12), and ITGB3 (Figure 4.15) were consistently
different between the chondrogenesis models.
Effect of time-course: The time-course had the greatest effect on the expression of integrin subunit
mRNA. In growth medium, statistically significant up-regulation was observed for ITGA1 (pellet culture
and type II collagen hydrogel), ITGA3 (pellet culture and type II collagen hydrogel), ITGA4 (type
II collagen hydrogel), ITGA7 (pellet culture), ITGA10 (pellet culture and type II collagen hydrogel),
ITGA11 (all chondrogenesis models), ITGAV (all chondrogenesis models), ITGB1 (all chondrogenesis
models), ITGB5 (all chondrogenesis models), and ITGB8 (all chondrogenesis models). Down-regulation
was not statistically significant for any integrin subunits. In chondrogenic medium, there was generally
less up-regulation of the integrin subunits. Statistically significant up-regulation was observed for ITGA4
(pellet culture), ITGA7 (pellet culture), ITGA11 (all chondrogenesis models), ITGAV (pellet culture),
ITGB5 (pellet culture), and ITGB8 (all chondrogenesis models). Down-regulation was observed for
ITGA2 (micromass), ITGA3 (pellet culture), ITGA5 (all chondrogenesis models), ITGA6 (type II
collagen hydrogel), and ITGB3 (all chondrogenesis models).
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Figure 4.9: Quantitative PCR established mRNA expression of integrin subunits in hMSCs cultured
in three different chondrogenesis conditions (pellet culture, micromass culture, or a type II collagen
hydrogel) in either growth or chondrogenic medium over a time-course of 21 days. Each square represents
mean expression relative to GAPDH and to hMSCs on tissue culture plastic in growth medium of N =3
independent experiments performed in technical triplicate. Down-regulation is represented in purple and
up-regulation is represented in yellow. In general, integrin mRNA was down-regulated in chondrogenic
medium and there were similar expression patterns between the different chondrogenesis conditions.
N.D.: not detected. This table is expanded in Figures 4.10-4.16. Statistical significance is in Appendix
B, Figures S1-S3.
102
4. INTEGRIN EXPRESSION OF STEM CELLS IN CHONDROGENESIS
Pellet culture
cba
IT
G
A
1 
re
la
tiv
e 
ex
pr
es
si
on
Micromass Col2 Gel
e fd
IT
G
A
2 
re
la
tiv
e 
ex
pr
es
si
on
-35
-30
-25
-20
-15
-10
-5
0
5
12 4 7 14 21Day
-35
-30
-25
-20
-15
-10
-5
0
5
12 4 7 14 21Day
-35
-30
-25
-20
-15
-10
-5
0
5
12 4 7 14 21Day
0
5
10
15
20
25
30
35
40
12 4 7 14 21Day
0
5
10
15
20
25
30
35
40
12 4 7 14 21Day
0
5
10
15
20
25
30
35
40
12 4 7 14 21Day
Figure 4.10: Quantitative PCR established mRNA expression of integrin subunits in hMSCs cultured in
three different chondrogenesis models (pellet culture, micromass culture, or a type II collagen hydrogel) in
either growth (black squares) or chondrogenic (red circles) medium over a time-course of 21 days. ITGA1
(a-c) and ITGA2 (d-f) were both affected by the medium composition, and the time-course. Each point
indicates mean expression relative to GAPDH and to hMSCs on tissue culture plastic in growth medium
of N =3 independent experiments, and error bars represent the range of values. Statistical significance is
in Appendix B, Figures S1-S3.
103
4. INTEGRIN EXPRESSION OF STEM CELLS IN CHONDROGENESIS
IT
G
A
4 
re
la
tiv
e 
ex
pr
es
si
on
-16
-14
-12
-10
-8
-6
-4
-2
0
2
12 4 7 14 21Day
-16
-14
-12
-10
-8
-6
-4
-2
0
2
12 4 7 14 21Day
-16
-14
-12
-10
-8
-6
-4
-2
0
2
12 4 7 14 21Day
IT
G
A
3 
re
la
tiv
e 
ex
pr
es
si
on
Pellet culture
cba
Micromass Col2 Gel
e fd
-50
-40
-30
-20
-10
0
12 4 7 14 21Day
-50
-40
-30
-20
-10
0
12 4 7 14 21Day
-50
-40
-30
-20
-10
0
12 4 7 14 21Day
Figure 4.11: Quantitative PCR established mRNA expression of integrin subunits in hMSCs cultured in
three different chondrogenesis models (pellet culture, micromass culture, or a type II collagen hydrogel) in
either growth (black squares) or chondrogenic (red circles) medium over a time-course of 21 days. ITGA3
(a-c) was affected by the medium composition, the chondrogenesis model, and the time-course. In the
pellet culture, ITGA4 (d-f) was affected by the time-course, and in the type II collagen hydrogel, it was
affected by the medium composition and the time-course. Each point indicates mean expression relative
to GAPDH and to hMSCs on tissue culture plastic in growth medium of N =3 independent experiments,
and error bars represent the range of values. Statistical significance is in Appendix B, Figures S1-S3.
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Figure 4.12: Quantitative PCR established mRNA expression of integrin subunits in hMSCs cultured in
three different chondrogenesis models (pellet culture, micromass culture, or a type II collagen hydrogel)
in either growth (black squares) or chondrogenic (red circles) medium over a time-course of 21 days.
Both ITGA5 (a-c) and ITGA6 (d-f) were affected by the chondrogenesis model and were down-regulated
in chondrogenic medium. Each point indicates mean expression relative to GAPDH and to hMSCs on
tissue culture plastic in growth medium of N =3 independent experiments, and error bars represent the
range of values. N.D.: not detected. Statistical significance is in Appendix B, Figures S1-S3.
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Figure 4.13: Quantitative PCR established mRNA expression of integrin subunits in hMSCs cultured in
three different chondrogenesis models (pellet culture, micromass culture, or a type II collagen hydrogel) in
either growth (black squares) or chondrogenic (red circles) medium over a time-course of 21 days. ITGA7
(a-c) was affected by the chondrogenesis model and the time-course, but was unaffected by the medium
composition. ITGA10 (d-f) was up-regulated in growth medium. Each point indicates mean expression
relative to GAPDH and to hMSCs on tissue culture plastic in growth medium of of N =3 independent
experiments, and error bars represent the range of values. Statistical significance is in Appendix B,
Figures S1-S3.
106
4. INTEGRIN EXPRESSION OF STEM CELLS IN CHONDROGENESIS
IT
G
A
11
 re
la
tiv
e 
ex
pr
es
si
on
IT
G
AV
 re
la
tiv
e 
ex
pr
es
si
on
-5
0
5
10
15
20
12 4 7 14 21Day
-5
0
5
10
15
20
12 4 7 14 21Day
-5
0
5
10
15
20
12 4 7 14 21Day
-10
-5
0
5
10
12 4 7 14 21Day
-10
-5
0
5
10
12 4 7 14 21Day
-10
-5
0
5
10
12 4 7 14 21Day
Pellet culture
cba
Micromass Col2 Gel
e fd
Figure 4.14: Quantitative PCR established mRNA expression of integrin subunits in hMSCs cultured in
three different chondrogenesis models (pellet culture, micromass culture, or a type II collagen hydrogel) in
either growth (black squares) or chondrogenic (red circles) medium over a time-course of 21 days. ITGA11
(a-c) was less affected by the culture medium or chondrogenesis model, but was up-regulated over time.
ITGAV (d-f) was affected by the culture medium and was slightly up-regulated over time. Each point
indicates mean expression relative to GAPDH and to hMSCs on tissue culture plastic in growth medium
of N =3 independent experiments, and error bars represent the range of values. Statistical significance is
in Appendix B, Figures S1-S3.
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Figure 4.15: Quantitative PCR established mRNA expression of integrin subunits in hMSCs cultured in
three different chondrogenesis models (pellet culture, micromass culture, or a type II collagen hydrogel)
in either growth (black squares) or chondrogenic (red circles) medium over a time-course of 21 days.
ITGB1 (a-c) was up-regulated in cells cultured in growth medium. ITGB3 (d-f) was affected by the
culture medium, the chondrogenesis model, and the time-course. Each point indicates mean expression
relative to GAPDH and to hMSCs on tissue culture plastic in growth medium of N =3 independent
experiments, and error bars represent the range of values. N.D.: not detected. Statistical significance is
in Appendix B, Figures S1-S3.
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Figure 4.16: Quantitative PCR established mRNA expression of integrin subunits in hMSCs cultured in
three different chondrogenesis models (pellet culture, micromass culture, or a type II collagen hydrogel)
in either growth (black squares) or chondrogenic (red circles) medium over a time-course of 21 days.
ITGB5 (a-c) and ITGB8 (d-f) were affected by the culture medium and the time-course. Each point
indicates mean expression relative to GAPDH and to hMSCs on tissue culture plastic in growth medium
of N =3 independent experiments, and error bars represent the range of values. Statistical significance is
in Appendix B, Figures S1-S3.
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4.4 Discussion
Tissue engineering strategies offer a promising treatment for diseased or damaged cartilage. However,
they have so far failed to deliver on this promise, and scaffolds are frequently marred by their inability
to support initial hMSC attachment and subsequent differentiation into chondrocytes. Our aim was to
develop a better understanding of the changing integrin expression during chondrogenesis. This could
lead to an improved scaffold design, incorporating the ligands required to promote initial attachment and
drive chondrogenic signalling to ultimately create a therapeutically useful cartilage construct.
We began by examining the expression of key chondrogenic phenotype markers in hMSCs undergoing
chondrogenesis in three relevant in vitro models. We found that the phenotype markers were remarkably
well-conserved in the three models, with only COL6A1 and RUNX2 being expressed differently across
the models. The disruption of RUNX2, as seen in the type II collagen hydrogel, has been shown to
block chondrocyte hypertrophy and the progression of osteoarthritis.287 Two commonly used indicators
of articular cartilage phenotype, the COL2A1 /COL1A1 and COL2A1 /COL10A1 ratios (p > 0.05),
were statistically similar (p > 0.05) in the different chondrogenesis models at all time points. We then
quantified the changing integrin expression of hMSCs undergoing chondrogenesis. While the 21 day time-
course was not long enough to produce mature cartilage, the trends of the integrin transcript expression
we measured in differentiation hMSCs were in agreement with the expression we found in cells derived
from healthy human articular cartilage. Generally, we found that integrin expression was generally higher
in cells cultured in growth medium than in chondrogenic medium and, like the phenotype markers, was
widely conserved across the chondrogenesis models. The most striking changes were in the changing
expression over the 21 day time-course. The hMSCs had significantly changing transcript expression for
most integrins, which should come as no surprise, given the role integrins play in virtually every aspect
of development.288
The changing integrin expression could be catered to with tissue engineering scaffolds incorporating cues
to activate integrins. It remains controversial as to whether ECM-derived peptides activate the same
signalling as the proteins from which they are derived, but whether proteins or peptides are used, they
could mimic the changing niche of hMSCs during chondrogenic differentiation.
Synthetic adhesion peptides were first derived from laminin but have been derived from many ECM
proteins since then.289 Most well-known is the RGD tripeptide derived from fibronectin (and ultimately
found in many other proteins).6 Since then, it has been incorporated in a number of substrates to improve
cell adhesion and used as integrin blockers in a wide range of research and therapeutic applications. Table
4.2 lists many of the peptide sequences derived from integrin ligands. Many of these have been repeatedly
shown to bind specific integrins, but there is a lack of information on whether they replicate the signalling
of the protein from which they are derived. Nonetheless, this repertoire of peptides has been used to
control cell behaviour in diverse cells types, including pancreatic islets96 and embryonic stem cells.98
In this study, ITGA3 , ITGA6 , and ITGA7 , which are known to heterodimerise with ITGB1 to bind
laminin, were typically down-regulated in chondrogenic medium, suggesting that while hMSCs may re-
spond well to laminin, chondrocytes will not. When GFOGER, a collagen-derived peptide was incor-
porated in PEG hydrogels, the positive effect on chondrogenesis was linked to the mechanical proper-
ties of the gel.313 Fibronectin and its peptide derivatives are frequently used to improve cell adhesion
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Table 4.2: Integrin binding peptides
Sequence Ligand Integrin
RGD Adenovirus penton base pro-
tein, bone sialoprotein, colla-
gen, decorsin, disintegrins, fib-
rinogen, fibronectin, prothrom-
bin, tenascin, thombospondin,
vitronectin, von Willibrand fac-
tor, etc.
α3β1, α5β1, α8β1, αvβ3, αvβ5,
αvβ6, αIIbβ36,290
PHSCN Fibronectin synergy region α5β1, αvβ3, αvβ5291
EILDVPST Fibronectin α4β1, α4β7292
IDAPS Fibronectin α4β1293
LDV Fibronectin α4β1292
REDV Fibronectin, vitronectin α4β1294
DGEA Collagen α2β1295
GFOGER Collagen α1β1, α2β1296
GLOGEN type III collagen α1β1297
GVOGEA type II collagen α1β1297
DYATLQLQEGRLHFMFDLG Laminin α1-chain α2β1298
IKLLI Laminin α1 α3β1299
LRGDN Laminin-111 αvβ3, α5β1300
SVVYGLR N-terminal fragment of os-
teonectin
α9β1301
KGGPQVTRGDVFTMP Vitronectin via RGD-binding integrins302
HHLGGAKQAGDV γ-chain of fibrinogen αIIbβ3303
GPR α-chain of fibrinogen, rotavirus
outer capsid protein
αxβ2, αvβ3304
GWTWFQKRLDGSV γ-chain of fibrinogen αMβ2305
KQAGDV Fibrinogen αIIbβ3306
YKSMKKTTMKIIPFNRLTIG γ-chain of fibrinogen αMβ2305
AEIDGIEL Tenascin-C α9β1307
RTDLDSLRTYTL (DLXX L) Tenascin-C αvβ6308
TTSWSQ Cysteine-rich angiogenesis in-
ducer 61 (CCN1)
α6β1309
GRWSGWPADL ICAM-1, -2, -3 αLβ2, αMβ2310
LDT MAdCAM-1 α4β7311
QIDS VCAM-1 α4β1312
GIET VCAM-1 α4β1312
DGE Rotavirus spike protein α2β1304
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though some studies demonstrate a negative effect on chondrogenesis when RGD is incorporated in scaf-
folds.276,314 In this study, we found some of the fibronectin-binding integrins (in particular, ITGAV )
maintained relatively constant expression during chondrogenesis. The presence of these receptors indi-
cates that both hMSCs and chondrocytes might maintain their phenotype in the presence of fibronectin.
While this is the first study to quantify changing integrin expression in multiple chondrogenesis models
over a 21 day time-course, it is by no means the first example of integrins and integrin ligands affecting
MSCs and chondrogenesis. The expression of a number of cell surface receptors has been previously
reported in MSCs.315 Some studies have looked at changing integrin expression in chondrogenesis and
in dedifferentiation of chondrocytes.316,317 For example, the β1 and α3 subunits have been implicated
in dedifferentiation, followed by an increase in fibronectin in the ECM.318 Cartilage sections have also
been stained for integrins, where it has been reported that the most abundant integrin in chondrocytes
is α5β1,277 and that only αv is differentially expressed in the different cartilage zones.319,320 Our results
are in agreement with many of the studies examining specific integrin expression. For example, α1 has
previously be detected in human articular cartilage, while α3 was not.320 We observed up-regulation of
α1 and down-regulation of α3 in chondrogenesis, in agreement with this result.
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4.5 Conclusion
In conclusion, we have completed a characterisation of integrin expression during three in vitro chon-
drogenesis models. We first studied how integrin transcript expression changes during chondrogenic
differentiation and saw that most subunits were temporally regulated. In Chapter 5, we examine the
effect of knocking down integrin β8 and seeing how it disregulates the chondrogenic phenotype mark-
ers. This study improved both our understanding of integrin expression in chondrogenesis and further
underlines the role of the ECM in influencing cell behaviour.
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Integrin αvβ8 in chondrogenic
differentiation of mesenchymal stem
cells
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5.1 Introduction
In Chapter 4, it was found that ITGB8 , the gene encoding integrin subunit β8, was up-regulated during
chondrogenic differentiation in vitro. Relatively little is known about the functions of this integrin,
though due to its conserved sequence across species but lack of homology with other integrin subunits,
it is expected to have a unique and important function. One of the known roles is in the proteolytic and
mechanical release of TGF-β from its latency complex, an important signalling event in embryogenesis
and adult tissue maintenance. In this Chapter, the effects of shRNA silencing of ITGB8 on the expression
of other integrin subunits and on phenotype markers and transcription factors related to chondrogenic
differentiation and chondrocytes were characterised. Following transduction of hMSCs, the cells were
differentiated in the micromass model of chondrogenic differentiation in either growth or chondrogenic
medium.
Mesenchymal stem cells
Multiple patients
PromoCell, UK
> 95% positive:
CD44 (hyaluronan receptor), CD105 (endoglin)
> 95% negative:
CD31 (endothelial), CD45 (hematopoietic)
Micromass for chondrogenic differentiation
250,000 cells
Low-adhesion 
round-bottom 
96-well plate
Scrambled shRNA transduction ITGB8 shRNA transduction
Puromycin selection
Expansion
Puromycin selection
89% knockdown
Expansion
Cell type: 
Wildtype
Control shRNA
ITGB8 shRNA
Medium: 
Growth
Chondrogenic
Analysis
Phenotype markers Integrin expression
qPCR of ECM protein and transcription factors Day 0, 4, 7, 21
α and β subunits
Figure 5.1: hMSCs were transduced with lentiviral particles containing either scrambled shRNA or
ITGB8 shRNA. Following chondrogenic differentiation in the micromass model, the effect of the integrin
β8 knockdown on the expression of other integrin subunits and on chondrogenic phenotype markers was
analysed was quantitative PCR.
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5.1.1 Integrin αvβ8
Integrin subunit β8 is highly conserved across species but is divergent from other β subunits, suggesting
an important and unique role. It is 769 amino acids long (approximately 90 kDa), with a 642 amino acid
extracellular domain. Like many other integrin subunits, it contains the von Willebrand factor sequence
in the extracellular domain but its cytoplasmic domain has no known homology with any other protein.
It was first isolated by Moyle et al., who also showed that it heterodimerises with integrin αv.321 Since
then, it has been found in brain, ovary, kidney, placenta, lung, and eyelid.322,323 This relatively short list
further suggests a specialised role for this integrin, especially in comparison to integrin β1, for example,
which is found in virtually all tissues.
All integrins except β8 have a lysine that interfaces between the α and β subunits, one of the many
structural differences in the integrin β8 subunit that has yet to be explained.268 It also has a shorter
transmembrane segment and a cytoplasmic domain that does not contain a talin or FAK binding site,
which is unlike all other β subunits except for β4 (with which it also does not have homology). When
the cytoplasmic and membrane spanning domains of β8 were cloned to replace those of β3, all β3-
mediated adhesion was abolished (despite an intact β3 extracellular domain). However, when a chimera
consisting of the β3 cytoplasmic and membrane spanning domains and the β8 extracellular domain was
transfected into HEK293 cells, it supported adhesion to vitronectin, albeit at a lower efficiency than
the β3 wildtype.324 The role of the cytoplasmic domain is still poorly understood but one recent report
showed that it is involved in G-protein signalling to activate Rac in kidney mesangial cells.325 It is now
believed that integrin αvβ8 has less of a role in adhesion and more in signalling. Astrocytes provided
a useful model to compare αvβ5 to αvβ8 and investigate this hypothesis. Both are the only integrins
containing the αv subunit expressed in astrocytes and both are known vitronectin receptors. However,
they had different roles in their interaction with vitronectin.326 Integrin αvβ5 bound vitronectin and
promoted adhesion but not migration, while αvβ8 promoted migration and not adhesion.
An integrin β8 ablation in mouse results in embryonic or perinatal lethality, with two thirds of homozygous
embryos dying between E9.5 and E11.5.327 Embryonic lethality was due to defective vascularisation in
the placenta and yolk sac. Mice that survived until birth had perinatal lethality caused by intracerebral
haemorrhage. The β8 subunit is therefore clearly involved in vascularisation but has not been detected
in the vasculature, suggesting instead that it provides environmental cues for patterning of vasculature.
Interestingly, the phenotype is similar to an αv mutant, indicating that β8 is the main partner of αv in
development.328,329
Functionally, one of the major roles of αvβ8 is the activation of TGF-β1, (and TGF-β2 and -3, though
-1 is best characterised) through two different mechanisms.330 In a protease-dependent mechanism, it
simultaneously binds the latent TGF-β1 complex and proteases (such as MMP14) along with αvβ3.
Their close vicinity at the cell surface is thought to improve cleavage of the latent complex and to release
active TGF-β1. The second mechanism implicates αvβ8 as a mechanotransducer. Along with three other
integrins (αvβ3, αvβ5, and αvβ6), it changes the conformation of latent TGF-β1 by transmitting cell
traction forces.331 As with many signalling initiators, integrin αvβ8 acts cooperatively to activate TGF-β
signalling. Mice lacking both integrin αvβ6 and αvβ8 had abnormalities not observed in either of the
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single integrin knockouts.332 These abnormalities were similar to those found in both TGF-β1-null and
TGF-β3-null mice.
5.1.2 Latent TGF-β
One of the known ligands of integrin αvβ8 is TGF-β. It has been said to be one of the most complex
integrin-growth factor relationships in terms of both biology and activation.331 The TGF-β family mod-
ulates many fundamental aspects of cell behaviour, from proliferation to ECM synthesis to apoptosis. It
exists in three isoforms: TGF-β1, TGF-β2, and TGF-β3, all of which as synthesised as pro-TGF-β, a
homodimer covalently attached to the latency associated peptide (LAP, Figure 5.2).333 The LAP peptide
has some sequence variation depending on the TGF-β isoform to which is binds. Cleavage generates
mature TGF-β, still attached (albeit non-covalently) to the LAP. This is called the small latent complex
(SLC) and confers protection from high affinity TGF-β receptors. The SLC can be thought of as a soluble
complex and is diffusible. However, TGF-β is usually secreted as part of the large latent complex (LLC),
which comprises the SLC covalently linked to one of the latent TGF-β-binding proteins (LTBPs). The
four LTBPs (-1, -2, -3, and -4) are all members of the fibrillin-like family and also bind to other ECM
proteins. It is the LLC that becomes ECM-bound and comprises the insoluble source of TGF-β.
The SLC and LLC provide a protective mechanism to prevent TGF-β from being bound by any high
affinity receptor. However, cells need a way to access it when it is required. Upon activation (liberation
from the LAP), of TGF-β, it binds the type II TGF-β receptor, activates and recruits the type I receptor,
and initiates Smad signalling.334 The method of activation depends on the cell type, but always results
in the release of TGF-β from the LAP in either the SLC or the LLC. The release of TGF-β1 is best
understood and involves both integrin-dependent and -independent mechanisms. It appears that the most
prominent mechanism is proteolytic cleavage of the LLC by BMP-1 and various MMPs.335 The integrin-
dependent mechanisms can take place in two major ways: by activating proteases or by transmitting cell
forces. Integrin αvβ8-specific mechanisms are discussed in Section 5.1.1.
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LAP-β1
SLC
LLC
TGF-β1
LTBP-1
Ca2+ binding EGF-like domain
non-Ca2+ binding EGF-like domain
hybrid domain
8-Cys (cysteine-rich) domain
transglutaminase linkage
disulphide bond
mannose-6-phosphate moiety
ECM
proteolytic 
digestion
proteolytic digestion
RGD sequence (integrin 
recognition)
Figure 5.2: TGF-β1 is secreted as part of the large latent complex (LLC) and binds to the ECM. The
small latent complex (SLC) contains the latency-associated peptide (LAP) and the growth factor. TGF-β
can be activated proteolytically (arrowheads) or mechanically (integrin-mediated). Adapted from Wipff
et al.331
118
5. INTEGRIN αVβ8 IN CHONDROGENIC DIFFERENTIATION
5.1.3 Matrix metalloproteinases (MMPs) and proteolysis
One of the ways cells remodel the ECM is with matrix-degrading MMPs. MMPs are endopeptidases
capable of cleaving almost all ECM components. There are 21 human MMPs that can either be secreted or
found in the cell membrane (MT-MMPs).336 They are briefly introduced here because of their association
with integrins in cell-ECM interactions. In one role, the MMPs are capable of unmasking cryptic, or
otherwise hidden, binding sites in ECM proteins such as fibronectin, collagen and laminin. It is thought
that cryptic sites exist so there is no need to persistently silence the pathway.
A well-described example of protease-mediated integrin switching is the regulation of epidermal migration
by laminin-322. This laminin isoform is recognised by integrins α3β1, α6β1, and α6β4 and can either
promote stable epidermal layers or cell migration for wound healing, depending on MMP activity. At the
edge of a wound, full length laminin is secreted, which binds integrin α3β1 and promotes migration to
facilitate wound closure. Away from the site, laminin proteolysis by MMPs exposes the cryptic binding
site for α6β4, which promotes stable epidermal layers over migration.337,267
MMP14 (or MT1-MMP) is associated with integrin αvβ8 and is known to be involved in the proteolytic
digestion that activates TGF-β.330 Integrin αvβ8 binds the RGD site in the SLC, in a manner independent
of its cytosolic domain. It then colocalises with MMP14 in stable clusters, allowing MMP14 to cleave the
LLC and release TGF-β.
5.1.4 RNA interference strategies
RNA interference (RNAi) is a method of using doubled-stranded RNA (dsRNA) to post-transcriptionally
silence gene expression. It has an essential role in normal development and an evolutionary basis in
protecting the genome from viral infections or genomic mutations which produce dsRNA as intermediates,
but here, its use as a basic research tool is highlighted. In 1998, the first paper identifying double-stranded
RNA as the molecule for RNA interference was published in Nature.338 Its authors were awarded the
Nobel Prize for their work in 2006. Since that first paper, an understanding of the mechanism of the
endogenous RNAi pathway has led to a number of tools that have been used to study signalling pathways
and have also been developed as therapeutics to correct aberrant gene expression.
siRNA: Small interfering RNAs are 21-25 nt long dsRNA molecules that can suppress mammalian genes
with sequence homology without inducing the non-specific interferon response that occurs when mam-
malian cells encounter the long dsRNAs that work to silence genes in lower organisms.339 However, they
can only transiently silence genes in mammalian cells, which lack the cellular mechanism to amplify the
trigger. The transient knockdown tends to last one week at the longest, depending on factors such as cell
proliferation and the initial concentration of siRNA.
shRNA: Short hairpin RNAs expressed in viral and plasmid vectors can be used to achieve long-lasting
gene silencing because they have a low rate of degradation. However, they are more likely to induce an
interferon response and the requirement of an expression vector makes them more difficult to synthesise
and handle. Most importantly, the viral integrations allows the silencing to be passed on to progeny,
thereby generating a stable knockdown.
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RNAi mechanism: Cytoplasmic long dsRNA is first processed into short 21-25 nt siRNA by Dicer, an
endonuclease specific to dsRNA.340 The use of exogenous siRNA bypasses the need for Dicer. The siRNAs
then bind an Argonaute protein, where a helicase causes it to unwind, with only one strand remaining
with the protein. This is called the guide strand and how it is chosen appears to the thermodynamically
driven. Along with other proteins, it now forms the RNA-induced silencing complex (RISC).341 The
sequence of the siRNA then directs RISC to bind to target mRNA, where Argonaute catalyses cleavage.
The mRNA is then degraded, preventing protein translation, thereby silencing the gene.
Delivery : For research purposes, the transfection of siRNA or the transduction of viruses containing
shRNA is usually adequate. However, delivery is a challenge for therapeutics where the dsRNA needs to
be delivered to target cells. Viral delivery has been used in gene therapy for many years and the more
recent use of lentiviruses and adenoviruses has overcome some of the safety problems associated with
retroviruses.342 Non-viral delivery methods are the subject of much innovation and a number of strategies
have been developed to improve the stability of dsRNA and the silencing efficiency. Some chemical
modifications, such as nucleic acid residues or modifications to the sugar backbone have been shown to
stabilise siRNA in serum.343 Another strategy to improve stability is to encapsulate siRNA in liposomes
or nanoparticles. These approaches tend to centre on cationic polymers, such as polyethyleneimine (PEI).
Recent developments have enabled targeting to specific tissues or organs by incorporating ligands such
as the RGD sequence or antibody fragments.344,345
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5.2 Materials & Methods
5.2.1 Cell culture
Human bone marrow-derived mesenchymal stem cells (hMSCs) were purchased from PromoCell (UK)
(CD44/CD105 > 95% positive, CD31/CD45 > 95% negative). Cells were maintained in growth medium
(Mesenchymal Stem Cell Growth Medium; PromoCell, UK) at 37◦C and 5% CO2. Prior to differentiation
experiments, cells were expanded to Passage 4 and lightly trypsinised using the DetachKit (PromoCell,
UK) according to the manufacturer’s instructions.
5.2.2 Lentiviral transduction
Lentiviral particles containing shRNA to silence ITGB8 and control (scrambled) shRNA were purchased
from Santa Cruz (Germany). Transduction conditions were optimised using Cop-GFP lentiviral particles
(Santa Cruz). hMSCs were seeded in 24-well plates at 6,000 cells/cm2 and grown to 50% confluency.
They were transduced with 10 µl virus in 5 µg/ml polybrene in growth medium. After 24 h, the medium
was changed and the cells were allowed to recover for a further 24 h. They were then switched to selection
medium, containing 4 µg/ml puromycin. After three days, cells were pooled and assayed for transduction
efficiency, and cultured under standard growth conditions until differentiation experiments.
5.2.3 Chondrogenic differentiation
250,000 hMSCs were suspended in 200 µl of growth medium in a 96-well round bottom suspension culture
plate (Nunc, UK). After 48 h, spheroids began to form spontaneously and cells were fed with either growth
or chondrogenic medium. Medium was changed every 2-3 days.
5.2.4 Western blot
hMSCs were washed in PBS and lysed in RIPA (Sigma, UK) supplemented with protease (Roche, UK) and
phosphatase (Sigma, UK) inhibitors. The lysate was clarified by centrifugation at 4◦C and total protein
was quantified with a Bradford assay (Sigma, UK). 15 µg total protein in Laemmli’s Sample Buffer was
loaded on a 10% SDS-PAGE gel. Protein was transferred to a PVDF membrane under wet conditions.
The membrane was blocked with 5% (w/v) BSA in TBS-T (0.1% (v/v) Tween-20 in TBS) and incubated
in antibodies against integrin β8 (1/200; sc-6638, Santa Cruz, Germany) and GAPDH (1/5000; Clone
2D4A7, Thermo Fisher, UK) overnight at 4◦C. After washing, it was incubated in secondary antibodies
against IgG (anti-goat 1/5000 and anti-mouse 1/5000; Li-Cor Biosciences, UK) labeled with IRDye. The
blot was visualised on an Odyssey CLx with Image Studio software (Li-Cor Biosciences, UK).
5.2.5 RNA extraction and cDNA synthesis
Cells were washed in PBS and 350 µl RLT supplemented with 1% (v/v) β-mercaptoethanol was added.
The samples were vigorously lysed with pipetting and vortexing and stored at -20◦C prior to RNA
extraction using an RNeasy mini kit (Qiagen, UK) according to the manufacturer’s instructions. RNA
quality and quantity were assessed on a NanoDrop 2000c. First-strand cDNA synthesis was performed
using Superscript III First-Strand Synthesis kit from Invitrogen (UK) according to the manufacturer’s
instructions. 100 ng total RNA was reverse-transcribed in a 20 µl reaction volume followed by an RNase
H treatment. cDNA was diluted 1:100 in dH2O prior to qPCR.
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5.2.6 Quantitative real-time PCR
Quantification of mRNA transcripts occurred after 1, 4, 7, and 21 days. A day 0 sample, consisting
of hMSCs prior to trypsinisation was used to normalise integrin subunit expression. Quantitative PCR
was performed in a 10 µl volume on a Rotorgene 6000 (Qiagen, UK) using a Platinum SYBR Green
Supermix-UDG kit (Invitrogen, UK) according to the manufacturer’s instructions. Primer sequences to
the phenotype markers and integrin subunits were obtained from PrimerBank (Harvard University, USA;
http://pga.mgh.harvard.edu/primerbank/; listed in Appendix A) with the exception of primers to
ACAN, COL6A1 , ITGA4 and ITGA6 , which were purchased from Qiagen (Quantitect). Thermocycling
was as follows: 95◦C for 2 min, 40 cycles of 95◦C for 15 s and 62◦C for 30 s, and a high resolution melt
curve from 70-95◦C. For the Quantitect primers, the annealing temperature was 63◦C instead of 62◦C.
All primers were validated with a standard curve to ensure an efficiency of 0.9-1.0 and amplicons were
run on an agarose gel to ensure a single product of the correct size. GAPDH was used as a house-keeping
gene (p > 0.7 over the time-course, no significant differences in GAPDH detected by Western blotting).
Data for the integrin subunits were plotted as 2−∆∆Ct (i.e.- relative to GAPDH and to hMSCs prior to
trypsinisation), except when this value was negative, where they were plotted as -1/2−∆∆Ct. Data for
the phenotype markers were plotted as 2−∆Ct (i.e.- relative to GAPDH ) because the genes were typically
not detected in hMSCs.
5.2.7 Statistical analysis
Student’s t-test and ANOVA were used to determine statistical significance (p < 0.05). Quantitative PCR
data are from three independent experiments performed in technical triplicates. Relative expression was
calculated using the ∆∆Ct method, but down-regulation is presented as the negative inverse.
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5.3 Results
5.3.1 Transduction optimisation
Lentiviral transduction conditions were optimised using a Cop-GFP control. Since hMSCs are notoriously
difficult to transduce and are sensitive to harsh conditions, their tolerance to polybrene and puromycin
was tested. Cells were incubated in polybrene, a cationic polymer, in concentrations ranging from 0-10
µg/ml for 18 h (Figure 5.3). No significant cell death or morphological changes were observed at any
concentration.
Figure 5.3: The tolerance of hMSCs to polybrene concentrations ranging from 0-10 µg/ml was tested for
18 h. Under light microscopy, none of the concentrations tested were found to have an effect on viability
or morphology. Scale: 50 µm.
The lentiviral particles contain a puromycin resistance cassette, allowing antibiotic selection for purifi-
cation following transduction. Since the susceptibility of hMSCs to puromycin was unknown, a titration
was performed over a period of 72 h to determine a concentration at which all wildtype cells would die.
Figure 5.4 demonstrates that at concentrations ranging from 2-10 µg/ml, some cell death occurred after
24 h and from 4-10 µg/ml, all cells were dead after 72 h. A concentration of 4 µg/ml was therefore chosen
for antibiotic selection.
Figure 5.4: The susceptibility of hMSCs to puromycin selection was tested at concentrations from 0-10
µg/ml for 72 h. With light microscopy, the lowest concentration seen to cause cell death was 4 µg/µl.
Scale: 50 µm.
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After the determination that hMSCs could tolerate high polybrene concentrations and that 4 µg/ml
puromycin would be sufficient for selection, the transduction conditions were optimised using a Cop-GFP
construct. After hMSCs reached 50% confluence in 24-well plates, they were transduced with 0, 2, 5, or
10 µl/ml lentiviral particles and 2, 5, or 10 µg/ml polybrene. Cells were fixed and viewed under a light
and fluorescent microscope for GFP expression 72 h after transduction and prior to selection (Figure 5.5).
Under these conditions, it appeared that 10 µg/ml polybrene was negatively affecting cell viability.
Figure 5.5: Fixed hMSCs were viewed under light and fluorescent microscopy (overlay shown) to deter-
mine optimal transduction conditions 72 h after transduction and prior to antibiotic selection. Only the
10 µm/ml polybrene had a negative effect at this time point. Scale: 20 µm.
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Starting 72 h after transduction, the cells were switched to selection medium (4 µg/ml puromycin in
growth medium), which was changed every two days. After the first day of selection, the cells were pas-
saged and it was one week after transduction that selection was complete and the cells were proliferating.
Figure 5.6 is a unfixed (live) plate, showing the appearance of the cells at this timepoint. A brief look
under the fluorescent microscope showed all cells were expressing GFP (except in the controls without
virus) but the plate was kept in culture.
Figure 5.6: Following lentiviral transduction and selection, all cells were expressing GFP (not shown),
so the morphology and cell number were used to determine the optimal transduction conditions. It was
determined that 5 µg/ml polybrene and either 5 or 10 µl/ml lentivirus (h and k) resulted in the highest
cell number. Light microscopy images were taken one week after transduction. Scale: 20 µm.
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5.3.2 Transduction efficiency
Figure 5.7a depicts the ITGB8 knockdown efficiency before and after puromycin selection. After selection,
quantitative PCR established a silencing efficiency of 89% in two independent experiments and the integrin
β8 protein was undetectable with Western blotting (Figure 5.7b).
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Figure 5.7: Transduction efficiency was determined by a) qPCR before and after selection (N =3) and
b) by Western blotting (N =2) after selection. ITGB8 mRNA levels were only 11% of the wildtype after
selection and integrin β8 was undetectable.
5.3.3 Effect of ITGB8 knockdown on integrin expression
After expansion, the transduced hMSCs were differentiated in the micromass model of chondrogenesis.
Integrin subunit expression in the knockdown was compared to the results from Chapter 4. None of
the α subunits had statistically different mRNA expression in the chondrogenic differentiation of ITGB8
knockdown hMSCs compared to the wildtype (Figures 5.8-5.9), except for a slight down-regulation of
ITGA11 after 21 days (Figure 5.9c). The β subunits were more affected, with ITGB1 being down-
regulated after 21 days (Figure 5.10a) and ITGB3 being undetectable after four days (Figure 5.10b).
One observation was that many of the integrin subunits had different expression at day 0 (prior to
the micromass) suggesting the hMSCs were more affected prior to the signals from being cultured in
a micromass. This effect was observed for ITGA3 , ITGA4 , ITGA6 , ITGA11 , ITGAV , ITGB1 , and
ITGB5 (all up-regulated in the ITGB8 knockdown).
126
5. INTEGRIN αVβ8 IN CHONDROGENIC DIFFERENTIATION
R
el
at
iv
e 
ex
pr
es
si
on
-5
0
5
10
15
20
25
30
0 4 7 21Day
-15
-10
-5
0
5
0 4 7 21Day
ITGA1 ITGA2 ITGA3
-20
-15
-10
-5
0
0 4 7 21Day
a b c
-10
-8
-6
-4
-2
0
2
0 4 7 21Day
-6
-5
-4
-3
-2
-1
0
1
2
0 4 7 21Day
ITGA4 ITGA5 ITGA6
R
el
at
iv
e 
ex
pr
es
si
on
-60
-50
-40
-30
-20
-10
0
0 4 7 21Day
d fe
Figure 5.8: Quantitative PCR established mRNA expression of integrin subunits in hMSCs (wildtype:
solid lines, ITGB8 knockdown: dashed lines) cultured in a micromass in either growth (black) or chon-
drogenic (red) medium over a time-course of 21 days. a) ITGA1 , b) ITGA2 , c) ITGA3 , d) ITGA4 ,
e) ITGA5 , and f) ITGA6 were unaffected by the ITGB8 knockdown after 21 days. Each point repre-
sents mean expression relative to GAPDH and to hMSCs on tissue culture plastic in growth medium of
N =2-3 independent experiments, and error bars represent the range of values. Statistical significance is
in Appendix B, Figure S6.
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Figure 5.9: Quantitative PCR established mRNA expression of integrin subunits in hMSCs (wildtype:
solid lines, ITGB8 knockdown: dashed lines) cultured in a micromass in either growth (black) or chon-
drogenic (red) medium over a time-course of 21 days. a) ITGA7 , b) ITGA10 , and d) ITGAV were
unaffected by the ITGB8 knockdown after 21 days, while c) ITGA11 was down-regulated. Each point
represents mean expression relative to GAPDH and to hMSCs on tissue culture plastic in growth medium
of N =2-3 independent experiments, and error bars represent the range of values. Statistical significance
is in Appendix B, Figure S6.
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Figure 5.10: Quantitative PCR established mRNA expression of integrin subunits in hMSCs (wildtype:
solid lines, ITGB8 knockdown: dashed lines) cultured in a micromass in either growth (black) or chon-
drogenic (red) medium over a time-course of 21 days. a) ITGB1 was down-regulated, b) ITGB3 was
undetectable, and c) ITGB5 was unaffected by the ITGB8 knockdown after 21 days. Each point rep-
resents mean expression relative to GAPDH and to hMSCs on tissue culture plastic in growth medium
of N =2-3 independent experiments, and error bars represent the range of values. N.D.: not detected.
Statistical significance is in Appendix B, Figure S6.
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5.3.4 Effect of ITGB8 knockdown on phenotype markers
All phenotype markers were affected by the ITGB8 knockdown. ACAN was down-regulated in the
ITGB8 knockdown cultured in chondrogenic medium after four days, though it was still up-regulated
compared to cells in growth medium and reached wildtype levels by day 21 (Figure 5.11a). COL2A1
expression had a striking change in the knockdown, and was not detected at any point (Figure 5.11b).
The two pericellular matrix markers, COL6A1 and HSPG2 , were up-regulated compared to wildtype in
both growth and chondrogenic medium, with a more significant up-regulation observed in growth medium
(Figure 5.12). COL1A1 was significantly down-regulated in chondrogenic medium but was unaffected
in growth medium (Figure 5.13a). COL10A1 was down-regulated in growth medium at day 4, but was
similar to the wildtype by day 21. In chondrogenic medium, this marker was unaffected by the knockdown
(Figure 5.13b). RUNX2 expression was abolished by knocking down integrin β8 in both growth and
chondrogenic medium at all time points (Figure 5.14a). SOX9 was significantly down-regulated after 21
days in chondrogenic medium but was unaffected in growth medium (Figure 5.14b).
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Figure 5.11: Quantitative PCR established mRNA expression of two key markers of a hyaline cartilage
extracellular matrix in hMSCs (wildtype: solid lines, ITGB8 knockdown: dashed lines) cultured in a
micromass in either growth (black) or chondrogenic (red) medium over a time-course of 21 days. a)
ACAN was down-regulated after 4 days but reached wildtype levels after 21 days, and b) COL2A1
was undetectable in the ITGB8 knockdown. Each point indicates mean expression relative to GAPDH
of N =2-3 independent experiments, and error bars represent the range of values. N.D.: not detected.
Statistical significance is in Appendix B, Figure S7.
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Figure 5.12: Quantitative PCR established mRNA expression of two key markers of a hyaline cartilage
pericellular matrix in hMSCs (wildtype: solid lines, ITGB8 knockdown: dashed lines) cultured in a
micromass in either growth (black) or chondrogenic (red) medium over a time-course of 21 days. a)
COL6A1 and b) HSPG2 were up-regulated after 21 days in the ITGB8 knockdown. Each point indicates
mean expression relative to GAPDH of N =2-3 independent experiments, and error bars represent the
range of values. N.D.: not detected. Statistical significance is in Appendix B, Figure S7.
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Figure 5.13: Quantitative PCR established mRNA expression of two key markers of a non-hyaline ex-
tracellular matrix in hMSCs (wildtype: solid lines, ITGB8 knockdown: dashed lines) cultured in a
micromass in either growth (black) or chondrogenic (red) medium over a time-course of 21 days. a)
COL1A1 was down-regulated and b) COL10A1 was unaffected by the ITGB8 knockdown after 21 days.
Each point indicates mean expression relative to GAPDH of N =2-3 independent experiments, and error
bars represent the range of values. N.D.: not detected. Statistical significance is in Appendix B, Figure
S7.
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Figure 5.14: Quantitative PCR established mRNA expression of two key transcription factors involved
in differentiation of hMSCs (wildtype: solid lines, ITGB8 knockdown: dashed lines) cultured in a micro-
mass in either growth (black) or chondrogenic (red) medium over a time-course of 21 days. a) RUNX2
was undetected and b) SOX9 was down-regulated in the ITGB8 knockdown after 21 days. Each point
indicates mean expression relative to GAPDH of N =2-3 independent experiments, and error bars repre-
sent the range of values. N.D.: not detected. Statistical significance is in Appendix B, Figure S7.
131
5. INTEGRIN αVβ8 IN CHONDROGENIC DIFFERENTIATION
The expression of two genes associated with integrin β8 function were also quantified. Figure 5.15a
depicts mRNA expression in hMSCs prior to trypsinisation. At this point, LTBP1 , the gene encoding
the latency associated peptide of TGF-β was unaffected by the ITGB8 knockdown, but MMP14 , the
MMP that associated with integrin β8, was down-regulated. Once chondrogenic differentiation began
(Figure 5.15b-c), there was a sudden down-regulation of LTBP1 in the knockdown after four days in
chondrogenic medium but the two genes were otherwise unaffected.
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Figure 5.15: Quantitative PCR established mRNA expression of two genes associated with integrin β8 in
hMSCs (wildtype: solid lines, ITGB8 knockdown: dashed lines) on tissue culture plastic, a) MMP14 was
significantly down-regulated in the ITGB8 knockdown compared to control shRNA. In hMSCs cultured
in a micromass in either growth (black) or chondrogenic (red) medium over a time-course of 21 days,
b) LTBP1 and c) MMP14 were generally unaffected by the ITGB8 knockdown. Each point represents
mean expression relative to GAPDH of N =2-3 independent experiments, and error bars represent the
range of values.
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5.4 Discussion
ITGB8 was one of the only integrin subunits consistently up-regulated in all chondrogenesis models in
Chapter 4. Given its role in the mechanical and proteolytic activation of TGF-β,331 its role in chon-
drogenesis was further investigated. Lentiviral shRNA against ITGB8 was used to generate a stable
knockdown in hMSCs, which could then be differentiated in the micromass model of in vitro chondrogen-
esis. A 89% knockdown was determined by qPCR and was validated by Western blotting, where integrin
β8 was undetectable. The control (scrambled) shRNA had no effect on gene or protein expression.
Most of the other integrin subunits were unchanged in the knockdown compared to the wildtype. After
21 days in the micromass in either growth or chondrogenic medium, the only subunits affected were
ITGA11 (down-regulated), ITGB1 (down-regulated), and ITGB3 (undetectable). There is a theory
that the β subunits compete for a limiting quantity of integrin αv. While this was not directly measured
in this study, the changing expression of ITGB1 and ITGB3 , both known to heterodimerise with ITGAV,
may be related to the competition and redundancy seen in previous studies.321 The biggest effect of the
ITGB8 knockdown on the integrin subunits was seen prior to chondrogenic differentiation, where many
subunits were up-regulated. This result is not easily explained but the increase in ITGB5 could at
least be partially explained by the reduction of integrin β8, thereby leaving more integrin αv available
for heterodimerisation. The recovery of integrin subunit mRNA expression to wildtype levels during
chondrogenic differentiation speaks to the robustness and redundancy of developmental processes.
In the ITGB8 knockdown, all phenotype markers were expressed differently compared to the wildtype.
The ECM markers were down-regulated, with COL2A1 expression notably abolished. The pericellular
matrix markers, COL6A1 and HSPG2 were both up-regulated. Both transcription factors were down-
regulated, with RUNX2 expression down-regulated to undetectable levels, and SOX9 down-regulated in
growth medium after four days and chondrogenic medium after 21 days.
TGF-β was not directly measured in this study, though it is expected that release of all isoforms would
be diminished by the knockdown of integrin αvβ8.324,346,347 Integrin αvβ8 has never been previously
implicated in chondrogenesis, but the TGF-β family has a well-described role and affecting its activation
could affect normal ECM formation and chondrogenesis.348 While the comparison of cell behaviour in
growth and chondrogenic medium is usually done as a reference, in this study, it is a key consideration.
Growth medium contains serum and for hMSC maintenance, there are typically low levels of TGF-β. In
chondrogenic medium, however, there is no serum and instead there is a high concentration of growth
factors, usually TGF-β3. The implication is in the different levels of soluble and insoluble TGF-β available
to the cells. It is expected that in growth medium, more of the TGF-β available would have been in
its insoluble (cell-secreted) form, which requires activation, while in chondrogenic medium, both soluble
and insoluble forms are present (but with large quantities of soluble TGF-β). In growth medium, there
was little change to COL1A1 , while in chondrogenic medium, there was a significant down-regulation.
Conversely, the up-regulation of the pericellular markers was much more pronounced in growth medium,
suggesting an important role of integrin αvβ8-mediated TGF-β activation. This could at least be partially
explained by the presence of insoluble over soluble TGF-β and perhaps by interfering with the ability
to activate insoluble TGF-β, the cells developed more pericellular over extracellular matrix. In the
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knockdown in chondrogenic medium (i.e.- in the presence of soluble TGF-β and by inhibiting the release
of insoluble TGF-β), RUNX2 expression was abolished, which may indicate a role for different TGF-β
isoforms in hMSC differentiation.
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5.5 Conclusion
In this chapter, the effect of disregulating integrin expressing during chondrogenic differentiation was
studied, by knocking down integrin β8 and seeing its effect on chondrogenic phenotype markers. The
knockdown resulted in a tendency towards pericellular matrix synthesis and eliminated COL2A1 expres-
sion. This study is the first example of a role for integrin β8 in chondrogenic differentiation and underlines
the importance of TGF-β signalling. It can impact the future design of tissue engineering scaffolds to
include cues to cater to the changing adhesion requirements of hMSCs in chondrogenic differentiation.
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Motivation of the thesis
In recent years, tissue engineering has produced a number of clinically successful tissues and organs. But
as an emerging field, the promise of an engineered replacement for disease or damaged tissue, has not
yet been realised. The tissue engineering literature describes a diverse selection of scaffold materials,
including examples derived from extracellular matrix and those designed from polymers. They all aim to
promote a specific cell behaviour, such as mineralisation for bone tissue engineering, or type II collagen
synthesis for a cartilage replacement. However, despite the established importance of the scaffold for
providing cues to influence cell behaviour, there is relatively little known in terms of design principles.
This is especially true in the case of stem cells, which are considered a viable cell source. Importantly,
some of the most promising features of stem cells– their prolonged self-renewal and their ability to form
many tissue types could also be their downfall because both uncontrolled proliferation and differentiation
are dangerous to the patient. Indeed, a better understanding of how cells respond to their substrate and
establishing the cues they require would improve the design of tissue engineering scaffolds.
There is good reason for using substrate cues to promote cell behaviour. Cells are known to respond to
cues from their substrates, whether they be physical signals such as substrate elasticity and topography,
chemical cues such as hydrophobicity, or the use of biomolecules to initiate signalling. And unlike soluble
cues, substrates are non-diffusible and tend to signal to cells in direct contact with them, rather than
systemically. Cells can sense their substrates both in the development and maintenance of all organs and
tissues, where cells are surrounded by and receive cues from their extracellular matrix so it should be no
surprise that the same is true in vitro.
For stem cells, their surroundings in vivo are called the stem cell niche. The niche can act to maintain
stem cell self-renewal, promote quiescence, or induce differentiation. For adult stem or progenitor cells,
the niche is highly variable between tissue types but generally acts to provide both short- and long-
range signals. The long-range signals are from secreted, soluble factors, and these act to regulate both
cell proliferation and differentiation. The TGF-β superfamily is one example of growth factors that
have been repeatedly shown to affect stem cell differentiation. Growth factors are often used in tissue
engineering in an attempt to replicate some of the endogenous signalling, and have been proven to be
effective in some cell types. The short-range signals from the niche are more relevant to the work in this
thesis. These primarily involve integrins and their interaction with the extracellular matrix. Integrins act
to hold cells in place and their disruption can lead to apoptosis or differentiation. They are also signalling
molecules that can directly act on extracellular matrix molecules, as in the release of TGF-β from its
latency complex, can recruit the coordination of molecules on the cell surface, or can initiate intracellular
signalling cascades through conformational changes. The extracellular matrix has biological components
that influence cell behaviour, but its physical properties are also an important part of niche signalling.
In recent years, tissue engineers have used biomaterials to recreate the niche or to at least mimic some
of its key components. They have aimed to sustain cell viability by permitting adhesion, and promote a
specific phenotype by physical and biological cues.
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The aim of this thesis was to answer two important questions related to cell-substrate interactions: 1)
how do stem cells respond to physical substrate cues, and 2) which cues do stem cells require as they
undergo differentiation. The answers to these questions could be incorporated by tissue engineers in the
design of scaffolds, which should ultimately improve cell behaviour and thereby improve clinical outcomes
of tissue engineering.
Cell response to physical cues
The use of physical cues to guide cell behaviour is established in tissue engineering. They can be incor-
porated at the manufacturing stage of the scaffold and by eliminating the need for biomolecules, they
solve the problems associated with immunogenicity. One of the major themes of the thesis was stem cell
response to physical cues. Two experiments were established to better understand how embryonic stem
cells respond to substrate topography and chemical composition. The aim for both was to contribute to
the understanding on how stem cell differentiation can be affected by substrate cues.
In the first experiment (Chapter 2), a substrate composed of highly ordered, closely packed silica colloidal
crystal microspheres was fabricated. Cells were cultured in the absence of differentiation inhibitors for
long time periods, and were observed to form highly distinct, reproducible central pits. Gene expression
analysis found that the substrates were preventing differentiation, particularly endoderm specification,
which is often considered to be the default lineage of murine embryonic stem cells. This was the first
example of central pit formation induced by a substrate and the first example of silica microspheres
preventing endoderm specification. Colonies grown on silica microsphere substrates were much more
spherical than on glass slides and therefore had more cell-cell contacts. There are two interesting outcomes
from this work. Firstly, it shows how topography can be used to specify lineage commitment, which could
be used in the design of materials to control cell fate. Secondly, it underlines the important role of cell-
substrate and cell-cell contacts in stem cell behaviour. Whether through topography or other substrate
cues, it is clear that controlling colony shape is important for controlling cell behaviour.
Future work on these substrates would aim to determine which property induced the cell behaviour. This
would make the results transferrable to other systems. If it was the topography that led to the observed
cell behaviour, then the results should be reproducible on another material with the same shapes. In fact,
the silica microsphere substrates could be used to template other materials, precisely reproducing the
topography. Otherwise, the results could be explained by the colony morphology. Even though this was
clearly a result of the silica microsphere substrates (as colonies were always more spread in monolayers
on glass slides), it would be interesting to develop a hypothesis about the relative frequency of cell-cell
contacts over cell-substrate contacts. First, the colony morphology could be reproduced by limiting cell
spreading through micropatterning techniques. Then, if the same cell behaviour occurred, it could be
attributed to colony morphology rather than specifically the topographical features. At the same time,
it would be interesting to see how focal adhesions were forming in the colonies and how this relates to
growing evidence that integrin clustering and signalling can explain many cell-substrate effects.
Next, the effects of nanometre topography and chemical composition on embryonic stem cells were studied
(Chapter 3). This was in response to growing evidence that cells can sense features on the scale of
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tens of nanometres. Some of the important cell surface proteins involved in cell-substrate adhesion
have diameters on the order of only a few nanometres so an experiment was designed to test whether
they could sense features under 5 nm. Furthermore, many studies have shown an effect of chemical
composition on embryonic stem cells. However, these have never been able to separate out the effects of
hydrophobicity and surface energy. Surface energy has an important role in protein adsorption, but it
is typically hydrophobicity that is measured in the context of cell adhesion experiments. To determine
cell response to nanometre scale cues, nanoparticles composed of a gold core surrounded by a mixture
of two alkanethiols (one hydrophobic, one hydrophilic) were synthesised. They were 4.5 nm in diameter
on average, and were covalently attached to a glass slide as a thin film. To control for the 4.5 nm
topography, the same alkanethiols were self-assembled on a glass slide. The central network of embryonic
stem cell transcription factors was affected by nanometre scale topography, where it appeared to have
a role in maintaining some degree of transcription. Substrate chemistry also had an effect and in some
cases, chemistry and topography appeared to work synergistically. The most significant effect of the
nanoparticle substrates was to decrease the expression of early differentiation transcripts. Similar to the
work in Chapter 2, this could be of interest to researchers wanting to use topography and chemistry to
control stem cell fate.
As the first example of embryonic stem cells responding to features under 5 nm, future work should
focus both on understanding the receptors through which the cells interacted with the substrates and
specifically which surface features influenced cell behaviour. Integrin signalling is known to be governed
by their ability to cluster and is also implicated in stem cell differentiation so it would be interesting to
understand how it was affected by such small features. Since the quantity of early differentiation markers
was affected by the chemical composition of the substrate but was not directly related to hydrophobicity, it
would be interesting to better understand how chemistry affects this signalling. It could be a synergistic
effect between chemistry and topography, but it could also have to do with surface energy affecting
protein adsorption. One of the advantages of using these nanoparticles is their non-linear relationship
between hydrophobicity and surface energy. However, to attribute any cell behaviour to surface energy,
its effects on protein adsorption would need to be better understood. In particular, its effects on the
major components of serum, such as albumin, should be studied.
Overall, the first part of the thesis aimed to understand the response of embryonic stem cells to certain
substrate features. Micrometre and nanometre scale topography, and bulk chemistry all affected stem cell
differentiation in ways not previously reported. There is still a great deal of work to be completed before
design principles would allow the prediction of how cells might respond to a substrate, but it nonetheless
has improved our understanding of cell-substrate interactions.
Requirements of differentiating cells
In the second part of the thesis, a different approach was taken to improving our understanding of cell-
substrate interactions. It was noted that a great deal of the tissue engineering literature reported on the
use of adhesion proteins (or their peptide derivatives) to influence cell behaviour. This was especially
apparent in cartilage tissue engineering, where there were reports of fibronectin-derived peptides both
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promoting and inhibiting the differentiation of mesenchymal stem cells into chondrocytes. This was
particularly puzzling, as the reports rarely discussed the native stem cell or chondrocyte extracellular
matrix. Additional reports of laminin-derived peptides only added to the confusion and in all cases, it
was unclear whether the peptide was signalling similarly to the full length protein or whether there was
another explanation for the observed cell behaviour.
To address the lack of clear information on the adhesion requirements of mesenchymal stem cells under-
going chondrogenic information, integrin transcript expression was measured over three weeks in cells
in three models of in vitro chondrogenesis (Chapter 4). These models are commonly used in tissue
engineering, and the experiments were performed in growth and chondrogenic differentiation medium.
Generally, integrin subunit expression decreased as the cells became chondrocytes, suggesting that many
of the strategies aimed at improving adhesion by providing adhesion peptides on a scaffold will not im-
prove chondrogenesis. Crucially, the differences in integrin expression between mesenchymal stem cells
in expansion conditions and chondrocytes derived from a human cartilage pellet were measured. This
information addresses the key aim of the thesis, which is to inform tissue engineering design decisions.
The future work for this experiment would be first to validate the findings on a functional level. This
would start with identifying the subunit heterodimers at the protein level and validating their presence
on the cell surface during differentiation. Since the results to date are on a population level, it would be
especially interesting to see how the integrins are spatially regulated throughout the cell pellet. Next,
to translate the findings to something directly useful for tissue engineering, a scaffold presenting binding
ligands for the integrins should be developed. Initially, it would be interesting to see if mesenchymal
stem cell self-renewal can be improved and then if chondrocyte dedifferentiation can be prevented. Then,
to address an ongoing question in scaffold design, to test whether extracellular matrix protein-derived
peptides have the same effect as the native proteins. Ultimately, the results of this chapter indicate that
a scaffold to promote chondrogenic differentiation should include ligands that are temporally presented.
Designing a scaffold to do this would be a first in the field.
The last experiment of the thesis was designed to validate one of the results from Chapter 4. Having
measured an up-regulation of the gene encoding integrin subunit β8, it was hypothesised that integrin
αvβ8 might have a role in chondrogenic differentiation (Chapter 5). The integrin has a known role in
the release of TGF-β from its latency complex, but had only been identified in a few tissues. In order
to investigate its role in mesenchymal stem cells and in chondrogenic differentiation, a stable knockdown
was made. The most striking results were seen in the establishment of chondrogenic phenotype markers.
Pericellular matrix markers were up-regulated, while hyaline cartilage markers were down-regulated. One
of the interesting and unexpected results was that knocking down integrin β8 led to different outcomes
depending on the culture medium. This points strongly to its role in the release of TGF-β.
Future work on the role of integrin αvβ8 in chondrogenic differentiation would also start at the protein
level to confirm the mRNA results. Following this, the effects of the medium composition should be
isolated. In these experiments, a proprietary formula was used, so the next experiments should see how
the concentration of soluble TGF-β affects cell phenotype markers. This represents another shortcoming
in the design of tissue engineering scaffolds. While the use of TGF-β3 is more common for promoting
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chondrogenic differentiation, there are still many reports of using TGF-β1 and some groups believe that
isoform works better. To determine how the different isoforms affect chondrogenic signalling would
represent another major advance to the field of cartilage tissue engineering.
Overall, the second part of the thesis aimed to understand the cues cells require from their substrate
as they undergo chondrogenic differentiation. The experiments were designed in the context of current
tissue engineering trends, using cells and methods commonly used to generate cartilage in vitro. Integrin
transcript expression was used to indicate the cell surface receptors and was measured over time to see how
it changed. Integrin transcripts were highly affected by the time-course of differentiation, and integrin
αvβ8 was shown to be important in the generation of a cartilage phenotype for the first time. These
studies underlined the importance of integrins in chondrogenic differentiation and addressed a major
shortcoming of tissue engineering, which is to provide adhesion cues catered to native cell behaviour.
Outlook
Unquestionably, the desire for tissue engineering solutions to address the clinical need for organ replace-
ments and damaged tissues is only going to increase. The current paradigm is to use patient-derived cells,
incorporated with a scaffold and biomolecules, developed in vitro, and implanted for final maturation.
Stem cells are an attractive cell type due to their propensity for prolonged self-renewal in culture and
their ability to differentiate into some of the cell types that are otherwise in short supply. But there is
a daunting task ahead for tissue engineers. Their approach to date involves attempts with an enormous
variety of scaffolds, soluble factors, and other design features. Some design principles are beginning to
be incorporated, many of these arising from signalling studies in development, but there is still a lack of
basic information pertaining to how cells respond to scaffold cues and which cues the cells require.
There is exciting work being done on a few major research fronts. High throughput studies have started
yielding information about a wide variety of substrate properties, such as chemical compositions and
topographical features. As these are put in the context of outside-in signalling, it is becoming increasingly
clear that the extracellular environment can have a powerful influence on cell behaviour. Stem cell
biologists are also beginning to understand the sensitive balance present in the stem cell niche, where a
single protein can be the difference between self-renewal and differentiation. Studies like the ones in the
first part of this thesis are improving our understanding of how stem cells respond to artificial cues, similar
to those they will encounter on many tissue engineering scaffolds. And finally, systematic measurements
of cells undergoing differentiation, like the ones in the second part of this thesis, are demonstrating tightly
regulated cell-substrate interactions.
The future of tissue engineering lies in our ability to combine lessons from development, studies of the
stem cell niche, results from high throughput experiments, and from studies of cell response to artificial
substrates. Only with all of these pieces will we be able to replicate the complex, robust, and highly
sensitive processes developed through evolution. Great headway has been made in recent years, and
receiving a tissue engineered organ is a current reality for some patients. In the future, no doubt will
the field be able to fulfil its original promise of repairing diseased or damaged organs for regenerative
medicine.
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Gene Species Forward (5’ - 3’) Reverse (5’-3’)
Chapter 2
Gapdh Mouse AACTTTGGCATTGTGGAAGG ACACATTGGGGGTAGGAACA
Nanog Mouse TTGCTTACAAGGGTCTGCTACT ACTGGTAGAAGAATCAGGGCT
Fgf5 Mouse TGTGTCTCAGGGGATTGTAGG AGCTGTTTTCTTGGAATCTCTCC
Foxa2 Mouse CCCTACGCCAACATGAACTCG GTTCTGCCGGTAGAAAGGGA
Chapter 3
Gapdh Mouse QuantiTect from Qiagen QuantiTect from Qiagen
Fgf5 Mouse QuantiTect from Qiagen QuantiTect from Qiagen
Foxa2 Mouse QuantiTect from Qiagen QuantiTect from Qiagen
Nanog Mouse QuantiTect from Qiagen QuantiTect from Qiagen
Pou5f1 Mouse QuantiTect from Qiagen QuantiTect from Qiagen
Nanog Mouse QuantiTect from Qiagen QuantiTect from Qiagen
Chapter 4 & 5
ACAN Human QuantiTect from Qiagen QuantiTect from Qiagen
COL1A1 Human GTCGAGGGCCAAGACGAAG CAGATCACGTCATCGCACAAC
COL2A1 Human GGTCTTGGTGGAAACTTTGCT GGTCCTTGCATTACTCCCAAC
COL6A1 Human QuantiTect from Qiagen QuantiTect from Qiagen
COL10A1 Human ATGCTGCCACAAATACCCTTT GGAATGAAGAACTGTGTCTTGGT
GAPDH Human ATGGGGAAGGTGAAGGTCG GGGGTCATTGATGGCAACAATA
HSPG2 Human QuantiTect from Qiagen QuantiTect from Qiagen
ITGA1 Human CAGCCCCACATTTCAAGTCGT ACCTGTGTCTGTTTAGGACCA
ITGA2 Human GCAACTGGTTACTGGTTGGTT GAGGCTCATGTTGGTTTTCATCT
ITGA3 Human TCAACCTGGATACCCGATTCC GCTCTGTCTGCCGATGGAG
ITGA4 Human QuantiTect from Qiagen QuantiTect from Qiagen
ITGA5 Human GCCTGTGGAGTACAAGTCCTT AATTCGGGTGAAGTTATCTGTGG
ITGA6 Human QuantiTect from Qiagen QuantiTect from Qiagen
ITGA7 Human TGACCAACATTGATAGCTCAGAC GCGCAGGATAACCACAGCA
ITGA10 Human CTTCAGTTCTGGGATATGTGCC CCAGTCTTCGTAGGAAGGTCT
ITGA11 Human TCACGGACACCTTCAACATGG CCAGCCACTTATTGCCACTGA
ITGAV Human CATCTGTGAGGTCGAAACAGG TGGAGCATACTCAACAGTCTTTG
ITGB1 Human TTATTGGCCTTGCATTACTGCT CCACAGTTGTTACGGCACTCT
ITGB3 Human AGAGCCAGAGTGTCCCAAG GGCCTCTTTATACAGTGGGTTGT
ITGB5 Human CAGGTGGAGGACTATCCTGTG GTGCCGTGTAGGAGAAAGGAG
ITGB6 Human CATGTCCGCCAGACTGAGG GAGCCCAGCTCCTTTATTGTG
ITGB7 Human TGGTTTTGGTTCCTTTGTGGA GGTGAAAGCTGAATGGTGACT
ITGB8 Human CAGCACTGTGTCAATTCAAAGG GCAGGCTGTATAACAGGTGGG
LTBP1 Human CTGACGGCCACGAACTTCC GCACTGACATTTGTCCCTTGA
MMP14 Human CGAGGTGCCCTATGCCTAC CTCGGCAGAGTCAAAGTGG
RUNX2 Human TCCTATGACCAGTCTTACCCCT GGCTCTTCTTACTGAGAGTGGAA
SOX9 Human AGCGAACGCACATCAAGAC GCTGTAGTGTGGGAGGTTGAA
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Appendix B: Statistical analysis
This appendix contains tables of p-values, resulting from the statistical analyses in Chapters 4 and 5.
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Chapter 4: Integrin expression of mesenchymal stem cells in
chondrogenic differentiation
In Chapter 4, integrin and phenotype transcript expression were quantified throughout a time-course
of 21 days in three chondrogenic differentiation models in either growth or chondrogenic medium. All
results mentioned in the text of the chapter were statistically significant (p < 0.05), but the results of
the individual tests are depicted in Figures S1-S5.
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Figure S1. The statistical significance of the effect of the medium composition on integrin expression
from Figures 4.9-4.16. p-values indicate whether there was a statistically significant difference between
cells cultured in growth or chondrogenic medium at each timepoint in each of the three chondrogenesis
models, a) pellet culture, b) micromass, or c) type II collagen hydrogel. N =3 independent experiments
in technical triplicates.
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Figure S2. The statistical significance of the effect of the time-course on integrin expression from Figures
4.9-4.16. p-values indicate whether there was a statistically significant difference between cells cultured
in growth or chondrogenic medium at each timepoint in each of the three chondrogenesis models: a and
d) pellet culture, b and e) micromass, or c and f) type II collagen hydrogel, when compared to hMSCs
in expansion medium. N =3 independent experiments in technical triplicates.
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Figure S3. The statistical significance of the effect of the chondrogenesis model on integrin expression
from Figures 4.9-4.16. p-values indicate whether there was a statistically significant difference between
cells cultured in pellet culture, micromass, or a type II collagen hydrogel in either a) growth medium, or
b) chondrogenic medium. N =3 independent experiments in technical triplicates.
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Figure S4. The statistical significance of the effect of the medium composition on phenotype marker
expression from Figures 4.4-4.7. p-values indicate whether there was a statistically significant difference
between cells cultured in growth or chondrogenic medium at each timepoint in each of the three chon-
drogenesis models, a) pellet culture, b) micromass, or c) type II collagen hydrogel. N =3 independent
experiments in technical triplicates.
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Figure S5. The statistical significance of the effect of the chondrogenesis model on phenotype marker
expression from Figures 4.4-4.7. p-values indicate whether there was a statistically significant difference
between cells cultured in pellet culture, micromass, or a type II collagen hydrogel in either a) growth
medium, or b) chondrogenic medium. N =3 independent experiments in technical triplicates.
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Chapter 5: Integrin αvβ8 in chondrogenic differentiation of mes-
enchymal stem cells
In Chapter 5, integrin and phenotype transcript expression were quantified through a time-course of 21
days in the micromass model of chondrogenic differentiation in either growth of chondrogenic medium
following the knockdown of ITGB8 . The results of the statistical analysis are depicted in Figures S6-S7.
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Figure S6. The statistical significance of the effect of the knockdown of ITGB8 on integrin expression from
Figures 5.11-5.14. p-values indicate whether there was a statistically significant difference in transcript
expression between the knockdown and the wildtype in either a) growth medium, or b) chondrogenic
medium. N =2-3 independent experiments in technical triplicates.
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Figure S7. The statistical significance of the effect of the knockdown of ITGB8 on phenotype marker
expression from Figures 5.11-5.14. p-values indicate whether there was a statistically significant difference
in transcript expression between the knockdown and the wildtype in either a) growth medium, or b)
chondrogenic medium. N =2-3 independent experiments in technical triplicates.
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